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1Zusammenfassung: Die Mikrostrahltherapie (MRT) ist ein neuer Ansatz in der Krebsthera-
pie. Hoch brillante Synchrotronstrahlung wird zu parallelen, wenige Mikrometer breiten, ebenen
Strahlenbündeln kollimiert und mit hohen Dosisraten auf das Tumorgewebe gerichtet. Dabei
sind die applizierten Peakdosen wesentlich höher als in der konventionellen Strahlentherapie. Die
Niedrigdosisbereiche zwischen den Strahlen bleiben jedoch unterhalb der gewohnten Gewebeto-
leranz. Die bisherige Forschung hat gezeigt, dass derartige Strahlgeometrien das gesunde Gewebe
schonen, während Tumore erfolgreich zurückgedrängt werden.
In der vorliegenden Arbeit werden physikalische und biologische Aspekte der Therapie un-
tersucht. Es wird ein Therapieplanungssystem für die ersten klinischen Behandlungen an der
Europäischen Synchrotronstrahlenquelle in Grenoble (Frankreich) entwickelt und ein Dosimetrie-
verfahren auf der Basis radiochromer Filme erarbeitet, um geplante Dosen im Mikrometerbereich
experimentell zu validieren. Schließlich werden Experimente auf zellulärer Ebene durchgeführt,
um physikalisch geplante Dosen und biologische Schäden zu korrelieren.
Die Unterschiede zwischen Monte-Carlo-Dosis und Messung sind geringer als 10% im Niedrig-
und 5% im Peakdosisbereich. Alternativ entwickelte schnellere Dosisberechnungsverfahren wei-
chen von den rechenintensiven Monte-Carlo-Simulationen um weniger als 15% ab und bestimmen
die Dosis innerhalb weniger Minuten. In den zellbiologischen Experimenten zeigt sich, dass in-
terzelluläre Signale maßgeblich über das Zellüberleben an Strahlengrenzen entscheiden. Diese
Beobachtung ist nicht nur für MRT sondern auch für die konventionelle Strahlentherapie von
Bedeutung.
Abstract: Microbeam Radiation Therapy (MRT) is a novel treatment strategy against
cancer. Highly brilliant synchrotron radiation is collimated to parallel, a few micrometre wide,
planar beams and used to irradiate malignant tissues with high doses. The applied peak doses
are considerably higher than in conventional radiotherapy, but valley doses between the beams
remain underneath the established tissue tolerance. Previous research has shown that these beam
geometries spare normal tissue, while being effective in tumour ablation.
In this work physical and biological aspects of the therapy were investigated. A therapy
planning system was developed for the first clinical treatments at the European Synchrotron
Radiation Facility in Grenoble (France) and a dosimetry method based on radiochromic films was
created to validate planned doses with measurements on a micrometre scale. Finally, experiments
were carried out on a cellular level in order to correlate the physically planned doses with the
biological damage caused in the tissue.
The differences between Monte Carlo dose and dosimetry are less than 10% in the valley
and 5% in the peak regions. Developed alternative faster dose calculation methods deviate from
the computational intensive MC simulations by less than 15% and are able to determine the
dose within a few minutes. The experiments in cell biology revealed an significant influence of
intercellular signalling on the survival of cells close to radiation boundaries. These observations
may not only be important for MRT but also for conventional radiotherapy.
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Preface
Usually a PhD thesis does not stand alone, but colleagues, students and collaborators make
contributions, carry out preparatory work, develop ideas further or help with the experiments
with their expertise and equipment. So it is with this work and I see it as an indispensable
matter of course to acknowledge this at the beginning. Without the people that were involved
in the work that I present in the following this thesis would be unimaginable.
My work started in October 2011 and was carried out for the most part at the German Cancer
Research Centre (DKFZ) in Heidelberg in the group “physical models in radiation oncology”
lead by Prof. Dr Uwe Oelfke who greatly supported me in my work with advice, ideas but
also financially. Despite his tight timetable he was always open to suggestions and discussions.
With his call to the Institute of Cancer Research (ICR) in London I moved to London myself in
October 2013.
Microbeam Radiation Therapy (MRT) uses synchrotron radiation and so we have a close
collaboration with the biomedical beamline ID17 at the European Synchrotron Radiation Facility
(ESRF) in Grenoble. Experiments that required the synchrotron beam were conducted there.
This applies especially to the dosimetry presented in chapter 4 and some of the cell culture
experiments in chapter 5. I thank Dr Alberto Bravin, who is responsible for the beamline ID17
and also the biomedical group around Dr Geraldine Le Duc. Especially I want to emphasise the
outstanding support by Dr Elke Bräuer-Krisch, who knows the MRT experiment at the ESRF
better than anybody else. With her talent to organise, her expertise and her persistence she
incredibly helped me with my work. Moreover it was a great pleasure to work with her.
For all biological experiments I am grateful to Dr Nathan Brady who leads a junior research
group on “system biology of cell death mechanisms” at the German Cancer Research Centre in
Heidelberg. He granted me access to his laboratory and allowed me to use all the consumables and
equipment there. He and his former PhD student Silu Chen-Lindner helped me with protocols
and methods in molecular biology and gave me essential advise for cell culture experiments.
So far this work led to two publications in Medical Physics with first authorship:
• Stefan Bartzsch and Uwe Oelfke. A new concept of pencil beam dose calculation for 40-200
keV photons using analytic dose kernels. Med. Phys., 40(11), October 2013
• Stefan Bartzsch, Michael Lerch, Marco Petasecca, Elke Bräuer-Krisch, and Uwe Oelfke.
Influence of polarization and a source model for dose calculation in MRT. Med. Phys.,
41(4), April 2014
Chapter 2 contains some texts and figures from the second article with kind permission of the
American Association of Physicists in Medicine (AAPM). My thanks are given to Dr Michael
Lerch and Dr Marco Petasecca, who measured the anisotropic beam absorption due to the po-
larisation of synchrotron radiation and facilitated a benchmarking of calculations with measured
data.
Work from this thesis also contributed to articles of other authors for example in Jean A.
Laissue et al., “Response of the rat spinal cord to X-ray microbeams”, Radiotherapy and Oncology
3
4(2013), Elisabeth Schültke et al., “Pencilbeam Irradiation Technique for Whole Brain Radiother-
apy: Technical and Biological Challenges in a Small Animal Model”, PLoS ONE (2013) and
Raphaël Serduc et al., “Synchrotron X Ray Induced Axonal Transections in the Brain of Rats
Assessed by High-Field Diffusion Tensor Imaging Tractography”, PLoS ONE (2014).
During my thesis I supervised several students who did their master thesis, bachelor thesis
or just a short project (“HiWi”) in the field of MRT. Charlotte Debus implemented the point
kernel algorithms presented in chapter 3 in C++ and linked them to a professional treatment
planning system and Jennifer Kieselmann worked on a kernel based dose calculation algorithm
in curved space which will also be discussed in chapter 3. Andreas Merrem investigated in
his project the affect of microbeams on a synthetic vascular network (see chapter 5). Vincent
Lami developed an analytic representation of polarised photon scatter kernels. Katrin Welsch and
Johanna Lott both worked on radiochromic film dosimetry and were involved in the development
of a densitometric film readout with an optical microscope. Their work contributed to chapter
4. Marc Bisch worked on a wavelet-transform algorithm for automated foci detection which is
important for the cell analysis in chapter 5. Moritz Beutel implemented a sophisticated interface
for an automated processing of fluorescence microscope images.
A very exceptional contribution to this work was given by Stephan Eismann. He constructed
in his Bachelor’s project an automated cell culturing device that performs molecular biological
staining protocols and reduces the influence of the experimentalist on experimental outcomes.
But far beyond his own project he accompanied and supported me for the radiobiological ex-
periments at the ESRF (chapter 5) and for a research stay at the STTARR facility in Toronto
(Canada). I thank him for all his work, professional advice, help, text revisions and company.
Outstanding and invaluable was his friendship and council in a moving time.
Stefan Bartzsch
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Chapter 1
Introduction
1.1 Cancer therapy and Microbeam Radiation Therapy (MRT)
The bodies of humans and animals are in a way a society or ecosystem of thousands of cells. The
human body contains in the order of 1014 cells that work together. Each cell has its place and
function. One very important property of these cells is "altruism". Cells subordinate themselves
to the well-being of the organism and even kill themselves if the organism signals them to do so. A
complex regulatory system exists in tissues and organs to control cell proliferation (cell division),
cell silencing and cell death. Cancer is associated with the escape of one or very few cells from
this regulatory system. It has its origin in a microevolution in the body. Certain mutations in
the genome can withdraw a cell from the regulatory system and give it a proliferative advantage
compared to others. In a way one could say the altruism is exchanged against egoism and the
mutated cell and its descendants start to drive out healthy cells. This pathogenic evolution is the
initiator of cancer, one of the most frequent deadly diseases in the western society. In Germany
the number of new cancer cases in 2010 was 477,3001. The incidence rates of cancer depend on
many factors and vary between different regions in the world. Age, gender and lifestyle have a
mayor influence on the occurrence of cancer, but genetic disposition is also an important factor.
Certain exogenous causes and carcinogenic compounds have been identified. Some but not all of
them induce mutations in the genome.
Not all cancer cells of a tumour have the ability to proliferate infinitely. Similar to normal
tissue only a small percentage of cells can renew themselves, differentiate and create fast, but
limited dividing daughter cells. These cells are called (tumour) stem cells2,3. For a successful
cancer treatment it is commonly accepted that the stem cells of the tumour need to be eradicated.
In this sense cancer treatment means (up to now) a removal of cancer cells and especially of cancer
stem cells. Hence all cancer treatments have the problem of specificity. While directed to kill
tumour cells a therapy needs to spare normal tissue.
Radiotherapy is the second most successful treatment strategy against cancer after surgery
and is followed by chemotherapy2. It kills cancer cells with ionising radiation, usually x-rays
and gains specificity from the fact that cancer cells are usually more sensitive to radiation than
normal tissue cells. This opens a therapeutic window between survival of normal tissue and
tumour control. Different approaches have been used to widen this therapeutic window further.
For example a combination of radiotherapy and treatment with radiosensitizers is applied or one
tries to increase the oxygen level in tumour cells which in turn increases the radiosensitivity of
often hypoxic tumours.
The radiation dose in terms of energy per mass is used as a physical measure for normal tissue
and tumour survival. Hence a very common approach in radiotherapy is dose conformality. A
high dose level is delivered to the entire malignant tissue with the aim to destroy all tumour
stem cells, while the dose to the healthy tissue is kept as low as possible to avoid normal tissue
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complications. By irradiating from different directions it is possible to increase the dose given
to the tumour and to reduce at the same time the dose to the surrounding normal tissue.
This technique is very successfully applied in stereotactic radiation therapy (SRS or SBRT)
and intensity modulated radiation therapy (IMRT) . Dose conformality to the tumour can be
further increased by using protons or heavy ions. These particles show a strongly decreasing
interaction probability with increasing kinetic energy. Therefore the particle beams lose most of
their energy close to the end of their range in matter and create there a peaked dose distribution
with a sharp decrease in depth, the so called Bragg peak. The position of this Bragg peak can
be adjusted by changing the particle energy. Thus the dose to the normal tissue along the beam
path can be significantly reduced. Already a few years after the discovery of x-rays by Wilhelm
Röntgen in 1894 these new beams were used for medical purposes and in particular for cancer
treatment. In 1909 Alban Köhler was treating tumours with radiation from an x-ray tube. He
was facing the problem that the dose required to control deeper seated tumours was exceeding
the tolerance of the skin. The necessary dose to control the tumour led to necrotic skin burns.
Therefore he used an iron grid with 1 mm thick wires and 2 to 2.5 mm squared stitches to protect
the skin. The grid was pressed directly against the skin. He described his discovery in the words
"The metal grid on the skin enables us to apply an unconventionally high dose without risking
an incurable x-ray ulcer."4. With this technique he was able to detain or cure large and deep
seated tumours. He realised that with the grid some healthy cells and vessels were left around
the wound that enabled rapid healing. The method had the primary aim to protect the skin. The
very divergent beams of an x-ray tube and the large size of the focal spot lead to a soon blurring
and loss of protection with depth. The technique known as grid therapy was used afterwards as
a palliative treatment for large tumours5.
Many years later the idea was picked up again in radiotherapy after the observation that very
narrow beams of high doses are extraordinarily tolerated by normal tissue. These observations
were made in the 1960s while studying the effects of cosmic radiations on the organism. Circular
deuteron microbeams of 25 µm diameter with a dose of 4,000 Gy were delivered to the brain of
mice6,7. Nevertheless the tissue was still intact and only in the microbeam paths there was a
reduction of neurons observable. In contrast a 1 mm diameter beam of 140 Gy lead to complete
destruction and necrosis of the tissue8. More than 20 years later with the development of large
synchrotron radiation sources the potentially clinical use of this effect was pursued. This was
the beginning of Microbeam Radiation Therapy (MRT).
Microbeam Radiation Therapy (MRT) is a treatment strategy in radiation oncology that
employs arrays of micrometre sized beams with 25 to 100 µm width and with several hundred
micrometre spacing from beam centre to beam centre. It is based on the dose-volume relation
which was formulated in 1988 by Rodney Withers et al. 9 : "Threshold absorbed doses for damage
to normal tissue increase as irradiated macroscopic tissue volumes are made smaller." In order
to treat patients with these beams great demands are placed on the radiation source that are
currently only met by 3rd generation synchrotrons.
1.1.1 The European Synchrotron Radiation Facility
The work in this thesis was carried out in cooperation with the European Synchrotron Radiation
Facility (ESRF) in Grenoble (France). It has a 844 m circumference storage ring for electrons with
an energy of 6 GeV. More than 30 beamlines use the synchrotron radiation produced in wigglers
and undulators in the periphery of the ring. It is the most powerful synchrotron radiation source
in Europe and a joint facility used by 19 contributing countries. The biomedical beamline ID17
deals with projects in imaging such as diffraction enhanced imaging (DEI) and radiotherapy.
The ESRF produces extremely brilliant radiation, i.e. radiation with a high photon flow
per area and solid angle in a narrow wavelength band. Dose rates of up to 16,000 Gy/s can be
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reached with a very small divergence of 1 mrad horizontally and 0.1 mrad vertically10. The high
dose rate presents a particular challenge in the beam application. The switching of the beam
has to be very fast and accurately timed. The dose rate is necessary, though, in order to avoid
dose blurring caused by respiratory or cardiovascular motions which could easily destroy the fine
dose profiles.
For MRT a wiggler produces synchrotron radiation 41.7 m upstream from the multislit col-
limator (MSC)11. This collimator is the central part for the creation of microbeams and shapes
in its current design for the first clinical trials 50 µm wide vertical beams with 400 µm centre to
centre spacing (ctc). Between wiggler and MSC a number of filters modify the spectrum of the
beam: 0.5 mm beryllium, 1.5 mm carbon, 1.5 mm aluminium, 1.0 mm copper12,13. The photon
spectrum for MRT at the ESRF has its maximum intensity at 83 keV and a mean energy of 100
keV14,15.
So far only preclinical studies were performed with MRT. However, MRT is now moving
forward to clinical trials. To that end different elements have been added to the beam line and a
safety system "PASS" (PAtient Safety System) was set up. The system collects information on
the state of the filters and the beam. Apart from the existing filters a Kr-gas filled absorber was
introduced as a pre-absorber that protects the main absorbers from heat. At 160 mbar pressure
in the Kr gas pipe, in case of a leak, the pressure would increase and the pipe would be filled
additionally with air. The pressure is monitored by the PASS and the beam will trip if there is
a pressure change16.
The sample (phantom, animal or patient) is located on a goniometer. Unlike in normal
radiation therapy the source cannot move around the target but the target has to be rotated and
moved. Several motors adjust the target position and irradiation angle. The maximum field size
is 41 mm in width and 2.5 mm in height. In order to increase the vertical field size the sample is
scanned vertically through the beam. Thereby the absorbed dose is determined by the vertical
collimator slit size h (52 µm or 520 µm), the dose rate and the scanning speed v which can be
varied from approximately 10 to 100 mm/s. The dose rate itself scales linearly with the current
in the storage ring and hence the absorbed dose for a broad field can be calculated via
D =
D˙ · h · I
v
(1.1)
where D˙ is the dose rate per current and I the current in the storage ring. D˙ is in the order
of 70 Gy/mA/s and is measured before the exposure with ionisation chambers (see for example
Prezado et al. 17).
A Taper FReLoN CCD camera for imaging was added to the beam line. The camera is
located opposite to the MSC.
The efficiency of tumour ablation can be increased by microbeam exposures from different
directions ("multiple ports")10,12,18. With an interlaced geometry the dose in the target regions
can be increased while there is still a high protection of the surrounding healthy tissue. Only
the accurate alignment of the beams is problematic. The brain can move up to 2 mm/s due to
perfusion. Serduc et al. 10 did, however, not find alignment problems after irradiating rat brains
from four different ports with 200 µm spaced 50 µm wide microbeams. They showed that a
precise, interlaced radiosurgical exposure of certain areas of the brain can reduce spontaneous
seizures of epilepsy in genetic absence epilepsy rats. Nevertheless they suggest to trigger the
exposure in multiport irradiations with the heart beat to limit the risk.
1.1.2 Biological evidence
The remarkable resistance of normal tissue to microbeams was shown for the first time for neutron
microbeams in the 1960s7,19–21. In the 1990s this resistance was confirmed by a great number
10 Chapter 1 Introduction
of experiments with synchrotron radiation12,22–24. Slatkin et al. 25 studied the brain damage
after microbeam irradiations of rats with skin entrance doses between 312 and 10,000 Gy at
the National Synchrotron Light Source (NSLS) in Brookhaven (USA). They observed a loss of
neuronal and astrocytic nuclei for doses of 1,250 Gy and above. However, except for some of the
rats exposed to 10,000 Gy peak entrance dose they did not find tissue necrosis or other kinds of
brain damage. Also the behaviour of the rats seemed to be normal up to 1 month after exposure.
When compared to seamless irradiations, doses of above 100 Gy led to death within days.
The response of larger animals to ionising radiation was examined by Laissue et al. 22 . They
irradiated the cerebellum of weanling piglets with 25 µm wide and 210 µm spaced microbeams of
150, 300, 425 and 600 Gy peak entrance dose. After exposure there was no difference observed in
the magnetic resonance (MR) images or in the weight when compared to unirradiated littermates.
Subsequent to the treatment the animals were kept on a farm in Switzerland. Farmers and
veterinary scientists were not able to distinguish the animals by their behaviour. 15 months
after treatment no traces of haemorrhage were found and the ratio of cerebellum to total brain
weight was identical in treated and untreated animals. The only difference was the occurrence
of stripes marking the microbeam paths. The group confronts their results to those of van den
Aardweg et al. 26 who found that 27 Gy seamless irradiation of 60Co g-rays leads in 50% of the
cases to leg paralysis 7 to 16 weeks after exposure.
MRT has also shown to be effective against brain tumours. Bräuer-Krisch et al. 27 reported a
therapeutic index for the treatment of 9L gliosarcoma (9LGS) with MRT of around 5. This index
is defined as the minimum dose required for tumour control to the maximum dose tolerated by
normal tissue. This is much better than for seamless irradiations.
Laissue et al. 28 and Bouchet et al. 12 treated a few weeks old Fischer rats bearing a 9LGS
tumour in the stratum and nucleus with microbeams and found a reduced tumour growth and
even tumour regression. In the experiments by Laissue et al. 28 22 of 36 rats had no brain tumour
after treatment with 625 Gy (unidrectional and bidirectional) peak entrance dose microbeams
with 25 µm width and 100 µm spacing. However, the adjacent tissue was considerably damaged.
Bouchet et al. 12 used 400 Gy for 50 µm wide and 200 µm spaced microbeams. The mean
survival time increased from 20 days in control rats to 65 days in the irradiated rats. 15 days
after exposure 2 out of 9 rats were without tumour and mice with tumour showed a reduced
tumour cell density and proliferation rate in the irradiated regions.
Miura et al. 18 compared microbeams with 35 µm beam width and 200 µm spacing at 422,
625 and 884 Gy and microbeams with 70 µm beam width and 200 µm spacing at 442 Gy in a
rather large field of 16×15 mm2 size. They found that the most effective tumour palliation was
given by 35 µm wide beams at 884 Gy peak entrance dose. Although the 70 µm wide beams
showed the second best tumour control, they exhibited at the same time the most substantial
damage. This damage is presumably caused by the high valley dose. The ratio of peak to valley
dose (PVDR) is to a large extend determined by the field size and the ratio of beam spacing to
beam width. Large fields and small ratios of beam spacing to beam width lead to a lower PVDR.
A similar observation was made by Regnard et al. 29 in Fisher rats that had an implanted
9LGS tumour. They irradiated either 100 µm or 200 µm spaced 25 µm wide microbeams with a
peak entrance dose of 625 Gy. Although there was a longer mean survival time and a larger frac-
tion of long term survivors for the 100 µm spaced beams the side effects were considerable. Rats
irradiated with 100 µm beam spacing did not gain weight after treatment and micro calcifications
in the beam path revealed substantial brain damage.
Schültke et al. 30 analysed the memory of C6 glioma bearing Wistar rats and F98 bearing
Fisher rats after treatment with 200 µm spaced and 25 µm wide microbeams at 350 Gy peak
entrance dose. For some of the rats they added the radiosensitizer buthionine-SR-sulfoximine
(BSO). They found a significant loss of memory 1 month after treatment. However, there was a
marked improvement 1 year post irradiation. For MRT alone the memory dysfunction was much
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less than for combined therapy of MRT and BSO.
MRT has a variety of treatment parameters. Their influence on treatment outcome has
physical and biological origins. From the physical point of view it seems to be favourable to keep
the valley doses as low and the peak doses as high as possible, i.e. a high PVDR. Furthermore
the beam penumbras should be small and the mean free path of the beam needs to be high if
deep seeded tumours should be treated. Obviously increasing the beam spacing and decreasing
the beam width will lead to higher PVDRs. The spectrum has an important influence on both,
beam penumbra and photon mean free path. Low energy photons produce in general low energy
secondary electrons with a short range (details will be discussed later). Furthermore photon
scattering is reduced at low energies which leads to a lower valley dose. However, low energy
photons have a high absorption coefficient and therefore a low mean free path. High energy
photons produce longer ranged electrons. These will travel out of the beam and blur the dose
profiles. Hence a compromise between low and high photon energies is needed14.
Under the assumption that the valley dose is crucial for normal tissue survival Serduc et al. 31
investigated the effect of 25, 50 and 75 µm wide and 200 µm spaced beams when used for
treatment of 9LGS tumours in rats for a constant valley dose of 18 Gy. Although the longest
survival was found when treating with 25 µm wide beams the mean survival time was not
different to untreated controls. 50 µm beam width seemed to provide the best therapeutic index
as a compromise between small beams with very high doses in the target and larger beams with
brain damage and oedema formation. For larger animals they proposed to increase the beam
width rather than the dose. Their findings promoted the arrangement of 50 µm wide beams of
400 µm inter beam spacing for the first veterinary trials at the ESRF. This arrangement was
further encourage by the fact that wider beams have the advantage that the MSC with regular
slits is easier to fabricate and also the dose calculation and measurement is less difficult, in
contrast to the 25 µm wide beams with 200 µm spacing used before in experiments at the NSLS
in Brookhaven.
1.1.3 Biological Mechanisms of MRT
So far the biological mechanisms behind the tissue sparing observed after high dose MRT treat-
ment have not been elucidated. Different mechanisms were proposed to have an influence. Most
authors agree with the theory that repair is mediated by the large interfaces between irradi-
ated and non-irradiated tissues27. Manifold experimental evidence suggests an important role of
blood vessels12,25,28,32.
The lack of haemorrhage after high dose microbeam exposure is one of the astonishing ob-
servations made already at the very beginning of MRT research. Defects caused by hectograys
of dose must be repaired very quickly33. One of the main complications after brain irradiations
is acute cerebral oedema. After microbeam exposure with 312 and 1,000 Gy only a transient
oedema was observed that disappeared within the first week after exposure24. Bouchet et al. 12
did not observe residual damage after MRT in blood vessels and hypothesised a very rapid repair
of blood vessels after MRT treatment. They found especially a high level of vascular endothelial
growth factor (VEGF) expression in treated normal brain tissue. This is a signalling protein that
stimulates vascularisation. A faster repair of blood vessels as compared to broad beam exposure
was confirmed by observations of Sabatasso et al. 32 . The vascular volume and the capillary
density does not change after exposure with microbeam fields whereas fractionated stereotactic
radiotherapy of brain tumours causes significant blood volume changes in the adjacent tissue23,34.
While larger vessels are unaffected by high doses of narrow beams, the destroyed microvas-
culature is quickly repaired. An exposure of the chicken embryo chorio amniotic membrane
(CAM) with a single 25 µm wide beam of 2,500 Gy did not cause lesions in large vessels while
the microvascular plexus was damaged33. The irradiation with arrays of microbeams with doses
12 Chapter 1 Introduction
between 300 and 1,200 Gy revealed an uninterrupted blood flow and showed vascular bridges
across areas situated in the beam path33. A high tolerance of small arteries to very high dose
microbeams was also reported by van der Sanden et al. 35 .
A high resistance to small injuries of vessels is supported by the work of Reidy and Schwartz 36 .
They report a rapid reendothelialisation after small areas of a mouse aorta had been injured.
Furthermore they realised a directional dependence. If the wound was circumferential a recovery
was seen after 8 hours whereas injury oriented parallel to the vessel axis was only repaired after
48 hours. Lost endothelial cells seem to be quickly replaced either by repopulation from the low
dose zones or by neighbouring cells that increase their surface33.
Possibly the little radiation damage in MRT is related to geometrical sparing as well. Is-
chemia, i.e. a deficit in blood supply, can be one complication after radiotherapy. Therefore it
was suggested that sparing of sufficient capillaries located outside the microbeam paths keeps up
the supply of normal tissue with oxygen and thereby enables fast repair8,32. In our group the
master project of Andreas Merrem37 was dedicated to the simulation of radiation damage to a
vessel system after an exposure with microbeams. He could show that spatial fractionation of
dose in microplanar beams can increase the survival fraction of vessels by a factor of three.
The differential effect of microbeams to normal tissue and tumours could be caused by differ-
ences in the microvasculature. Risser et al. 38 compared normal and tumour vascular networks
in primate and rat brains. They found that vessels in normal tissue have fractal properties for
vessel diameters from 1.4 up to approximately 50 µm. For larger vessel diameters the network is
homogeneous. In contrast tumour vasculature remains fractal to much higher scales and exhibits
also a higher fractal dimension. The latter observation is probably related to a higher blood
supply to fast proliferating tumour cells.
Tissue maturation plays a central role for the sensitivity to radiation damage. Sabatasso
et al. 32 irradiated chick chorioallantoic membrane (CAM) at days 8 and 12 of the embryo devel-
opment. While the vasculature of the CAM is still immature consisting of naked capillaries at
day 8 it has significantly matured at day 12 possessing a hierarchical organisation and in partic-
ular protecting, multifunctional pericytes. They compared exposures with MRT fields with 200
or 300 Gy peak entrance dose and seamless exposures between 5 and 40 Gy. 12 day old CAM
showed after treatment with 200 and 300 Gy microbeams significantly less damage than CAM
at day 8. They observed in the more mature 12 day old CAM that the fraction of unperfused
microvasculature is much lower 6 hours after exposure and that the vascular transpermeability
returns to a normal level a few hours after irradiation. Much higher damage was inflicted in
homogeneous irradiations. At 20 Gy only few supplying arterioles were spared and at 40 Gy the
vasculature was completely destroyed. Sabatasso et al. 32 propose therefore that pericyte cover-
age increases the resistance to ionising radiation. In fact pericytes have various functions such
as stabilisation, blood flow regulation and angiogenesis. The vascular systems of tumours show
a higher tortuosity, increased vessel diameters and permeability and resemble in many aspects
an immature vasculature12,39,40.
Another explanation of the MRT principles is cell communication. Various surprising findings
have recently challenged traditional views on radiobiology. Not only cells that are directly hit
by radiation show stress related responses but also unexposed adjacent cells. These effects are
called bystander responses (one of many good reviews can be found in Prise et al. 41). Not
only neighbouring cells, but even cells of other organisms can be affected by bystander signals.
Mothersill et al. 42 observed bystander effects in unexposed fish swimming with exposed fish or
in the water that was previously occupied by irradiated fish. It is difficult to judge whether these
bystander effects are detrimental or advantageous.
As demonstrated by Smith et al. 43 there are differences in the proteom after MRT and
homogeneous radiation exposures. After analysing the proteom in 2D gel electrophoresis they
came to the conclusion that microbeams activated bystander effect proteom responses may be
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anti-tumorigenic, while most of the changes by homogeneous irradiations were associated with
tumourigenesis. In this work we investigated the influence of bystander effects in MRT and our
results document a strong influence of cell-cell communication. This will be presented in chapter
5 where we will discuss these fascinating effects in more detail on a molecular biological basis.
1.2 Challenges and focus of this work
An understanding of the biological effects and parameters in MRT is just one prerequisite before
moving towards a clinical application. MRT also demands for a high accuracy in the beam
exposure when high doses are delivered in fractions of a second. In cross firing irradiations an
exact aiming to the target is indispensable and any motion of the patient has to be reduced to
a minimum between the exposures from two ports. Furthermore the dose distribution in the
patient needs to be estimated in advance. Here dosimetry and dose calculation strategies are
required that meet the demands set by some of the extraordinary parameters in MRT. In contrast
to conventional radiotherapy MRT stands out due to the following properties:
• A spectrum in the keV photon energy range with a mean energy of approximately 100 keV
and a maximal intensity at 83 keV
• A beam that is linearly polarised in the plane of the storage ring
• Extremely high dose rates of up to 16,000 Gy/s
• A high dynamic range of treatment relevant doses, from around 5 Gy in the valley to 1000
Gy in the peak region
• High dose gradients
• A bulky radiation source which cannot be placed in a normal hospital environment and
which delivers the beam always in the same direction.
This work focuses on two main topics. The topic in the first part is treatment planning in
MRT which will be covered in the chapters 2, 3 and 4. Chapter 5 deals with the effect of spatially
fractionated doses on living cells.
Prior to a clinical treatment with MRT the physician sets certain objectives for an exposure.
Typical objectives may be the peak dose in the tumour region or upper limits for the valley
dose in organs at risk (OARs). In order two achieve these goals the irradiation direction, the
field size and the peak entrance dose can be manipulated. Although not yet possible one could
also imagine to adjust beam widths, ctc, the energy spectrum (by changing the filter set) or to
add more irradiation ports in order to influence the dose distribution in the patient. A variety
of equipment and tools have been developed to control the parameters of the exposure and to
simulate the treatment objectives.
We have developed a treatment planning system for MRT that is incorporated into the user
interface VIRTUOS. VIRTUOS is a platform for 3D radiotherapy planning that was developed
at the German Cancer Research Centre (DKFZ) in Heidelberg44. The therapist can use it to
import patient data (CT, MR, PET and ultrasound images) and contour target volumes and
organs at risk (OARs) on the three dimensional patient model. Treatment plans can be created
in a plan mode and several of the just mentioned treatment parameters can be specified. Among
these parameters are the irradiation direction, characterised by couch, gantry and collimator
angle, the width of the microbeams and the ctc.
The central part of the treatment planning is the dose calculation which will be discussed
in chapter 3. We developed two independent algorithms that calculate peak and valley doses
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Figure 1.1 – A concept of therapy planning in MRT.
on the CT-voxel based grid. One algorithm is based on Monte Carlo simulations and will be
presented in chapter 3.2. The other algorithm is based on analytically derived kernels and the
superposition of these kernels weighted by the total energy released per mass (TERMA). Two
realisations of this algorithm will be discussed in chapter 3.3.
Both, the kernel based dose calculation and the Monte Carlo simulations require information
about the radiation source and the materials in the patient. The transformation of the informa-
tion in the CT provided in the form of Hounsfield units (HU) to material parameters such as
density and elemental mass fractions is based on the work of Schneider et al. 45 . A brief analysis
of the uncertainties introduced by these transformations will be discussed in chapter 3.4.
The radiation source is characterised by the physics of synchrotron radiation and various beam
modifying elements such as filters and collimators. We dedicate the description of the source a
separate chapter, chapter 2. The linear polarisation of the photon beam, a particular property
of synchrotron radiation, and its effects on the dose absorption is analysed there. Furthermore a
model is developed that accurately describes the radiation source and serves as an input for all
dose calculation methods.
The result of the dose calculation is a distribution of relative dose values. These have to be
calibrated and translated into machine parameters, such as collimator height and goniometer
speed (see above). The dose of a broad beam radiation field at a certain depth in homogeneous
water is determined by the goniometer speed, the vertical collimator slit height h, the current in
the storage ring and equation 1.1. The dose in a microbeam is, however, smaller, because of a
lacking electronic equilibrium at the beam centre. The beam entrance dose of a microbeam can
be derived by scaling the homogeneous beam entrance dose with a beam size dependent output
factor OF.
Output factors need to be determined by measurements and Monte Carlo simulations. Fur-
thermore dosimetric validations of the calculated dose distributions are essential before a clinical
application of MRT. Dosimetry in MRT is a very challenging task due to several factors: the
high resolution required, extremely high dose rates, the high dynamic range of relevant doses
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(approximately 5 to 1000 Gy), the required accuracy and the energy dependence of most dosime-
ters at low photon energies. We developed a dosimetry protocol with radiochromic films and
readout with light microscopy. In chapter 4 the dosimetry protocol is presented. It is applied
to the measurement of output factors (chapters 4.2.7 and 4.3.4) and to measurements of various
beam geometries. There results from dosimetry and dose calculations will be compared.
Dose measurements serve as calibration for the relative dose calculations of the treatment
planning. Irradiation angles in the therapy planning system also need to be benchmarked with
the treatment system. To this end markers are added during CT-imaging. They can also be
visualised in low dose projection images from different ports by the FReLoN CCD camera at the
beam line. The subsequent determination of the correct goniometer angles to fulfil the treatment
plan was worked out by Mattia Donzelli [his Master thesis will be submitted in Heidelberg soon].
In figure 1.1 therapy planning in MRT is illustrated in a structure chart.
Chapter 5 leaves the area of treatment planning and presents some fascinating results of
radiobiological experiments in vitro with spatially modulated radiation fields. It pursues the
question whether signal exchange between neighbouring cells influences the response of tissues
to ionising radiation in MRT. We show evidence for gap junction and soluble factor mediated
signals and demonstrate that bystander effects influence the cell cycle. Furthermore some of our
results suggest that the vicinity of high dose regions to low dose regions facilitates damage repair
in the high dose region. The chapter is supposed to establish a link between the physical doses
and the biological effect. However, due to the complexity of this topic we cannot give a final
answer to the relation between dose, dose distribution and biological damage.
The final chapter 6 summarises the main results and presents conclusions.
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Chapter 2
Characterisation of the radiation source
2.1 Introduction
This chapter is dedicated to the description of the radiation source in MRT.i The analysis is
confined to the set-up at the biomedical beamline ID17 of the ESRF. With this in mind this
chapter is not generally applicable to other centres in the world that conduct research in the
field of MRT. Yet, some of the analysed properties such as the beam polarisation or the low
beam divergence are common properties of synchrotron radiation and apply to other sources as
well. The source characterisation was achieved with the aid of Monte Carlo simulations. Dose
calculation was performed with different Monte Carlo codes in the past, for example Geant447,
EGS448,49 and PENELOPE15 and there is the question of comparability. Here the Geant4 tool
set is used. De Felici et al. 50 carried out a code comparison for MRT between different Monte
Carlo codes including Geant4 and did not find significant differences. This gives confidence in
the use of Geant4, although clearly results should be interpreted with the appropriate care and
should not be taken as an ground truth. Some of the limitations of Geant4 will be discussed in
the final section of this chapter.
For a long time microbeams have been assumed to be ideal parallel beams. Nettelbeck et al. 51
studied as one of the first the influence of the collimator and the divergence of the beams. They
found an increase in the penumbral dose of up to 26% when incorporating the divergence of
the beams compared to calculations with ideal parallel microbeams. In the peak and midvalley,
however, differences disappeared. Including inclined incidence on the collimator at the field
edges produced up to 30% differences in the penumbra doses and lead to a variation of the full
width half maximum (FWHM) of the microbeams of up to 4 µm. However, collimator scattering
was found to be of no importance within the 2% uncertainties of the Monte Carlo simulations.
Martínez-Rovira et al. 13 have performed a complete simulation of the beamline from the wiggler
source down to the MSC. But a detailed study of the influence of the gathered phase space
information and the important parameters on the dose distribution in MRT was still missing
and is presented here.
Another particular property of synchrotron radiation is its linear polarisation. The polarisa-
tion effect has been a matter of debate in the past and its influence has not been totally clarified.
Orion et al. 49 used for the first time Compton and Rayleigh scattering cross sections (DCS) for
polarised photons in the EGS452 Monte Carlo code for the dose calculation of microbeams. De
Felici et al. 53 also used an EGS4 version to analyse the polarisation influence on PVDRs. They
calculated 3×3 cm2 microbeam fields with 25 µm wide beams and 200 µm spacing in a 16 cm
long and 16 cm diameter water cylinder and found in 7 to 8 cm depth a dose change of (1± 1)%
iA large part of the work in this chapter was published in Bartzsch et al. 46 and some of the figures and
texts are taken from the article with kind permission from the American Association of Physicists in Medicine.
Especially texts in the sections 2.1 and 2.3 are borrowed with slight changes.
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in the field centre, (3± 3)% at the field edge and (10± 2)% outside the field when rotating the
polarisation direction by 90◦. Hence they concluded that polarisation is of minor importance
for therapy planning. They also investigated the asymmetric dose absorption around a pencil
beam from 0 to 150 µm distance from the beam centre and found between 7% and 18% direction
depending differences. However, they did not analyse asymmetric dose absorption outside this
range. The importance of the photon polarisation for the dose prediction in treatment planning
was emphasised by Hugtenburg et al. 54 , though. They concluded that the distortions emerging
from the photon polarisation are beyond the usual criterion in conventional radiation therapy
and hence that it will be essential to take photon polarisation into account for any future MRT
therapy planning.
In this chapter we study the influence of the source model and the polarisation on the dose
distribution in MRT in a water phantom. Results of Monte Carlo simulations are compared
with dosimetric measurements. We develop a source model of parallel microbeams with cor-
rections motivated by our analysis that shows agreement to dose calculations with complete
source simulations within the measurement uncertainties. This model simplifies Monte Carlo
dose calculations and facilitates the application of alternative dose calculation methods such as
kernel based algorithms. Here we show the applicability of the developed model exemplarily for
a semi-adjoint Monte Carlo simulation, but more applications of the model will be presented in
chapter 3
2.1.1 Polarisation states and Stokes parameters
Electromagnetic waves in free space are transversal waves. The wave-vector ~k, electric field
vector ~E and magnetic field vector ~B are pairwise perpendicular to each other. This follows
directly from the Maxwell equations. The polarisation of an electromagnetic wave is defined by
the electric field of the wave. Polarisation can be described best in a photon bound reference
frame. Geant455 and PENELOPE56 distinguish between the laboratory frame and the particle
frame. In the particle frame the z-axis points towards the propagation direction and the x-axis
of the particle frame is in the x-y-plane of the laboratory frame. The y-axis of the particle frame
is the remaining axis to obtain a right-handed system ~ex, ~ey, ~ez.
The electric field of a monochromatic, plane, electromagnetic wave can be described in the
beam system by
~E = E<
[(
x
y
)
e−i(ωt−kz)
]
with |x|2 + |y|2 = 1 (2.1)
Here x and y are complex amplitudes, ω is the the frequency, k the wave number, t the time
and E the electric field intensity. The function < returns the real part of its complex argument.
We define the complex polarisation vector ~q as
~q = x~ex + y~ey. (2.2)
Its general representation except for an irrelevant phase can be written as
~q =
(
cos(α)
sin(α)eiδ
)
(2.3)
with the angles a and d. The amplitudes in x and y are Eˆx = E cos(α) and Eˆy = E sin(α). In
the x-y-plane at any z = z0 of the particle frame the electric field vector moves on an ellipse. We
define the phase as φ = ωt− kz0 and find for the components of the electric field vector
Ex = Eˆx cos(φ),
Ey = Eˆy cos(φ+ δ).
(2.4)
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Figure 2.1 – The trajectory of the electric field vector describes an ellipse, the polarisation ellipse (left). The
polarisation vector ~q can be illustrated on the Poincaré sphere (right). The radius of the sphere is the polarisation
degree.
Hence the polarisation state of a plane monochromatic wave is completely determined by the
amplitudes Eˆx, Eˆy and the phase difference δ. However, the polarisation is preferably described
by the Stokes vector S = (1, s1, s2, s3)ii with the parameters
s0 =
〈
E2x + E
2
y
〉
s1 =
〈
E2x − E2y
〉
/s0
s2 = 〈2ExEy cos δ〉 /s0
s3 = 〈2ExEy sin δ〉 /s0
(2.5)
The angle brackets indicate an averaging over time. For a totally polarised wave we have s21 +
s22 + s
2
3 = 1. A geometric interpretation of the Stokes vector can be obtained by writing the
parameters depending on the angles q and y shown in figure 2.1 (left). At the vector orientations
(x1, y1) and (x2, y2) the relations
x1 = Eˆx cos(φ) = a cosψ
y1 = Eˆy cos(φ+ δ) = a sinψ
x2 = −Eˆx sin(φ) = −b sinψ
y2 = −Eˆy sin(φ+ δ) = b cosψ
(2.6)
apply. It follows that a2 + b2 = Eˆ2x + Eˆ2y . A transformation of these equations regarding that
tanχ = b/a yields
s1 = s0 · cos(2χ) cos(2ψ)
s2 = s0 · cos(2χ) sin(2ψ)
s3 = s0 · sin(2χ)
(2.7)
This result can be visualised in a Poincaré sphere and is illustrated in figure 2.1 (right). Linearly
polarised light is defined by χ = 0. y defines the orientation of the polarisation. The Stokes
iiSometimes the Stokes vector is defined as S = (s0, s1 ·s0, s2 ·s0, s3 ·s0) where s0 gives the total beam intensity.
We follow here the definition in Geant4 where the polarisation state is defined by the parameters (s1, s2, s3) only.
Care has to be taken when interpreting data from other Monte Carlo codes. Whereas Geant4 uses the optical
order of Stokes parameters, PENELOPE uses a different order of the Stokes parameters (s3, s1, s2) which follows
from the quantum mechanical treatment (see below).
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vector (1, 1, 0, 0) refers to an in x linearly polarised wave, (1,−1, 0, 0) is linearly polarised in y.
If q is increased the polarisation becomes elliptical and reaches finally circular polarisation for
χ = ±pi/4 at the poles of the Poincaré sphere. The sign of q decides upon right or left handed
circular or elliptical polarisation.
In quantum mechanics the polarisation state of a single photon is a linear combination of a
polarisation in x and y.
|E〉 = x |ex〉+ y |ey〉 =
(
x
y
)
(2.8)
defines the quantum state of the photon with complex amplitudes x and y. The probability
to find the photon in one of the two states is 1 and hence |x|2 + |y|2 = 1. As discussed for
the classical description of the monochromatic plane wave the single photon has again one of
the pure polarisation states. For an ensemble of many photons with states |Ei〉 the polarisation
state of the beam can be described by the density matrix
ρ =
∑
i
pi |Ei〉 〈Ei| , (2.9)
where pi is the relative frequency of the state |Ei〉 (with
∑
i
pi = 1). The density matrix may be
represented in any basis,
ρjk =
∑
i
pi 〈ej |Ei〉 〈Ei|ek〉 , (2.10)
e.g. in the bases of (|ex〉, |ey〉). For a pure polarisation the representation in this basis is
ρ =
(
x
∗
x x
∗
y
∗xy y∗y
)
=
(
cos2(α) cos(α) sin(α) e−iδ
cos(α) sin(α) eiδ sin2(α)
)
. (2.11)
Here we used the parametrisation of the polarisation vector in equation 2.3. ρ is hermitian, i.e.
ρ† = ρ and its trace is one. The bases of all hermitian 2×2 matrices are the Pauli matrices σ1,
σ2, σ3 and the diagonal matrix 12. With respect to equation 2.11 one finds
ρ =
1
2
(12 + S3σ1 + S1σ2 + S2σ3). (2.12)
This is the quantum mechanical representation of the Stokes vector. A measurement of the
polarisation of the system is the trace of the product of density matrix with the observable. For
example S1 can be measured by
S1 = tr(ρσ2). (2.13)
The vector (S3, S1, S2) is equivalent to the spin vector of spin-12 -particles. Each photon has a
fixed polarisation and S21 + S22 + S23 = 1. However, usually a beam is a mixture of photons with
different polarisations and hence does not exhibit a pure polarisation. An unpolarised beam has
the Stokes vector S = (1, 0, 0, 0). The polarisation degree is defined as
P =
√
S21 + S
2
2 + S
2
3 . (2.14)
In general a beam will be partially polarised with 0 < P < 1. These beams can be regarded as
an incoherent mixture of an unpolarised and a polarised beam. The density matrix is composed
of two parts,
ρ = (1− P )1
2
12 + P
1
2
(
12 +
S3
P
σ1 +
S1
P
σ2 +
S2
P
σ3
)
. (2.15)
The first matrix is the density matrix of an unpolarised beam and the second is that of a purely
polarised beam.
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Figure 2.2 – Left: Angle relations for the polarised Compton scattering are illustrated. The incoming wave
vector ~k0 points along the z-axis, and the polarisation of the incoming photon ~e0 points along the y-axis. ~k is the
wave vector of the scattered photon, it forms with ~k0 the scattering angle θ. The angle between the ~e0-~k0-plane
and the ~k-~k0-plane is denoted with φ. The parallel component of the scattered polarisation vector ~e|| lies in the
~e0-~k0-plane (y-z-plane) and is perpendicular to ~k. Right: Graphical illustration of the differential scattering cross
section for a photon with 100 keV energy. The axis are defined as on the left. The colours (blue-low, red-high) and
the distance from the origin shall give an illustration of the scattering probability. Scattering into the direction
of the primary photon polarisation is less likely than perpendicular to it.
2.1.2 Compton scattering of polarised photons
Several photon and electron interactions depend on the particle polarisation state or produce po-
larised particles. The two most important photon interactions at the for MRT relevant energies,
photoelectric absorption and Compton scattering, are both influenced by the polarisation state
of the photon. For the photoelectric absorption the angle of the emitted photoelectron depends
on the polarisation of the incoming photon. Most electrons are ejected in the direction of the
primary photon polarisation. However, due to the frequent scattering of electrons this does not
play an important part for the energy absorption.
The Compton interaction of a linearly polarised photon with a free electron is schematically
illustrated in figure 2.2. An incoming photon with the energy E0 and polarisation ~e0 transfers a
part of its energy to an electron and is scattered off with an energy E < E0 and a polarisation
~e. The wave vector of the incoming photon ~k0 and the outgoing photon ~k form the scattering
angle θ. The angle between the plane containing ~k0 and ~e0 and that containing ~k and ~k0 is φ.
Energy and momentum conservation yield the relation
E =
E0
1 + E0
m0c2
(1− cos θ) , (2.16)
where m0 is the electron rest mass and c the velocity of light. The differential scattering cross-
section was first derived by Klein-Nishina57 from quantum electrodynamics. A comprehensive
derivation can be found in Heitler 58 . The scattering cross-section reads
dσ
dΩ
=
1
4
r20
E2
E20
[
E0
E
+
E
E0
− 2 + 4 cos2 Θ
]
. (2.17)
Here r0 is the classical electron radius and Θ is the angle between the polarisation of the incoming
photon and the polarisation of the scattered photon. To further analyse this formula it is useful to
decompose the polarisation vector ~e of the scattered photon into a component ~e⊥ perpendicular
to ~e0 and another component ~e‖ in the plane of ~k and ~e0. From figure 2.2 we use that ~e0 = ~ey,
~k0 = k0~ez and
~k = k
 sin θ sinφsin θ cosφ
cos θ
 . (2.18)
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For the component e⊥ cos Θ is 0 and disappears. ~e‖ can be calculated from
~e‖ =
(~ˆk × ~e0)× ~ˆk
|(~ˆk × ~e0)× ~ˆk|
=
(
~e0|~ˆk|2 − ~ˆk · (~ˆk · ~e0)
)
√
1− sin2 θ cos2 φ
, (2.19)
where ~ˆk = ~k/|~k|. Therefore we obtain for cos Θ
cos Θ = 1− sin2 θ cos2 φ. (2.20)
In the non-relativistic case E0 and E are approximately equal (from equation 2.16 for E0 
m0c
2). Therefore the scattering cross section becomes
dσ⊥
dΩ
= 0 (2.21)
for the perpendicular component and for the parallel component
dσ
dΩ
= r20(1− sin2 θ cos2 φ). (2.22)
In the non relativistic case a linearly polarised primary photon produces a completely linearly
polarised scattered photon. In the ultra relativistic case, i.e. E0  m0c2 one needs to differentiate
between small and large scattering angles. For small angles E ≈ E0 again holds true and therefore
the scattering cross section is identical to that of the non-relativistic case. For large scattering
angles there is E0  E and the scattering cross-section for the two final polarisation components
~e⊥ and ~e‖ are identical,
dσ⊥
dΩ
=
dσ‖
dΩ
=
r20E
4E0
(2.23)
Scattering into a single direction irrespective of the final polarisation state is given by the sum
of dσ⊥/dΩ and dσ‖/dΩ,
dσ
dΩ
=
1
2
r20
E2
E20
[
E0
E
+
E
E0
− 2 sin2 θ cos2 φ
]
. (2.24)
This scattering cross-section is illustrated in figure 2.2 (right) for a primary photon energy of
100 keV. If the primary beam is unpolarised averaging over φ yields
dσ
dΩ
=
1
2
r20
E2
E20
[
E0
E
+
E
E0
− sin2 θ
]
. (2.25)
2.2 Methods
Monte Carlo simulations were performed in the Geant4 toolkit version 9.3.p2 using the Livermore
low-energy polarised physics libraries. These libraries incorporate the polarised Compton scat-
tering and also polarised electron interactions. In the simulation Compton scattering, Rayleigh
scattering and photoelectric absorption were activated for photons. Electron processes were mul-
tiple scattering, ionisation and bremsstrahlung. All dose comparisons were carried out in cuboid
homogeneous water phantoms with dimensions similar to those used for dosimetry experiments
with 30×30×12 cm3 side lengths. Energies of the simulated photons were distributed according
to the previously measured spectrum (see e.g. Slatkin et al. 14 , Siegbahn et al. 15). In order
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Figure 2.3 – Sketch of all beam modifying elements. This image was adapted from Martínez-Rovira et al. 13 .
to accelerate the Monte Carlo simulations and to enhance the statistics adjoint Monte Carlo
techniques were employed apart from forward simulations (see chapter 3.2.3).
The study consists of two parts. In one part of the analysis the effect of the phase space
on the dose absorption in the phantom is considered. In Monte Carlo simulations the radiation
source was defined to deliver either perfectly parallel microbeams, to produce photons following
the source phase space or according to a developed source model. The phase space of the
source at the ID17 of the ESRF was completely characterised by Martínez-Rovira et al. 13 . They
simulated the particle transport from the wiggler to a plane (phase space plane 1) in front of
the vertical slit 38.8 m from the source with the ray tracing program Shadow59 and the Monte
Carlo code PENELOPE56,60. For all photon trajectories that passed the phase space plane 1,
direction, polarisation state and energy of the photons were stored in a phase space file (PSF 1).
The location of the plane in the beamline ID17 (in MRT mode) and all filters, beam modifying
elements and the phantom are illustrated in figure 2.3. Three different primary vertical slit
apertures of 1, 2 and 3 cm width were used by Martínez-Rovira et al. 13 for the generation of
PSF 1 with a beam height of 1 mm. The number of photon trajectories was 5.2 · 107, 6.3 · 107
and 12.5 · 107 at 1, 2 and 3 cm aperture respectively. Technical details on the simulations can
be found in the work of Martínez-Rovira et al. 13 .
The simulations with the complete set of phase space information was performed in two steps.
In a first step photons were created in the phase space plane 1 according to the information in
the PSF 1 and passed through the horizontal slit and the multislit collimator (MSC), i.e. the
photon trajectories were continued. In a plane directly behind the MSC, the phase space plane 2,
the residual particle trajectories were stored again in a second phase space file, PSF 2. The MSC
and the horizontal gap absorb the majority of photons from the PSF 1. Therefore the particle
yield behind the absorber is pretty low and not sufficient for a reliable simulation in the patient
geometry. For that reason these particles were reused and 1010 photons were created from the
PSF 2. The intrinsic uncertainties of PSF 2 are of course still present in the final simulation.
However, the statistics of dose absorption in the phantom could be significantly enhanced.
These simulations with the complete phase space information were compared to simulations
with ideal microbeams. To ideal microbeams we refer as perfectly parallel planar beams with
100% intensity in the beam and no photon fluence in the valley region. The centre to centre
distance and the beam width were set to those at the phantom surface, deduced from the beam
divergence in the PSF and the slit sizes of the MSC, 412.3 and 51.5 µm. For these simulations
it was convenient to use adjoint Monte Carlo techniques.
In another part of this study the polarisation effect was investigated by simulating an in-
finitesimally narrow beam in the water phantom which was 100% linearly polarised. Dose was
scored in a cylindrical detector geometry shown in figure 2.4. While the slice spacing along
the beam and also the angles are equidistant, the radii of the detector segments increase expo-
nentially. The detector geometry allowed both, studying the absorption of electrons created in
primary interactions close to the beam and the scattered photon absorption extending to a larger
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Figure 2.4 – Detector geometry to score an infinitely small microbeam in homogeneous water46.
distance from the beam. Nonetheless the number of particle histories required for statistically
significant results remained reasonable.
The simulation results were benchmarked against experimental data. The data was collected
by Michael Lerch and Elke Bräuer-Krisch at the biomedical beamline ID17 of the ESRF. Mea-
surements were performed under standard MRT conditions for filters and the wiggler gap size.
A homogeneous 2×2 cm2 field was radiated onto a phantom with stacked 30×30 cm2 solid water
slabs of various thickness (figure 2.5) by vertically moving the phantom through the 20 mm
wide and 0.051 or 0.52 mm high beam. The phantom was set approximately 42.9 m from the
wiggler source. A PTW semiflex ionisation chamber (IC) in combination with a PTW UNIDOS
electrometer (model T10002) served as detectors. The electrometer was operated at 400 V.
Dosimetry followed the IAEA dosimetry protocol61 no. 398.
The advantage of using the semiflex IC is its excellent response uniformity with photon
energy for the spectral range in MRT. A major challenge of dosimetry in MRT is the dose rate
dependency. For measurements in the beam the dose rate was reduced by using the narrower
0.052 mm high slit. Therefore the speed of the goniometer can be reduced and thus the effective
dose rate at the IC. Previous studies62 showed that measurements at this slit height require only
a very small correction for ion recombination effects, while for the out-of field dose no correction
is necessary.
The measurements were carried out at 0, 2 and 4 cm distance from the beam axis in two
orientations. One measurement was done in the plane of the storage ring, i.e. the plane of
polarisation and one perpendicular to it. The depths in the phantom were chosen in a range
between 5 and 120 mm. The thickness of the backscattering material was always kept constant.
2.3 Results
2.3.1 Polarisation effects
For a monoenergetic pencil beam of 150 keV figure 2.6A shows profiles perpendicular and parallel
to the polarisation direction. Scattering of a photon perpendicular to its polarisation direction
is more likely than parallel to it. In the profile there are clearly three domains in distance
from the primary beam visible, separated by steep dose fall-offs (compare Spiga et al. 63). The
first domain forms a region of approximately 10 µm radius around the beam. Photoelectric
absorption and Compton scattering produce electrons in the central beam. At low energies the
Compton electrons get just around 20% of the primary photon energy, whereas a photoelectron
gets, neglecting binding energies, the whole photon energy. Hence the range of photoelectrons
is much larger than that of Compton electrons. For a few tens of keV the electron range is in
the order of a few microns, where as the electron CSDA range at 150 keV is around 280 µm64.
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Figure 2.5 – A: Photo of the experimental set-up at the ESRF. B: Schematic diagram showing the orientation of
the ionisation chamber for measuring the (i) vertical and (ii) lateral out-of-field dose components. The radiation
field is indicated by the hashed region46.
Energy absorption in the first 10 µm around the central beam is therefore mediated by Compton
electrons. Momentum conservation implies that electrons scatter off opposite to the scattered
photons and hence they are mainly produced in the plane perpendicular to the polarisation. In
a distance between 10 and 200 µm from the beam the region of photoelectrons can be found.
The photoelectric absorption is independent of the photon polarisation and thus there are no
directional differences observed. Figure 2.6B shows the ratio between the profile perpendicular
and parallel to the polarisation. In the second domain from 10 to 200 µm the ratio is almost 1
whereas inside the 10 µm radius a strong directional dependency can be seen. Electrons become
maximal ionising at the end of their path. Hence at the end of the Compton electron range the
polarisation effect is strongest and the ratio is peaked there.
Beyond 200 µm energy absorption is mediated by scattered Compton photons. Primary
photons are preferentially scattered perpendicular to their polarisation. The difference between
the dose deposited perpendicular and parallel to the primary polarisation direction is around
60%. This difference is almost independent of depth and distance from the beam. Only at very
shallow depths the difference increases slightly with distance.
Looking at this data we expected a strong influence of the polarisation on the dose distribution
in MRT in patients. The simulated pencil beam was used to calculate the dose in an MRT
field of 2×2 or 3×3 cm2 size, 400 µm ctc and 50 µm beam width. Figure 2.7 compares the
calculation results with those without polarisation. The dose differences are up to 45% outside
the microbeam field (figure 2.7A and 2.7B). Within the field, differences between polarised and
non-polarised treatment appear in a narrow region at the microbeam penumbras (figure 2.7D).
These regions have a width of around 20 µm and the differences can be as high as 9%. They
are caused by the polarisation sensitive Compton electrons and doses in the beam penumbras
are lower for polarised photons. Differences in the peak doses are very small, though. The peak
dose differences are smaller than 0.1% throughout the whole field. The valley dose difference
between calculations with and without polarisation is lowest in the centre and increases towards
the field edges. If polarisation is taken into account, valley dose values are a bit lower, but the
deviations remain below 3% for a 3×3 cm2 field except for a 3 mm wide field edge. In the centre
the polarisation has an effect of around 1%. For other field sizes, e.g. a 2×2 cm2 microbeam
field deviations are very similar (results are not shown here).
In the beam set-up at the ESRF in Grenoble the polarisation is perpendicular to the alignment
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Figure 2.6 – (A) shows the lateral dose profile from the beam axis parallel and perpendicular to the polarisation
direction for a photon pencilbeam of 150 keV. In (B) the ratio between the profile perpendicular to the polarisation
direction and parallel to the polarisation direction is plotted. There are three different regions distinguishable46.
of the microbeams. This means that scattering perpendicular to the microbeams in the direction
of the valley regions is less frequent than parallel to the microbeams. Amazingly, this does not
necessarily lead to a constantly lower valley dose. In order to understand this effect we need to
consider the microbeam field as a whole. The total scattering cross section does not depend on
the photon polarisation. Going from non-polarised to polarised photons only the distribution
of scattering angles changes. With linear polarisation in a plane perpendicular to the beam the
scattering is no longer isotropic but has a quadrupole structure. Its minima are placed on a line
perpendicular to the microbeams and its maxima parallel to it. In a point in the centre of a large
field the dose is determined by interactions homogeneously distributed around. Positive and
negative parts of the quadrupoles cancel each other and hence the absorbed dose does not differ
from the dose of isotropically scattering non-polarised photons. Close to the beam edges, there
are fewer interactions in a certain direction. This is true for polarised and non-polarised photons.
However, for polarised photons the orientation of the edge is important. If the off-beam region
is located in the direction of the positive lobe of the quadrupole the decrease will be stronger,
because the lacking dose of back scattering particles is higher. Whereas an off-beam region in
direction of the negative lobe of the quadrupole implies a less pronounced dose decrease towards
the beam edge, because particles from this direction did anyway contribute less to the dose.
In the peak dose region for instance there are only electron producing photon interactions
along the microbeam. Perpendicular to the microbeam there are less interactions. The conse-
quence is a slightly higher peak dose close to the peak edge and a dose reduction in the penumbra
region just outside the beam. For the valley dose photon scattering is important. In the centre
of the field there is an equilibrium of in- and out-scattering photons. Close to the field edge there
are less photons scattering in from a particular direction. Polarisation leads to an anisotropic
lack of photons compared to non-polarised isotropic scattering. However, the average range of
scattered photons is much larger than the field size. Therefore there is no dose increase towards
the field edges visible but only the decrease outside the field moving perpendicular to the mi-
crobeam direction. Hence in the valley dose the effect leads to the relative differences shown in
figure 2.7B(C).
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Figure 2.7 – Differences between dose calculations regarding and ignoring photon polarisation in a 3×3 cm2
microbeam field in a water box. It is positive if the dose of a calculation with polarised photons is higher. Figure
(A) shows the whole field in 5 cm depth. The colour coding states the differences in %. Figure (B) shows
differences at different depths outside the microbeam field and figure (C) compares peak and valley doses inside
the field. In figure (D) differences in the centre of the field for three adjacent microbeams are shown. Except for
the overshoot in the beam penumbra difference are very small46.
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Figure 2.8 – Dose rate per mA of storage current deduced from measured IC response falls off with distance
up to 6 cm from the central axis in the vertical (diamonds) and lateral (crosses) direction for the three different
depths indicated. Measurements are compared to Monte Carlo (MC) simulations in the vertical (solid lines) and
lateral (dashed lines) direction46.
2.3.2 Comparison with measurements
In the case of MRT the primary photon flux emerging from the superconducting wiggler is well
known to be proportional to the current in the synchrotron storage ring. The dose rate was
deduced by multiplying the measured dose by the ratio of the speed of the goniometer (typically
20-100 mm/sec) and the slit size that defines the height of the primary photon beam (0.051 mm
in this case). As such the dose rate is therefore more specifically the average dose rate for a
volume defined within the primary radiation field (2×2 cm2 being the standard field size). The
semiflex IC has a well documented significant dose rate dependence. In order to minimise this
dependence the height of the primary beam was reduced to 0.051 mm (usually 0.520 mm) and
the dose was independently checked within the primary field against a pin point IC (no such dose
rate dependence) previously62. For all measurements made outside the primary radiation field,
where the dose rate is orders of magnitude less than that within the primary field, the measured
dose scaled within 1% in going between the 0.051 and 0.520 mm slits, which gives confidence to
this data. Figure 2.9B shows the deduced dose rate per milliampere of storage ring current.
Figure 2.8 shows how the measured IC response falls off with distance up to 6 cm from the
central axis in the vertical (solid lines) and horizontal (dashed lines) direction for four different
depths (0.5, 2, 4 and 12 cm). Each measurement at the positions and depths indicated were
repeated three times and the measurement uncertainty for the 99% confidence limit is below
5% for all measurement points. The scattered energy deposited outside the 2×2 cm2 radiation
field generally falls off at a double exponential rate, at all depths. The measured dose fall-off
with distance from the central axis out to 6 cm, appears to decrease with depth in the solid
water phantom. This is due to the contribution to the energy deposition from forward scattered
photons which increases with depth, in the case of the photon energy spectrum of the primary
MRT radiation field. It can also be seen immediately that the presence of the polarised primary
beam effects the vertical and horizontal scattered photon distribution (and hence dose delivered)
differently, which is significant for MRT dose planning if the radiation field is near or adjacent to
critical organs. For all depths the vertical dose is consistently greater than the horizontal dose,
which is consistent with that expected from theory and is in agreement with the Monte Carlo
simulations. Monte Carlo simulations conform to the measurements to less than 10% (except for
1 value). Some of the values lie outside the uncertainties provided by the measurement. However,
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Figure 2.9 – Dose rate fall of with depth measured on the axis and in 2, 4 and 6 cm distance. Measurements are
again compared to Monte Carlo (MC) simulations. Measurement uncertainties remain below 5% and differences
to MC simulations are, except for one value, below 10%46.
the scattered dose in contrast to the peak doses depends heavily on collimator scattering and
back scattering from surfaces surrounding the phantom that were not taken into account in the
Monte Carlo calculations. Hence the agreement between Monte Carlo and measurement in the
off-beam, low dose domain is reasonably good.
2.3.3 Source Phase Space
PVDRs calculated with Monte Carlo simulations regarding the phase space information are
on average 8% smaller than simulations assuming ideal microbeams. This result can be seen
in Figure 2.10C. Although peak doses in the field centre are equal in both simulations, valley
doses are substantially lower in calculations with ideal microbeams. Where do these differences
originate from? In the following we investigate the physical and technical reasons for these
deviations. An analysis was done on the PSF 1 in the phase space plane 1 and on the PSF
2 created directly behind the collimator. In the following y is the propagation direction of the
photons, z the direction parallel to the collimator slits and x perpendicular to both. The direction
of the photon momentum is denoted by ~u = (ux, uy, uz) with |~u| = 1. We concentrated on the
following deviations from ideal microbeams and show that they explain the deviations observed:
1. Geometrical beam divergence of the whole field: Although the collimator is in a distance
of 39.3 m from the wiggler source and the field is just a few centimetre in size, there is a
measurable geometrical divergence. One consequence is that at the phantom surface 1.2 m
from the collimator, ctc and width of the microbeams have slightly increased.
2. Imperfect absorption of the absorber material in the tungsten carbide collimator leads to
leakage radiation.
3. Associated with the geometrical divergence could be a more pronounced absorption at
the MSC for beams at the field edge, because the beam incidence is inclined towards the
collimator walls.
4. The photon fluence is not completely flat. I.e. the photon flux in a plane in front of the
MSC is higher at the centre than close to the beam edges.
To estimate the error made by the neglect of the geometrical beam divergence we have plotted
phase space points over x and ux in figure 2.11A. All phase space points are more or less aligned
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Figure 2.10 – Comparison of calculations with phase space information (red "+"), adjoint Monte Carlo calcu-
lations with phase space model (blue line) and calculations without phase space information (green "2"). (A)
illustrates the whole field and (B) a few beams in the field centre. In (C) and (D) the PVDR and valley dose is
plotted over the beam number46.
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Figure 2.11 – Analysis of the phase space after tracking the photons from the phase space plane through the
MSC. Figure (A) shows the tangent of the deflection angle depending on the position in the beam. Figure (B)
shows the same graph in detail at the field centre. Graph (C) plots the mean photon energy depending on the
position x. There is a considerable energy difference observable between photons in the beam and between the
beams. This is shown in more detail in figure (D). As a red line the spectrum in the microbeams is plotted and
as blue “+” the photon spectrum behind the absorber material. The black dashed line is the expected spectral
shift of the red spectrum after the photons penetrated 8 mm WF2046.
along a straight line. As shown before by Martínez-Rovira et al. 13 the linear dependence between
x and ux with the regression coefficient g is given by
ux = γx = 2.56(4) · 10−5mm−1x. (2.26)
The beam divergence remains unchanged after the photons have passed the MSC. The conse-
quence of this divergence is that the beam width of the microbeams has increased from 50 µm
to 51.5 µm and the ctc from 400 µm to 412.3 µm when reaching the phantom surface in 120 cm
distance from the MSC. The divergence itself inside the phantom is of negligible importance. At
the back side of a 20 cm thick phantom the beam parameters have not significantly changed and
are 51.8 and 414.4 µm. This difference is hardly measurable and is unlikely to have any clinical
impact (compare measurements in chapter 4.).
Apart from this over all geometric divergence there is an intrinsic beam divergence emanating
from collimator scattering superimposing the geometrical divergence. Figure 2.11B shows the
dependence of x and ux in the centre of the field in more detail. The actual trajectories in the
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phase space scatter around the found linear relation. Each beam has an intrinsic divergence
which is given by ux = 2 · 10−6 in the centre of the field and 4.8 · 10−6 at the field edges. The
consequence for the beam shape at the phantoms surface in 120 cm distance from the collimator
is that the beam edges are smeared out between 2 and 4.8 µm with a more or less Gaussian
distribution. As long as the beam sizes and spacing are much higher than that, there is no
substantial influence on the absolute peak and valley dose values to be expected. Therefore the
valley dose contribution from collimator scattering is small enough to be neglected.
Higher valley doses, however, could also be a result of imperfect absorption from the collimator
material. The collimator material is a tungsten carbide alloy (WF20) containing 39.41% tungsten,
40.72% carbon, 18.11% cobalt, 0.44% vanadium and 1.32% chrome11. Its thickness is 8 mm. The
photon flux behind the absorber material is around 1.0 · 10−3 of the flux behind the aperture.
However, the average energy of the photons behind the absorber material is about 2.4 times
higher than the average photon energy behind the apertures. Figure 2.11C shows the average
photon energy depending on the position (x) in a region close to the centre of the field. The
average energy in the beam is around 100 keV. In the off-beam region the average photon energy
is 240 keV. Due to less particles penetrating the absorber the noise level is higher than in the
peaks. In order to confirm that the photon flux behind the collimator is caused by photons
of the primary beam passing through the absorber we have calculated the spectral change of
the beam after penetrating 8 mm WF20 and compared it with the actual spectrum behind the
absorber material in Figure 2.11D. The red curve shows the MRT beam spectrum and the black
dashed line is the derived spectrum after the beam has penetrated 8 mm of WF20. The actual
observed spectrum is shown with blue plus symbols. The maxima of the spectra are normalised
to 1. Calculated and observed spectrum behind the absorber coincide except for energies beneath
around 135 keV. The energy contribution of photons with less than 135 keV is 1.35% and can
probably be attributed to scattering at the collimator edges. Its small contribution consolidates
the finding that collimator scattering into the valley region is of minor importance. Furthermore
the divergence of the beam behind the absorber matches that of the microbeams as can be seen
from figure 2.11B. So even after penetrating 8 mm absorber material the divergence of the beam
has not increased.
In the plane directly behind the MSC the flux per microbeam changes depending on the
position of the beam. The flux is highest in the centre of the field and decreases by about 9% to
the edge of the field (see figure 2.12B, blue “+”). This deviation consists of two parts. On the
one hand the photon flux in the phase space plane is smaller at the field edges than in the field
centre. This is shown in figure 2.12A. The photon flux follows the quadratic profile
I = I0(1− 0.0196 cm−2x2), (2.27)
where I0 is the maximum dose in the centre of the field. The caused variations in the photon
flux per beam are around 4%. On the other hand the inclined incidence of the beam outside the
field centre leads to a partial shielding of the microbeams. Assuming the MSC made of ideal
absorbing material (absorption coefficient µ → ∞) simple geometrical considerations yield for
the ratio of actually transmitted photons N to the number of transmitted photons in the field
centre N0
N
N0
= 1− γ(absorber_thickness)
(beam_width)
|x| = 1− β|x|. (2.28)
A derivation is provided in appendix A. Using the linear divergence γ = 2.564 · 10−5 mm−1, the
absorber thickness of 8 mm and the beam width of 50 µm gives b = 0.041 cm−1. However, due
to imperfect absorption at the collimator edges the actually observed value is b = 0.030 cm−1.
From the centre to the edge of a 30×30 mm2 field the number of photons per beam decreases by
5% due to this effect. Taking both effects together the photon numbers per beam can accurately
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Figure 2.12 – (A) shows the photon flux of the primary field in front of the MSC (blue "+") and a quadratic fit
(red line) of this data. (B) shows the relative number of photons per beam (blue "+") and the developed model
(red line)46.
be described as shown in figure 2.12B. The total variations of peak doses are around 9% of the
maximum.
Summarizing these findings we established the following simplified source model:
1. Parallel microbeams of 51.5 µm width and 412.3 µm spacing comprised of photons with
energies according to the ESRF spectrum impinge the sample.
2. Parallel leakage radiation with an altered spectrum in the spacing between the beams
contributes to the valley dose. The photon flux is reduced to 0.10% of the primary beam.
3. The photon flux in the beam varies with the beam position according to I0(1−αx2−β|x|)
with the constants α = 0.0196cm−2 and β = 0.030cm−1.
4. The leakage radiation follows the profile of the primary beam in the phase space plane,
I0(1− αx2).
This simple source model can easily be implemented in Monte Carlo simulations, but also in other
dose calculation techniques. Kernel based dose calculation algorithms especially benefit from the
simplification to parallel beams. Only the primary photon fluence needs to be modified. The
implementation of the model to the MRT dose calculation algorithms is a subject in chapter 3.
The correction for the leakage dose can easily be performed by calculating the photon absorption
of a broad parallel field with 0.1% flux of the primary field with the spectrum shown in figure
2.11D. In the following section we describe the usage of the established source model in semi-
adjoint Monte Carlo simulations and compare the results with a forward calculation using the
complete phase space information.
2.3.4 Semi-Adjoint Monte Carlo simulation
The developed source model can be employed in a semi-adjoint Monte Carlo simulation. The
principles of this technique are explained in chapter 3.2.3. We define the adjoint detector in the
phase space by the formulae below (there are no directional constraints).
D(x, y, z, E) = ΘXZ(x, z)∆(y − y0)
(
Θ(w − x mod a)(1− αx2 − β|x|) + . . .
. . . +Θ(x mod a− w)(1− αx2)ρAbs(E)
)
.
(2.29)
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Here we use E as the photon energy, x, y and z are the coordinates as defined before, w = 51.5µm
is the beam width, a = 412.3µm the centre to centre distance of the beams, y0 the depth of
the detector in water and ρAbs characterises the transmission of the primary photons through
the absorber material. It is defined as number of photons N with energy E that penetrate the
absorber per number of primary photons N0 with energy E, ρAbs(E) = e−µWF20(E)·d, with d =
8 mm being the absorber thickness and µWF20 the absorption coefficient of tungsten carbide.
The operator mod stands for modulo (remainder of division), the function Θ is one for positive
arguments and zero otherwise; and the function ΘXZ is one in the microbeam field and zero
otherwise. ∆(y − y0) is one in a region around y = y0 and characterises the sampling in y. For
the simulations presented here the mesh size in y was chosen to be 4 mm, i.e. ∆(y − y0) is one
for y ∈ [y0 − 2mm, y0 + 2mm] and zero otherwise.
The adjoint source is a point source at the surface of the phantom sending a parallel photon
pencil beam into the phantom. The photon energy is distributed according to the spectrum of
the primary beam (red line in figure 2.11D).
The results of this calculation can be seen in figure 2.10, which compares profiles in 8 cm depth
from forward Monte Carlo simulations with PSF and adjoint Monte Carlo using the described
detector. In figures 2.10A and 2.10B profiles of the microbeam field are shown in the field centre.
Although the forward calculation used 10 times more particles, the statistical uncertainties are
much higher than in the adjoint MC. Within the uncertainties both methods, adjoint Monte
Carlo simulation and forward Monte Carlo simulation, provide the same results.
In figure 2.10C the PVDR is compared between Monte Carlo simulations with the PSF
(red “+”), adjoint Monte Carlo simulation (blue line) and a Monte Carlo simulation with ideal
microbeams (green squares). Figure 2.10D shows the valley doses for the same three calculations.
The adjoint Monte Carlo coincides with the forward calculation with the PSF. The valley dose
for the forward calculation with ideal microbeams is significantly lower. This difference originates
from the neglect of leakage photons in the valley region. The peak dose also shows a modulation
across the beam (see figure 2.10A). Moving out from the field centre peak doses calculated with
our phase space model or the PSFs from Martínez-Rovira et al. 13 decrease, whereas the peak
dose for ideal microbeams remains approximately constant.
2.3.5 Comparisons with measurements and unexplained deviations
In figure 2.13 results of the adjoint Monte Carlo simulation are compared with film dosimetry
measurements and Monte Carlo simulations from Martínez-Rovira et al. 13 . The comparison
is made in a 60×24×60 cm3 solid water phantom for a 20×20 and a 30×30 mm2 microbeam
field. The results obtained with our model are for most of the measurement points within the
uncertainty limits of the experimental data. At shallow depth for the 30×30 mm2 field PVDRs
tend to be slightly lower in the measurement. However, uncertainties of the film dosimetry are
too high and more accurate measurements need to be performed to validate this effect. Compared
to the Monte Carlo simulations by Martínez-Rovira et al. 13 our calculations are closer to the
measurement. The origin of the difference between the two simulations has not yet been resolved.
2.4 Conclusions
In this chapter we developed an understanding of important beam parameters in MRT. A simple
approximation of ideal microbeam profiles (see chapter 2.2) leads to considerable differences in
the peak and valley doses. However, we were also able to show that a complete simulation of
the beamline is not necessary. As key parameters the flux profile across the broad beam, the
leakage radiation from the MSC in the valley regions and the diminishing microbeam intensity
with increasing beam incidence angle at the field edges were identified. They allow an accurate
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Figure 2.13 – The graph compares PVDRs in depth calculated with the adjoint Monte Carlo simulation using
the model developed in this work (solid line) for a 20×20 mm2 and a 30×30 mm2 field in water and compares the
result with film measurements (circles) and Monte Carlo simulations by Martínez-Rovira et al. 13 (dashed line).
dose calculation with planar perfectly parallel beams if the spacing and width of the beams are
adapted to their size at the position of the phantom. Whereas the MSC produces beams with
50 µm width and a ctc of 400 µm the beam divergence leads to slightly larger parameters at the
phantom surface. Nevertheless the beam divergence does not seem to affect the dose absorption
in the phantom.
These findings were incorporated in a source model. The valid assumption of parallel beams
allows the application of many alternatives to inefficient forward Monte Carlo simulations. This
was shown for semi-adjoint Monte Carlo techniques as one example (see also chapter 3.2.3).
The presented source model is the input for all dose computations within this work. It was
incorporated into the Monte Carlo codes as well as the analytic dose calculation algorithm. The
exact implementation will be a topic in the respective chapters (e.g. chapter 3.2.2).
Nevertheless it should be noted that the model has several short comings. Scattering from
the collimators into the valley regions was found negligible in this study. It should be kept in
mind however, that Monte Carlo simulations also rely on necessary simplifications. Surfaces in
the collimator are not perfectly plane and there may be sedimentations of atoms and molecules
on the surface of the absorber material. An unpublished chemical analysis of the collimator
surface revealed significant amounts of copper. Furthermore the fabrication of the MSC leads
to variations from beam to beam – although they have drastically improved in recent years11.
Certain interactions are not incorporated in Monte Carlo simulations. For example diffraction
and interference at crystalline structures in the collimator or total external reflection. The
refractive index of absorber materials for electromagnetic waves in the x-ray range is slightly
smaller than one.
n = 1− δ − iβ (2.30)
Where β is the absorption and δ the refractive part of the complex refractive index. δ is very
small. The measurement of the refractive index is difficult. The imaginary part β can, however,
be derived from the photoelectric absorption. Real and imaginary part of the refractive index are
related to each other by the Kramers-Kronig relation. Kuznetsov 65 calculates by these means
δ = 1.27 · 10−6 at 50 keV and δ = 3.20 · 10−7 at 100 keV photon energy. The critical angle of
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Figure 2.14 – Left: Geometry of the beam incidence to a 50 µm wide slit of the MSC at the edge of a 20 mm
wide MRT field. The sketch is not in scale. Right: Film dosimetry of a single 100 µm wide beam. The dose
elevation at the beam edge could originate from total external reflection.
total external reflection can be obtained from the Snellius refraction laws,
cosx ≈ 1− x
2
2
= 1− δ (2.31)
where x is the angle between the beam and its projection onto the surface. At 50 and 100 keV
the critical angles are 2.3 and 0.8 mrad. This is much higher than the beam divergence angle
at the field edges as can be inferred from figure 2.11B. Consequently the synchrotron beams
that are hitting the wall of the collimator slits are reflected. We assume for now ideally plane
surfaces. What is the effect of these reflections and how do they contribute to the dose? Let us
consider the geometry presented in figure 2.14 (left) for a beam at the edge of a 20 mm wide
MRT field. For this aperture the beam grazing the inside edge of the collimator and the axis
of the synchrotron beam form an angle z of 0.254 mrad. In the beams eye view the aperture
appears under an angle of h = 1.27 µrad and the outside edge of the collimator under an angle of
x = 0.052 µrad. This would mean that about 4.1% of the photons reaching this slit are reflected.
The position of the reflection can be calculated relative to the outside edge of the beam in the
phantom which is in approximately 1.2 m distance from the MSC. The angle r is given by
ρ = 2 · (ζ + η − ξ) ≈ 0.510 mrad (2.32)
and hence the distance d is approximately 611 µm. The reflection is located outside the beam
itself.
However, these reflections have not been observed in dosimetry of MRT fields. The reason
is presumably the rough surface of the collimator walls. Similar to light reflected on a rough
surface the reflection will be diffuse. Moreover bumps in the surface may increase the incidence
angle of the beam towards the surface and therefore the reflected beam intensity may be even
less than the predicted 4.1%. Total external reflection will hence to some extend increase the
dose in peak and valley and therefore reduce the PVDR.
Although no reflections were observed in the dosimetry of MRT fields we detected an effect
when measuring output factors which will be a topic in chapter 4. In these measurements a
single aperture was positioned as accurately as possible on the axis of the synchrotron beam.
The profile of such a 100 µm wide beam is presented in figure 2.14. On the right side of the beam
there is a dose elevation between 5 and 9% of the peak dose observable. The asymmetry is very
likely caused by a slight tilting of the collimator. A deviation of 1 µrad is sufficient to cause this
kind of asymmetric response and a collimator wall which is located just 100 µm off-axis (perfect
parallel alignment) will cause a displacement between reflection and primary beam of about 6
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µm. It will be very hard to predict the effect of total external reflection because information
on the exact collimator surface quality is necessary. Therefore dose measurements will remain
indispensable for the benchmarking of dose calculation methods.
Synchrotron radiation is polarised. The Compton scattering cross section depends on the po-
larisation state of the primary photon and therefore dose absorption is not isotropic for polarised
beams. Especially outside the radiation field in the region of scattered photons the polarisation
leads to up to 40% dose differences as compared to unpolarised beams. However, inside the mi-
crobeam and therefore in the therapeutically most relevant region we were able to show that the
effect of the polarisation is less than 3% for the valley and negligible for the peak doses. Therefore
PVDRs may be calculated without regarding the photon polarisation. The phase space model
has a much higher influence on the dose calculation. Ignoring the phase space information leads
to deviations of approximately 10%. This is important for the interpretation of previous pre-
clinical treatments of animals. Dose calculations that assumed ideal microbeams and neglected
photon polarisation differ by less than 15% from the simulations presented here. In view of the
high biological uncertainties this is probably not a matter of concern when the data is used as
a basis for the first veterinary trials. For human clinical trials, the dose differences outside the
radiation field must be correctly taken into account including the polarisation effects, since the
dose must be determined accurately for the normal tissue and organs at risk (OAR).
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Chapter 3
Dose calculation in MRT
3.1 Introduction
Dose calculation is an important component in therapy planning. The absorbed dose is a sur-
rogate for quantification of tissue tolerance and tumour control. Although the dose response
of tumours and normal tissue in MRT is not known it is evident that applied therapy doses
crucially determine the therapy outcome. The peak doses are supposed to decide on tumour
control whereas valley doses influence the survival of normal tissue.
As it has become clear in the last chapter, beam properties in MRT differ from those in
conventional radiotherapy. In this chapter we develop different dose calculation approaches
for MRT and integrate them into an existing treatment planning system (TPS). The chapter
starts off with some general considerations on dose absorption in MRT. In section 3.2 a slow
but relatively accurate Monte Carlo dose calculation algorithm is presented which is integrated
into the TPS. Furthermore an alternative, faster Monte Carlo method is presented which places,
however, certain demands on the phantom geometry. In section 3.3 we discuss significantly faster
but less accurate point kernel methods which are also incorporated into the TPS.
Dose planning is based on the information provided by CT images. Different materials in
the organism have different radiological properties and are represented by different Hounsfield
Units (HU) in the CT. The conversion of the CT-data into material parameters has of course
an important influence on the dose computation. The conversion algorithm and its uncertainties
are presented in section 3.4.
In section 3.5 we show some example dose calculations and compare the accuracy of the
different calculation methods. We cease the chapter with some final conclusions and remarks.
3.1.1 Physics of dose absorption in MRT
The photon energy spectrum in the current filter set-up for MRT is depicted in figure 2.11D.
Between 45 and 175 keV the spectrum has an intensity above 10% of the peak intensity at 80
keV. In this energy range photons interact via Compton scattering, photoelectric absorption and
Rayleigh scattering. The interaction probability of these processes depends on both, energy and
material composition. At low energy photoelectric absorption becomes dominant and at high
energy photons mainly interact via Compton scattering. Rayleigh scattering plays a minor role.
In photoelectric absorption an electron in the atomic shell of an atom absorbs the energy of the
photon completely. The photon energy is much higher than the binding energy of the electron.
Energy in excess of the binding energy is transformed into kinetic energy of the electron. If a
photon of energy E0 interacts with a free electron via Compton scattering it transfers a part of its
energy to the electron and scatters off with an energy E < E0. The energy fraction transferred to
the electron is determined by momentum and energy conservation (compare equation 2.16). For
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Figure 3.1 – The graph on the left shows the scattering/absorption coefficients for Compton scattering, Rayleigh
scattering and photoelectric absorption in bone [source: Berger et al. 64 ]. On the right the mean free path in
mm for photons is drawn over the photon energy. It is defined as the average distance a photon travels without
interacting. The graph shows the CSDA ranges in µm of Compton and photoelectrons as well.
photons in the relevant energy range this fractions is pretty low between 7 and 20%. The fraction
increases with energy. The scattered Compton photon may interact again. While photoelectric
effect and Compton effect produce secondary electrons, no secondary particles are created in
Rayleigh scattering . The photon only changes its direction. The absorption and scattering
coefficients of these three processes in compact bone are presented in figure 3.1 (left).
The total absorption coefficient of a 100 keV photon beam is much higher than that of
MeV photon beams commonly used in conventional radiotherapy treatment where photons are
produced in linear accelerators (so called linacs). The average mean free path depth of a photon
beam is therefore much lower. In figure 3.1 the mean free path, defined as the average distance a
photon travels without interacting, is plotted against the photon energy. While the photon mean
free path slowly increases with energy above 40 to 50 keV, there is a strong drop of mean free
path with decreasing energy below 40 keV. This is due to the strength of photoelectric absorption
at these energies. The photoelectric absorption coefficient possesses a strong energy dependence,
µPh ∼ E−3.27. (3.1)
Electrons produced in primary photon interactions can lose their energy by collisions and
radiation. Unlike photons, charged electrons frequently interact with the electric fields of the
atoms. At energies below 1 MeV Coulomb scattering is the dominant interaction process. In each
interaction just a small fraction of the kinetic energy is transferred to shell electrons in the atoms.
However, the frequency of these interaction leads to a rapid slowing down. In interactions with
the electric field of the atomic nucleus or shell electrons, secondary electrons may also produce
"bremsstrahlung". This radiative energy loss of electrons at around 100 keV kinetic energy is
extremely low and can usually be neglected. The electron range is in the order of a few tens of
micrometre.
On the one hand the range of secondary electrons at an energy of around 100 keV is a few
micrometres. On the other hand the mean free path length of photons is in the order of several
centimetres. That means photons travel larger distances without scattering and produce in
interactions secondary electrons that are absorbed rather locally. Electrons transfer the energy
to the medium and are responsible for the majority of ionisations. The peak dose in an MRT
field has a width of just a few microns. Hence the peak dose is built up by electrons produced
in interactions of the primary photon beam. We define the order of energy absorption by the
number of photon interactions prior to the interaction that created the secondary electron. That
means the peak dose is built up by 0th order absorption. If a secondary electron is produced in
a photoelectric absorption its energy will be approximately equal to that of the primary photon,
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whereas if the electron is produced in a Compton process its energy will be 5 to 20% of the
primary photon energy. The range of a Compton electron will therefore be much shorter than
that of a photoelectron.
The range of secondary electrons is crucial for high dose gradients between peak and valley
regions. The lower the energy of the photons and thus the energy of secondary electrons the
steeper is the beam penumbra region. However, the lower the photon energy the smaller gets
the photon mean free path. The spectrum in MRT is a trade-off between high photon mean free
path and narrow beam penumbras. This is illustrated for water in figure 3.1 (right). The red
curve is the photon mean free path. The blue curve represents the photoelectron and the green
curve the Compton electron CSDA range. The currently used spectrum has a mean energy of
100 keV. The range of photoelectrons is approximately 150 µm and the photon mean free path
has a length of around 6 cm. However, at 100 keV photoelectrons are just of minor importance
in water and Compton electrons have a much lower range of approximately 5 µm. Therefore it
could be considered to move the spectrum towards higher energies. At 200 keV photon energy the
Compton electron range is 25 µm. This should still be small enough for 50 µm wide microbeams.
The photon mean free path would be increased by about 25%. Another advantage of going
to slightly higher energies is the energy transfer to Compton electrons. The higher the photon
energy the higher the energy fraction transferred to Compton electrons. This would increase
the ratio of primary energy absorption which builds up the peak dose to the scattered photon
absorption which is responsible for the valley dose.
3.2 Dose calculations based on Monte Carlo simulations
3.2.1 Challenges for Monte Carlo techniques in MRT
Monte Carlo algorithms solve numerical problems with random numbers and are widely used
for the simulation of radiation transport but also for other applications. In radiation transport
Monte Carlo methods treat each particle track as a sequence of stochastic processes, where
random numbers determine path lengths, scattering angles etc.. Averaging over many particle
tracks allows the estimation of measurable quantities, as for example the dose. The outcome is
not exact but deviates with a certain probability from the correct result.
"All problems solved by Monte Carlo are essentially equivalent to integrations."i This sur-
prising statement can be understood from the following considerations. Any quantity Q that
is computed in Monte Carlo simulations is a function of a certain number N of random num-
bers r1, r2, ..., rN . Without loss of generality these numbers can be assumed to be uniformly
distributed. Any other distribution can be obtained by applying transformation rules. Thus 〈Q〉
is an estimation of the N-dimensional integral
〈Q〉 =
1∫
0
1∫
0
. . .
1∫
0
Q(r1, r2, . . . , rN ) drN . . . dr2 dr1. (3.2)
Monte Carlo techniques are especially useful in solving high dimensional integrals. The relative
error F made by Monte Carlo simulations is proportional to
F ∼ σ
µ
√
M
(3.3)
where M is the number of particle histories, s the standard deviation and µ the expectation
value of a single simulation.
iLux and Koblinger 66 , chapter 4, p. 81
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There are two main challenges for Monte Carlo techniques in MRT dose calculations. The
first challenge is the rapid spatial variation in the dose. Voxel sizes have to be smaller than 5
µm perpendicular to the microbeam planes in order to describe beam penumbras, valley and
peak doses accurately. Such small voxels increase the standard deviation s in equation 3.3. The
probability that a particle hits the detector volume is very unlikely. If the volume is hit, the
produced dose in this event Devent is very high because the voxel volume Vvoxel is small.
Devent =
E
Vvoxel
(3.4)
If we consider a Bernoulli process and only look at the probability for the events "voxel hit" p
and "voxel not hit" (1-p) then we obtain for the ratio of the standard deviation σB to mean µB
σB
µB
=
√
1− p
p
≈
√
1
p
. (3.5)
For the last approximation it was assumed that p  1. The probability for a hit is inversely
proportional to the voxel size
p ∼ 1
Vvoxel
. (3.6)
Although the radiation transport is more complicated than a Bernoulli process, we should expect
that the ratio σ/µ is more or less proportional to
√
Vvoxel. If the voxel size in one dimension
is decreased from 1 mm to 5 µm 200 times more particle histories need to be simulated in
order to keep the relative simulation error F in equation 3.3 constant. That means a 200 times
longer calculation time. If we now also want to compute the dose distribution for an MRT
multiport exposure where we require 5 µm voxel side lengths in all three dimensions the number
of simulated particle tracks needs to be increased by a factor of 8 · 106. It becomes evident that
straightforward Monte Carlo simulations are not reasonable. Apart from the simulation time
there is also the problem of data storage and finally visualisation.
The second challenge in MRT is the high dynamic range of doses. Both, peak and valley doses
have to be accurately determined, that differ in a factor of 20 or more. In order to achieve a low
statistical uncertainty in the valley region, simulations need to precisely predict low scattered
dose effects. If in conventional dose calculations 5% accuracy of the maximum dose is required,
this means in the MRT valley dose calculation a maximum of 5% uncertainty in an anyhow small
scattered dose contribution of 5% or less.
How can we solve these problems? In this section two strategies are pursued that both
reduce the ratio σµ in equation 3.3. The first approach constrains the information extracted from
the simulation and is described in chapter 3.2.2. It is useful to think again about the essential
quantities required for treatment planning. Most experiments suggest that the peak dose and the
valley dose (or the peak to valley dose ratio, PVDR) are the quantities that decide upon therapy
success. A high peak dose is supposed to be crucial for tumour ablation and a low valley dose
presumably ensures normal tissue sparing. We therefore developed a Monte Carlo simulation
tool that calculates an average peak and an average valley dose on the voxel-grid of a CT.
The second approach artificially increases the scoring volume by partially inverting source
and detector geometry. This will be presented in chapter 3.2.3. Unfortunately this approach does
only work with certain phantom geometries and is therefore not suitable for dose calculations in
general.
3.2.2 Forward Monte Carlo simulations
Monte Carlo simulations were set up in Geant4 version 9.5. The calculations were performed
with the interaction models of the Livermore polarised physics libraries. Cut-off ranges for
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electrons were set to 1 µm. Activated photon interactions are Compton scattering, photoelectric
absorption, Rayleigh scattering and also pair production – although the latter process does not
occur at energies below 1 MeV. For electrons multiple electron scattering, ionisations and the
production of bremsstrahlung are taken into account.
Set-up of the detector geometry
In Geant4 materials, objects and detectors are defined in a class derived from the class G4User-
DetectorConstruction. There elements and compounds can be defined and various tools exist to
describe geometries and to align objects. The set of all objects is called the detector. Materials
that are assigned to objects in the detector have to be predefined in the storage. Therefore the
number of definable materials Nmat is limited and is predefined in the beam set-up text file.
The simulation reads in the Hounsfield units (HU) from the CT file, the voxel size and voxel
number of the CT. The maximum and the minimum HU values in the CT data is determined.
Within these limits equally spaced HU-intervals I1, . . . , INmat are defined according to the number
of materials Nmat. Each interval is assigned to a material. The necessary material properties
mass density and elemental mass fractions of hydrogen, carbon, nitrogen, oxygen, phosphorous
and sodium are calculated from the mean HU value of the interval following the method of
Schneider et al. 45 (see chapter 3.4).
The detector is set up as a three dimensional array of voxels. Each voxel gets the material
definition according to the HU interval it belongs to. The reference system Σ is equivalent to the
patient or treatment planning system (x: right-left, y: anterior-posterior, z: head-foot). Each
voxel is used as a sensitive volume.
Beam configuration
Whereas the MC simulation is performed in the reference system of the CT-image Σ, the radiation
source is defined in a beam reference frame ΣS spanned by the three pairwise orthogonal unit
vectors ~exs , ~eys and ~ezs . This reference frame is at the same time the laboratory frame in which
the beam propagates along ~ezs and the microbeams are parallel to ~exs . The origin of the reference
system is the fixed isocentre of the beam in the patient. This is at the same time the invariant
point for all rotational motions of the goniometre motors. Neglecting beam-air interactions, the
z-position of the source in ΣS is not as important, since we assume parallel beams in the source
model presented in chapter 2. The patient and laboratory system (Σ and ΣS) are illustrated in
figure 3.2 (left).
The photon source was simulated according to the model developed in chapter 2. The beam
width and the ctc were set to 51.5 µm and 412.3 µm, respectively. The photon trajectories start
at
xs = W
x
F · (r − 12)
ys = nbeam · ctc− W
y
F
2 + q · w
zs = −d
(3.7)
and point into the positive zs-direction. Here W xF ,W
y
F are the field sizes in x and y, w the
beam width and ctc the beam spacing. q and r are random numbers generated from an uniform
distribution with 0 ≤ q, r ≤ 1. The number of the beam nbeam is selected randomly according
to the fluence profile I = I0(1 − αy2s − β|ys|). This profile can be interpreted as a probability
density function f(ys),
f(ys) =

1−αy2s−β|ys|
y=W
y
F
/2∫
y=−Wy
F
/2
1−αy2−β|y| dy
for − W
y
F
2 < ys < −
W yF
2
0 otherwise
(3.8)
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(3.9)
it is possible to generate random numbers that follow the intensity profile with the inverse-
transform method (see for example Salvat et al. 56 or Ahrens and Dieter 67): If ξ is a uniform
random variable in [0, 1], then the random variable
η = F−1(ξ) (3.10)
follows the distribution described by the probability density function f. The beam number nbeam
is therefore selected as the integer number that is closest toii (η/ctc +W yF /2).
We also use the inverse-transform method to choose the photon energies from a spectrum
which is given as intensities I(Ei) at discrete energies E1, . . . , EN in ascending order (i.e. Ei > Ej
for i > j). The cumulative distribution function at the discrete energies is given by
F (Ei) =
i∑
n=1
I(En)/
N∑
n=1
I(En); (3.11)
for all other values, F (E) is linearly interpolated.
The leakage photon flux is 0.001 of the primary beam. Therefore a fraction of
0.001 · ctc− w
w
(3.12)
of the photons is simulated to originate from points between the microbeams with a different
energy distribution given by the leakage spectrum (see chapter 2). The distribution in xs is
uniform and the distribution in ys follows the profile (1 − αy2s). The coordinates ys are again
sampled with the inverse-transform method.
iiStrictly speaking this is an approximation, because the fluence is averaged over a 400 µm wide range around
the beam and not just the beam itself. However, it should be kept in mind that the position of the microbeams
is anyway not precisely known and presents an experimental uncertainty.
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Coordinate transformations
The simulations are performed in the patient reference system. Therefore all vectors of the
laboratory frame have to be transformed into the patient system. The necessary information are
provided in the VIRTUOS plan file. They are stored in the plan file as gantry angle φ, couch
angle θ, collimator angle γ and the coordinates of the isocentre
#     »
ISO in the patient system. These
are the typical parameters in conventional radiotherapy and they are shown in figure 3.2 (right)
in a system Σ′ which is obtained by translating the patient reference system Σ along the vector
#     »
ISO (figure 3.2, left). Gantry and couch angle define the beam direction ~S in Σ′
~S =
 − sinφ cos θcosφ
sinφ sin θ
 . (3.13)
The collimator angle γ describes the tilting of the microbeam direction ~B to the vector ~v. ~v is
perpendicular to ~S and lies in a plane spanned by the y′-axis and ~S. Its representation in the
system Σ′ is given by
~v =
 − cosφ cos θ− sinφ
cosφ sin θ
 . (3.14)
With the vector ~w = ~v × ~S the microbeam direction can be written as
~B = cos γ ~v + sin γ ~w. (3.15)
The vectors ~B and ~S form the coordinate vectors ~exs and ~ezs of the beam reference system ΣS .
The missing vector ~eys is chosen such that the vectors ~exs , ~eys and ~ezs form a right handed
system. Therefore the coordinate matrix M of these three vectors in the reference system Σ′
(and also in Σ) is
M = (~exs , ~eys , ~ezs)
=
 − cosφ cos θ cos γ + sin θ sin γ sin θ cos γ + cosφ cos θ sin γ − sinφ cos θ− cos γ sinφ sinφ sin γ cosφ
cosφ sin θ cos γ + sin γ cos θ cos θ cos γ − cosφ sin θ sin γ sinφ sin θ

(3.16)
The transformation of a vector ~rs = (xs, ys, zs) in the beam reference system ΣS into the vector
~r in the patient reference system is therefore described by
~r = M~rs +
#     »
ISO = xs ~B + ys(~S × ~B) + zs~S + #     »ISO (3.17)
Scoring of peak and valley doses
Dose is scored in voxelised structures based on the CT-grid. Since the microbeams are usually
smaller than the voxel size, dose accumulation has to be separated into a peak and a valley
part. To achieve this the interaction point ~P is transformed into the beam reference frame by
projecting onto the vector ~exs , ~eys and ~ezs ,
xs = < ~exs , ~P >,
ys = < ~eys , ~P >,
zs = < ~ezs , ~P > .
(3.18)
The absorbed energy is assigned to the peak if the interaction occurred in a microbeam path and
it is assigned to the valley if the interaction occurred in the central 80% of the inter-beam region,
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Figure 3.3 – Figure (A): Microbeams intersperse the voxels in the Monte Carlo dose calculation and cut out a
certain volume. As an example figure (B) shows the volume fraction for microbeams that are perpendicular to
the x-axis and microbeams that are perpendicular to direction (1, 1, 1) as illustrated in (A). The calculation was
done for a ctc of 400µm and a beam width of 50µm.
avoiding the microbeam penumbras. Furthermore, in order to calculate the dose, the volume V
is required for
D =
E
V ρ
, (3.19)
where ρ is the mass density of the voxel material. The peak and valley volume in a voxel depend
on the size, orientation and position of the voxel in the microbeam field. The problem is visualised
in figure 3.3A. The geometric problem is complex and involves an extensive case-by-case analysis.
We therefore opted for a numeric, Monte Carlo based volume determination.
All voxels of the CT are equally oriented. In other words the direction of the microbeam
incidence is for all voxels the same. For a given irradiation geometry the peak or valley volume
fraction depends on the voxel position perpendicular to the microbeam planes modulo ctc only.
In the beam reference system this is given by the ys-coordinate modulo ctc. Figure 3.3B shows
the beam volume fraction of a 1×1×1 mm3 voxel for two beam directions, a ctc of 400 µm and a
beam width of 50 µm. The volume fractions were calculated by randomly choosing points in the
voxel from a uniform distribution. The relative number of points that fall inside a microbeam
path is a measure for the volume fraction of the peak region. In a similar way the valley volume
is estimated.
In the just described scoring peak and valley doses are defined as averages over a certain
volume. There are of course other ways to define peak and valley doses. Unfortunately there is
no generally agreed definition of peak and valley dose. This has to be regarded when comparing
the simulations with measurements and calculations of others.
3.2.3 Semi-adjoint Monte Carlo simulations
Introduction to adjoint Monte Carlo methods
In MRT dose estimates have to be made for very small detector volumes. This is problematic for
Monte Carlo simulations because the energy scored in small volumes is low and the statistical
noise for the dose in this volume is high. In order to resolve the structure of microbeams classical
forward Monte Carlo simulations require a huge amount of particle histories. This leads to long
calculation times.
In this chapter a section is presented that circumvents this problem by partly exchanging
the detector and the source geometry. It is based on the well-established adjoint Monte Carlo
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techniques. These methods have another advantage: The simulation of various source geometries
can be handled more efficiently. Whereas studies on source parameters require a repetition of
the entire simulation in forward Monte Carlo simulations they can often be performed with
a single simulation using adjoint Monte Carlo approaches. One typical example where this is
advantageous is the calculation of output factors (see chapter 4).
In the theory of Monte Carlo simulations and partial differential equations, problems with
small detector volumes or varying sources are often treated in their adjoint form68,69. The idea
is that in the adjoint representation of the problem detector and source exchange their position.
In this context detector and source have to be understood as pay-off or source functions in the 6
dimensional particle phase space consisting of three spatial and three motion (e.g. momentum)
dimensions.
As mentioned before all problems solved by Monte Carlo simulations are essentially equiva-
lent to integrations70. For particle transport Monte Carlo calculations integrate the Boltzmann
transport equation
~Ω~∇Φi(~r, ~E) + ΣiT (~r, ~E)Φi(~r, ~E) = Si(~r, ~E) +
∑
j
∫
d ~E′ΣijS (~r, ~E
′, ~E)Φj(~r, ~E′) (3.20)
(integro-differential form). In this equation ~Ω = (sin θ, cos θ cosφ, cos θ sinφ) is the directional
vector, Φi the flux of particles, S characterises the field of particle sources, ΣiT and Σ
ij
S determine
the particle transport and scattering in the phase space. The vector ~E describes the motion of
the particles and consists of ~E = (E, φ, θ). The superscript indices indicate the particle type. For
low energy photon interactions it may denote photons and electrons. Particles may convert into
each other. Therefore the scattering term includes a matrix ΣijS coupling the fluxes of different
particles to each other. In the following we simplify the notation and skip the superscripts. The
particle flux Φ for low energy photon transport can, however, be regarded as a two component
vector including photons and electronsiii. Therefore we write
~Ω~∇Φ(~r, ~E) + ΣT (~r, ~E)Φ(~r, ~E) = S(~r, ~E) +
∫
d ~E′ΣS(~r, ~E′, ~E)Φ(~r, ~E′). (3.21)
Instead of solving the forward Boltzmann transport equation, it is also possible to consider
the adjoint flux Φ∗. For this purpose we may rewrite equation 3.21 as an operator equation in
the form [
~Ω~∇+ ΣT (~r, ~E)−
∫
d ~E′ΣS(~r, ~E′, ~E)
]
Φ = S(~r, ~E). (3.22)
Scoring of a physical quantity J in Monte Carlo simulations corresponds to calculating the scalar
product of the flux Φ with a pay-off detector function D,
J(Φ) =
∫
d ~E
∫
d~r Φ(~r, ~E)D(~r, ~E) = 〈D,Φ〉 (3.23)
For a simple scorer in space with density ρ and scoring volume VS the function D would have
the representation
D(~r, ~E) =
{
EAbs/(ρVS) ~r ∈ VS
0 ~r /∈ VS (3.24)
As shown by Marchuk 68 this problem can be reformulated into its adjoint representation. Con-
sider the operator equation
AΦ = S, (3.25)
iiii.e the source is then also a two component vector, ΣS is a 2×2 matrix and ΣT a diagonal 2×2 matrix.
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where we are interested in the scalar product
J = 〈D,Φ〉 . (3.26)
If we then consider the equation with the adjoint operator A∗ for a function Ψ∗
A∗Ψ∗ = D (3.27)
then we realise that
J = 〈D,Φ〉 = 〈A∗Ψ∗,Φ〉 = 〈Ψ∗, AΦ〉 = 〈Ψ∗, S〉 . (3.28)
Equation 3.27 is called the adjoint equation to 3.25. The adjoint of the Boltzmann transport
equation reads [
−~Ω~∇+ Σ∗T (~r, ~E)−
∫
d ~E′ΣS(~r, ~E, ~E′)
]
Ψ∗ = D(~r, ~E), (3.29)
J = 〈Ψ∗, S〉 . (3.30)
In these two equations source and detector are exchanged. Equation 3.29 is solved once for a
certain detector geometry. To that end particles are tracked backwards in time from the detector
to the source. Afterwards the quantity J can be determined by simply computing the scalar
product between the source function S and the adjoint flux Ψ∗. A small detector volume D(~r, ~E)
does not negatively influence the solution of equation 3.29 with Monte Carlo techniques. As long
as the source function S covers a sufficiently large phase space volume this adjoint equation can
even provide Monte Carlo solutions for a point-like detector.
On the one hand, in MRT dose needs to be scored in a very small geometrical volume since
dose is changing on a micrometre scale. On the other hand there are no constraints on the
energy and angular dimensions for the detector. The detector scores particles independently of
the direction they are coming from and independent of their energy.
For the source this is the other way around. The source volume is comparably large per-
pendicular to the beam; but the constraints on the angles φ and θ are high since the beams are
extremely parallel. In this sense both, the forward and the adjoint Monte Carlo simulation face
the problem of small detector volumes in the phase space: Small in the spatial directions for
forward Monte Carlo simulations and small in the directional dimensions for the adjoint Monte
Carlo simulations. Instead of exchanging source and detector in all phase space dimensions it
would be favourable to exchange just some dimensions of the source and detector in order to
increase the scoring volume in the simulation.
Extension of the adjoint Monte Carlo method
Let us consider the irradiation geometry given in a coordinate system with the x-axis pointing in
the direction of the parallel beams and the y- and z-direction perpendicular to the beam (Figure
3.4A). θ is the angle between a particle trajectory and the x-axis. φ denotes the angle between
the projected trajectory in the y-z-plane and the y-axis. If in the y-z-plane the size of the source
is large and the detector size small it would be useful to have a semi-adjoint method that adjoints
the Boltzmann equation only in the y-z-plane. Especially if the phase space volume of the source
in other dimensions is small a complete adjoint calculation has disadvantages.
We describe a solution of this problem in the situation of a phantom which is homogeneous
in y and z and we assume that the radiation source can be described in phase space as
S(~r, ~E) = δ(x)fS(y, z)
1
2pi sin θ
δ(θ)fE(E) = s(x, ~E)fS(y, z). (3.31)
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Figure 3.4 – The forward geometry (A) and semi-adjoint geometry (B) are illustrated.
fs(y, z) describes the aperture of the source or collimator, fE(E) characterises the spectrum of
the source. S integrates over the phase space to 1. The detector can be written as
D(~r, ~E) = ∆(x− xD)fD(y, z) = d(x, ~E)fD(y, z). (3.32)
fD describes the geometry of the detector in the y-z-plane. The function ∆(x) is the detector
shape in the direction of the primary beam. For a scoring mesh ∆ will typically look like
∆(x) =
{
1/d −d/2 < x < d/2
0 otherwise . (3.33)
It is now possible to exchange the geometry of detector and source only in y-z-coordinates and
keep all other coordinates constant. The homogeneity of the material in the y-z-plane implies
ΣT (~r, ~E) = ΣT (x, ~E),
ΣS(~r, ~E
′ → ~E) = ΣS(x, ~E′ → ~E).
(3.34)
Therefore we find in equation 3.21 one operator acting on the (x, ~E) subspace,
Ax,E = Ωx
∂
∂x
+ ΣT (x,E)− E
〈
ΣS(x,E
′ → E)∣∣ (3.35)
and one operator acting on the (y, z) subspace,
By,z = Ωy
∂
∂y
+ Ωz
∂
∂z
. (3.36)
In equation 3.35 we have made use of the convenient bra/ket notation. Thus equation 3.22 can
be rewritten as
(Ax,E +By,z) Φ = s(x, ~E)fS(y, z). (3.37)
The semi-adjoint version of this equation transforms only operators and functions that act on
the y-z-subspace. The semi-adjoint flux Ψ∗ has to obey the equation(
Ax,E +B
∗
y,z
)
Ψ∗ = s(x, ~E)fD(y, z). (3.38)
The dose or quantity J that we are interested in is then calculated in a scalar product with
d(x, ~E) and fS(y, z) (compare equation 3.28),
J =
〈
Ψ∗, d(x, ~E)fS(y, z)
〉
(3.39)
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The geometric interpretation of the semi-adjoint equation can be seen from figure 3.4. For the
same number of simulated particles the dose measured in the detector in figure 3.4A and in the
inverted detector in B are going to be the same.
This can be explained by the following argumentation. Let us consider a photon leaving
the source element dS = dySdzS . This photon has the same expectation of energy absorption
dE in the detector volume dVD = dxdyDdzD as a photon in the inverted geometry has, leaving
the inverted source element dS′ = dyDdzD for the energy absorption in the inverted detector
element dV ′D = dxdySdzS as long as dySdzS = dyDdzD and the geometry is homogeneous in
y and z. More complicated detector and source geometries can be considered as composed of
infinitesimally small detector and source elements. For each pair of detector and source volume
element (dVDj , dSi) the equality of energy absorption expectation holds, i.e. 〈E(dSi → dVDj)〉 =〈
E′(dS′j → dV ′Di)
〉
, if each source element emits the same amount of photons. In the forward
geometry the total energy absorbed by the detector is the sum over all detector elements dVDj .
For each detector element the absorbed energy is the sum over contributions from all source
elements dSi. Thus obviously absorbed energy in the forward and inverted geometry is equal,
E =
∑
i
∑
j
〈E(dSi → dVDj)〉 =
∑
i
∑
j
〈
E′(dS′j → dV ′Di)
〉
= E′ (3.40)
It is important to note that this equality holds for the same photon fluence of the source. Or,
respectively, if the number of particles is identical in both simulations the dose will be the same.
The statistics is of course better with the larger detector.
Applications and results
A modified version of MRT are pencilbeam irradiations where small rectangular beams of a few
micrometer side length are delivered in two dimensional arrays. The hope is to enable with this
technique whole brain irradiations without a breakdown of the therapeutically important peak
to valley dose ratio. First studies were done in mice by Schültke et al. 71 . In these experiments
arrays of 45×21 beams sized 50×50µm2 having 400 or 200 µm spacing were created at the
ESRF using a step and shoot method. The dose estimations for this study were performed in
this work in Monte Carlo simulations of the beams in a water phantom of 16×16×16 cm3 side
length employing semi-adjoint instead of forward Monte Carlo simulations. Simulations were
carried out in the Geant4 tool set (Version 9.3 p02). The source was a point in the y-z-plane
at (y0, z0) emitting photons in the x-direction. Energy was scored on a grid of bins sized 5×5
µm2 in the y-z-plane and at 0.5 or 4 mm depth from the beam entrance into the phantom. 107
photon histories were simulated. The energy that corresponds to the energy scored in the direct
simulation in a point at (y0, z0) is the scalar product 〈Ψy0,z0(y, z), d · fS(y, z)〉 which needs to be
evaluated, ∑
y
∑
z
fS(y, z)Ψ(y, z, y0, z0). (3.41)
Ψy0,z0(y, z) is the fluenceiv that was created by the adjoint source positioned at y0, z0. Due to
the homogeneity of the problem in y, z, a shift of the source is equivalent to a shift in the fluence
Ψy0,z0(y, z) = Ψ(y − y0, z − z0), where Ψ is the fluence with y0, z0 = 0. Therefore the energy
absorption in equation 3.41 can be calculated in a convolution,
E(y0, z0) = [fS ∗Ψ] (y0, z0) (3.42)
and can for example be efficiently evaluated in Fourier space.
ivWhile we refer to the flux f as the particle density in phase space, the fluence Y denotes the number of
particles passing through a certain area.
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Figure 3.5 – Dose of a pencilbeam field in a cubic water phantom with 16 cm side length in 4 cm depth. (A) shows
the dose distribution of the whole field at this depth. The spatial dependency is obtained by convolving the dose of
a pencilbeam over the detector shape (equation 3.42). (B) shows a comparison between direct forward calculation
with 1010 particle histories and the semi-adjoint calculation with 107 histories. The statistics is significantly
poorer in forward calculations.
Figure 3.5A shows the 2D result of the dose calculation in 4 cm depth. For comparison a
forward calculation on the same scoring grid with 1010 photons was performed, i.e. with 1000
times more photon histories. Nevertheless the statistical uncertainties of the forward calculation
are much higher. A profile through the centre of the field in 4 cm depth is shown in figure 3.5B.
The profiles of the direct method and the semi-adjoint method coincide. If the irradiation pattern
is changed the forward Monte Carlo simulation has to be repeated. In the inverted geometry
only the convolution in equation 3.42 has to be recomputed for the new source shape fS .
Another very useful application of the semi-adjoint Monte Carlo method is the calculation of
output factors. The output factor is the ratio of the peak dose of a collimated beam to the peak
dose of a reference field at identical primary particle flux. In forward Monte Carlo calculations
each collimator aperture has to be calculated separately. With the semi-adjoint method the
Monte Carlo simulation has to be carried out only once and all future computations can be
reduced to a single convolution (equation 3.42). The computation and measurement of output
factors and a comparison of the results will be presented in chapter 4. The method was also
applied to studies where layer structures were assumed, for instance in Laissue et al. 72 .
Conclusion and Outlook
The adjoint Monte Carlo technique is a useful approach if the detector has a small and the source
a large volume in the phase space or if for various sources the response of the same detector shall
be determined. This technique traces particles backwards in time from the detector to the source.
In this chapter we have presented a method that adjoints only a part of the simulations. This is
especially advantageous in MRT where the detector volume is small perpendicular to the beam,
but where also the source volume is small in the momentum subspace. In the semi-adjoint
method the exchange of source and detector geometry is only applied to some dimensions and
particles are still tracked forward in time.
The method uses the simulated particle tracks more efficiently. For forward Monte Carlo
simulations in MRT most of the simulated photon histories are rejected because they do not hit
the detector volume. Hence most of the computational power is spent for photon paths that do
not actively take part in the determination of the final dose. In the semi-adjoint Monte Carlo
method this ratio of actively contributing to simulated photon histories is remarkably enhanced.
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Consequently the statistics of the results is significantly better than in forward Monte Carlo
simulations. In an example we were able to show that the statistical noise in the result of the
adjoint Monte Carlo method was much less than in that of forward Monte Carlo simulations,
although 1000 times more photon histories were simulated in the forward Monte Carlo simulation.
Semi-adjoint Monte Carlo methods are used for several studies in this work. Among others
it was employed to calculate the effect of polarisation on microbeam fields in homogeneous
phantoms in chapter 2, it was used in the calculation of output factors and for the calculation of
the absorbed dose in the cell culture experiments presented in chapter 5. Possibly the method
could be further developed for more complicated geometries.
3.3 Dose calculation with kernel based techniques
3.3.1 Introduction
Apart from Monte Carlo simulations analytic approaches were developed for dose calculations
in MRT. They are based on point kernel superposition algorithms with analytically calculated
dose kernels. Given a photon interaction at a certain point (x0, y0, z0) in a radiation field, a
point kernel K(x0,y0,z0)(x, y, z) describes the energy distribution by scattering particles around
this point. These kernels are superimposed along the primary beam depending on the interaction
probabilities. For MeV-photons scattering kernels need to be provided for water only. The dose
absorption in other materials can be calculated by applying O’Connors73 theorem which states
that the absorbed dose in materials that differ from water can be obtained by scaling depths
and field sizes with the electron densityv. However, for photons at energies relevant in MRT
the theorem is not applicable, due to the higher importance of the photoelectric absorption. Its
cross-section scales much stronger with the atomic number Z than that of the Compton effect
which dominates at higher photon energies.
The principles of the point kernel algorithm were presented in our previous work75,76. The
basic idea of the approach is the splitting of electron and photon absorption due to the differences
in their ranges. Electrons travel a maximum distance of 100 to 200 µm in the relevant energy
domain of around 100 keV, but the photon mean free path in water is about 6 cm (see figure 3.1).
Hence, when describing the photon scattering, the energy transport by secondary electrons can
be ignored. The assumption of a local energy absorption is reasonable. Nevertheless, electrons
produced in primary interactions on the initial beam are responsible for the beam penumbras
and need to be regarded because of the micrometre-structure of the radiation field.
Both, photon and electron scattering are described in a point kernel algorithm. The kernels
are computed analytically. For electrons the absorption is derived from Bethe’s equation of the
stopping power S of charged particles77,
S = −dE
dx
=
Ze4NAρ
8pi20EMA
ln
(
4E
I
)
(3.43)
In this equation Z, ρ, MA and I are material parameters, namely atomic number, density,
molecular weight and ionisation energy. e is the electron charge, NA the Avogadro constant and
0 the dielectric constant. The equation describes the amount of kinetic energy that a charged
particle loses per distance travelled in matter. The equation is valid for non-relativistic energies.
At high but non-relativistic photon energies the equation can be approximated by75
S = KE−p. (3.44)
vIn fact O’Connor limited his analysis to materials that differ from water only in density. His work was
extended by others. For more information see for example Pruitt and Loevinger 74
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The quantities K and p can either be derived from material parameters or from data tables listing
the stopping power for electrons.
Analytic electron kernels can be obtained with some additional assumptions: Electrons cre-
ated in a primary photon interaction, i.e. photoelectric absorption or Compton scattering, are
assumed to be emitted isotropically in all directions. The unsteady path of the electrons is
approximated by a straight line. The production of bremsstrahlung is neglected. The initial
electron energy depends on the primary photon energy and on the interaction that created the
electron. However, Compton electrons are treated as monoenergetic, irrespective of the scatter-
ing angle. Finally it is assumed that the material is homogeneous within the electron range, i.e.
within a radius of less than 200 µm. The derived kernels are in reasonable agreement with Monte
Carlo simulated electron kernels. Comparisons were carried out previously75.
Photon kernels are calculated by differentiating between scattering orders. An incoming
photon might interact a first time by photoelectric absorption or Compton scattering. We call
the energy transferred to electrons in this first interaction as 0th scattering order. In the case of
Compton scattering a scattered photon is created that can interact again via the two interaction
processes. We call the transferred energy from this scattered photon 1st scattering order and
so on. The higher the scattering order the more the energy is spread in space. Therefore the
dose decreases with increasing order. If qi is the fraction of photons that interacts via Compton
scattering in ith scattering order,
qi(E) =
µC(Ei)
µC(Ei) + µPh(Ei)
, (3.45)
and if pi(E) is the fraction of photon energy that is on average transferred to an electron in a
Compton scattering event then the fraction of energy absorbed in nth order can be calculated
with
On = (qnpn + 1− qn)
n−1∏
i=0
(qi(1− pi)). (3.46)
In equation 3.45 µC and µPh are the total scattering or absorption coefficient of the Compton
effect and photoelectric absorption. The spatial distribution of energy in the point kernel is
calculated from the differential scattering cross sections of the Compton effect. For different
scattering orders the kernels are calculated separately. From the third scattering order an an-
alytical or numerical integration is impossible. The photon scattering is therefore simplified to
a random walk process with isotropic scattering. Details on the derivation of the spatial en-
ergy distribution can be found in Bartzsch and Oelfke 76 . The final scattering kernel KE,M (~r)
for photon energies E and materials M is obtained by adding up contributions of all scattering
orders.
Dose calculation itself is performed in a convolution algorithm. Kernels KE,M (~r) are pre-
calculated for various materials M and energies E for the scatter dose (order n > 0). Currently
implemented are the materials presented in table 3.1 at the photon energies E1 = 45, E2 = 55,
E3 = 65, E4 = 80, E5 = 105 and E6 = 135 keV . As for the Monte Carlo dose calculation
algorithm the material conversion from HU to the parameters in table 3.1 is based on the method
of Schneider et al. 45 .
In the dose calculation first the photon scattering is calculated. The spectral energy is
assigned to the six energies E1, . . . , E6 and separately at each energy E the "interaction strength"
SE is determinedvi, defined by the equation
SE(x, y, z) = µ(E, x, y, z)e
−
x∫
x′=0
µ(E,x′,y,z) dx′
, (3.47)
viSE is closely related to TERMA T (x, y, z), as defined by Ahnesjö et al. 78 : SE = Tρ/E.
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M HU ρ H C N O P Ca
1 -700 0.31 3.86 22.65 50.46 22.00 0 0
2 -350 0.67 8.36 49.07 21.24 20.72 0 0
3 -99 0.93 11.59 68.02 0.28 19.80 0 0
4 99 1.12 9.41 20.59 6.15 62.35 0 0
5 408 1.26 7.77 37.00 2.99 37.75 4.44 9.57
6 617 1.38 6.63 31.40 3.31 39.25 5.96 12.94
7 779 1.48 5.88 27.71 3.51 40.24 6.97 15.16
8 1038 1.63 4.87 22.71 3.80 41.57 8.33 18.16
9 1167 1.71 4.43 20.56 3.92 42.15 8.92 19.46
10 1416 1.86 3.69 16.91 4.12 43.12 9.92 21.65
Table 3.1 – Materials for which kernels are pre-calculated at 45, 55, 65, 80, 105 and 135 keV. The table states
the material index M, Hounsfield units (HU), density (ρ) in g cm−3, and the weight fractions of the elements
hydrogen (H), carbon (C), nitrogen (N), oxygen (O), phosphorous (P) and sodium (Ca) in percent.
where x denotes the propagation direction of the beam. The calculation is performed on the
macroscopic voxel grid of the CT and each voxel in the phantom is assigned to the most similar
kernel material M = 1, 2, . . . , 10 in table 3.1. Afterwards the scattered dose is calculated by
convolving the interaction strength SE and the kernelsKE,M in an energy and material dependent
manner,
DE,M (~r) = (KE,M (~r) ∗ SE,M ). (3.48)
Here we defineDE,M as the dose contribution of material M and energy E. SE,M is the interaction
strength for the material M, which is SE for all voxels that are assigned to M and 0 otherwise.
After the calculation of all DE,M (currently 6 · 10 = 60) the total scattered dose is computed as
the sum
Dscattered =
∑
E
∑
M
DE,M (3.49)
For broad beams the total dose is the sum of scattered and primary dose Dscattered+Dprimary,
where the primary dose is directly obtained from the “interaction amplitude” SE and the 0th
energy absorption fraction obtained from equation 3.46
DPrimary =
∑
E
SE (q0(E)p0(E) + 1− q0(E)) E
mV oxel
. (3.50)
In order to calculate the peak and valley dose the microscopic structure of the beams has to be
regarded. The valley dose has two components, the scattered photon dose Dscatter and electrons
that scatter from the peak region into the valley region. The peak dose is almost exclusively
defined by the primary dose Dprimary. The structure of the microbeam profile is computed by
convolving the electron kernels over the photon fluence pattern F (y). Since we consider planar
microbeams it can be assumed that the dose does only vary perpendicular to the microbeam
planes, parallel to the y-axis. Therefore the electron kernel is calculated in one dimension as a
function of y and reads
Ke
−
(y) =
C
σ
Iα(1− y
σ
) (3.51)
wherevii
Iα(q) =
q∫
0
rα
1− r dr. (3.52)
viiThe derivation can be found in Bartzsch 75 p. 35 ff.
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σ and a are material dependent. s corresponds to the electron range. The constant C is chosen
such that Ke− integrates to one. The fluence profile F(y) of primary photons is zero in the valley
regions, constant in the peak regions and is normalised that it integrates to one as well. Hence
the dose profile in the voxel is obtained in the convolution
D(y) = Dscatter +Dprimary · (Ke− ∗ F )(y). (3.53)
3.3.2 Implementation of the method, benefits and limitations
The described algorithms were implemented in a C++ program and connected to VIRTUOS by
Charlotte Debus79, a master student at the DKFZ. The program reads in plan files and CTs
from VIRTUOS and converts Hounsfield units to material parameters. In contrast to the Monte
Carlo calculations presented in chapter 3.2.2 calculations are performed in the beams eye view.
The CT is rotated and resampled on a grid such that the beam is parallel to the z-axis. At the
end of the dose calculations the calculated dose is rotated back into the CT system.
Similar to the Monte Carlo simulations the source model presented in chapter 2 was included
in the dose calculation. The ctc and beam width were set to 412.3 and 51.5 µm respectively.
The fluence profile was applied to the calculation of the interaction strength SE . The leakage
radiation dose was calculated from the leakage spectrum and added to the scattered dose.
The calculation time depends on the hardware, on the field size and the CT dimensions.
Typical calculation times are in the order of several minutes on a normal modern PC. This is a
major advantage over Monte Carlo simulations where typical calculation times are in the order
of several weeks, if the processes are not parallelised.
The disadvantage of the analytic dose calculation method is a lower accuracy due to the ap-
proximations made. Particularly problematic are interfaces of materials with highly contrasting
properties in the phantom. The point kernel algorithm assumes a locally homogeneous envi-
ronment for the point kernels. The problem is illustrated in figure 3.6 (left) for a bone-water
interface. The energy absorption in the scattering kernel in bone is more concentrated at the
centre, whereas the kernel in water spreads the energy over a larger volume. In the figure a
bone-scattering kernel (blue curve) is added close to the bone-water interface, assuming a ho-
mogeneous bone environment. The correct dose contribution of the scattering photons would,
however, follow the red curve. There are two effects that are important here: First, the range
of the photons is much higher in water, leading to an underestimation of the dose distant to the
material interface and secondly the absorption coefficient is lower in water and therefore there
is a sudden dose drop at the interface which leads to a lower kernel contribution than predicted
by the bone kernel close to the boundary. The consequences are smeared out dose edges in the
point kernel algorithm which are in reality much sharper. The effect can be seen in figure 3.6
(right), where a depth dose curve from a 30×30 mm2 broad beam field is plotted. The phantom
consists of water and contains a bone cylinder of 15 mm radius and a 200 mm axis perpendicular
to the beam in 35 mm depth (The graph was taken from Bartzsch 75).
How is it possible to reduce these errors without jeopardizing the speed of the dose calcula-
tion? A straight forward procedure would be a ray tracing and a directional scaling of the dose
kernels. But this is a very time consuming procedure, because from each interaction point it
would be necessary to perform a ray tracing into all beam directions. Instead we took another
approach. Similar to the optical path length a radiological distance dL can be defined via
dL = µds (3.54)
where ds is the geometrical distance and µ the total absorption coefficient. Instead of deforming
the kernels a deformation of the geometry in the phantom around the interaction point can be
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Figure 3.6 – Left: The figure illustrates the dose errors made by the point kernel algorithm at material interface.
The drawing shows a bone kernel close to a material interfaces to water. The superposition algorithm assumes a
homogeneous bone material around the kernel and therefore the dose contribution at this point follows the blue
curve. However, the correct contribution would be the red curve. Right: The consequences are smeared out dose
edges as shown in the example of a depth dose curve in a water phantom with a piece of bone.
performed. This leads to a superposition algorithm in curved space. The modified method which
is based on differential geometry part of the master thesis of Jennifer Kieselmann80. It will be
presented in outlines in the next section. As a short hand we refer to the presented method as
convolution point kernel algorithm (CPKA) and the method in the next chapter as superposition
point kernel algorithm (SPKA).
3.3.3 A superposition algorithm in curved space
In Bartzsch and Oelfke 76 point kernels in homogeneous medium are derived in different scattering
orders in the relevant energy range of MRT. In spherical coordinates ~r = (r, θ, φ) centred at the
primary interaction point, the first scattering order kernel has the principle shapeviii
Khom(~r) = F (E0, θ, φ) · µ
r2
q(E0)(p(E1)q(E1) + 1− q(E1))e−µr, (3.55)
where F (E0, θ, φ) is a factor that does not depend on material parameters anymore. Mate-
rial dependent quantities are the total attenuation coefficient µ and the fraction of Compton
interactions for photons, i.e.
q =
µC
µ
, (3.56)
where µC is the Compton attenuation coefficient. p is the fraction of energy which is transferred
to the electron in a Compton scattering event. While E0 is the primary photon energy, E1 = (1−
p)E0 is the mean photon energy of the scattered photon. For simplicity we focus on monoenergetic
beams in the following and we will not write energy dependencies explicitly. We write q0 for
q(E0), p0 for p(E0), q1 for q(E1) and p1 for p(E1). As already discussed, polychromatic beams
can easily be calculated as a weighted sum over all spectral components.
Moving to inhomogeneous phantoms the kernel becomes
Kinh(~r) = F (θ, φ) · µ(~r)
r2
q0(~0)(p1(~r)q1(~r) + 1− q1(~r))e
−
r∫
0
µ(r′,φ,θ)dr′
, (3.57)
where we denoted the primary interaction point with ~0.
viiiIn this shape the kernel yields the energy in a certain voxel. The dose is obtained by division by the mass
density.
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Kernel in ΣKernel in S
g
Figure 3.7 – The function g maps the inhomogeneous kernel in the physical system S into a system S where the
kernel corresponds to the homogeneous water kernel. The blue lines symbolise isodose curves. If the coordinate
transformation g is known a ray tracing is unnecessary.
This kernel can be split in four factors: The material independent factor F, the factor q0(~0)
which depends on the material at the primary interaction point only, a factor p1(~r)q1(~r)+1−q1(~r),
which depends on the material at the scattering point only and the factor G = e−L, which
depends on the radiological distance L between primary and scattering point,
L(r, θ, φ) =
r∫
0
µ(r′, φ, θ)dr′. (3.58)
The inhomogeneous kernel can therefore be obtained from the homogeneous (e.g. water) kernel
in the equation
Kinh(~r) = Khom
(
L(r, θ, φ)
µhom
, θ, φ
)
p1(~r)q1(~r) + 1− q1(~r)
p1,homq1,hom + 1− q1,hom ·
q0(~0)
q0,hom
(3.59)
Equation 3.59 inspires the following procedure for a dose calculation in an inhomogeneous
phantom:
1. The scattering power SE (see equation 3.47) is modified to S∗E(~r) = SE(~r) · q0(~r)q0,hom .
2. The homogeneous water kernels are superimposed after deformation in spherical coordi-
nates around ~r ′ with a function g~r ′ : (r, θ, φ) → (L/µWater, θ, φ). The superposition is
weighted by the modified scattering power S∗E :
D′(~r) =
∑
~r ′
[
S∗E(~r
′)KWater(g~r ′(~r − ~r ′))
]
(3.60)
g is determined by the absorption coefficient around the primary interaction point.
3. Finally all dose values are multiplied with p1(~r)q1(~r)+1−q1(~r)p1,homq1,hom+1−q1,hom .
D(~r) =
(
p1(~r)q1(~r) + 1− q1(~r)
p1,homq1,hom + 1− q1,hom
)
D′(~r) (3.61)
Step 2 can be understood as a deformation of the physical space via g : S → Σ, such that
the kernel in the inhomogeneous phantom has the shape of a water kernel in S. The mapping
g allows a transformation to the real physical space. Given the transformation g a ray tracing
is no longer required. The procedure is graphically illustrated in figure 3.7. Unfortunately the
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transformation
g~r ′ : (r, θ, φ)→ (L/µWater, θ, φ) (3.62)
is just locally defined and it has to be found individually for all primary interaction points at
~r ′. It would be tempting to try to find a global transformation of the space, because than
the superposition could be carried out as before in a convolution (see equation 3.48). This is,
however, not possible since the radiological distance depends on the integration path.
The general metric which describes radiological distances is given by
ds2 = µ2(r, θ, φ)dr2 + µ2(r, θ, φ)r2dθ2 + µ2(r, θ, φ)r2 sin2 θdφ2. (3.63)
The transformation g is a parametrisation for the arc length in radial direction (i.e. along the
photon paths).
Jennifer Kieselmann developed and implemented in her masters project an algorithm to
approximate g and superimposing inhomogeneous kernels in a superposition algorithm. This
work is now part of the dose calculation in the TPS and its accuracy at material boundaries is
significantly improved as compared to the convolution based point kernel algorithm. The price
for the higher accuracy is an increase in the calculation time by a factor of around 3, which is
still acceptable compared to Monte Carlo simulations. Further details of the method are given
in the master thesis80.
3.4 CT transformations: From HU to material parameters
Apart from the models used, the accuracy in the dose calculation substantially depends on the
conversion of Hounsfield units (HU) to material parameters. The method that we used for the
point kernel and for the Monte Carlo dose calculation was introduced by Schneider et al. 45 .
The conversion of HU to material parameters is not unambiguous. A CT device measures
the absorption coefficient of a material. The measured value depends on the spectral energy of
the CT. Therefore the absorption measured by a certain device cannot easily be compared with
that of other CT-devices. Hounsfield units present a way to compare different devices to each
other by the definition of a relative scale. On this scale water gets the value HU = 0 and air HU
= -1000 using the formula
HU = 1000 ·
(
µ
µH2O
− 1
)
. (3.64)
The Hounsfield unit scale simplifies comparisons between different CT images. But still the
relation between HU and material remains device dependent. In fact beam hardening effects
may even alter the HU representation of a material within the same CT image. Moreover, two
different materials may have the same HU representation because their absorption values are
coincidently equal at the photon energy of the source.
Schneider et al. 45 developed an interpolation method for the HU material conversion. They
realised that most tissues in the body can be described as a mixture of two main components.
The composition and density can therefore be calculated by an interpolation with the material
weights W1 and W2 of component 1 and component 2. The weight fraction of an element i,
ωi, for example can be interpolated from its weight fractions ωi,1 and ωi,2 in component 1 and
component 2 by
ωi = W1(ωi,1 − ωi,2) + ω2,i. (3.65)
Here we exploited the relation W1 +W2 = 1. Similarly the density can be obtained in
ρ =
ρ1ρ2
W1(ρ2 − ρ1) + ρ1 . (3.66)
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Material density [g/cm3] RED HU DHU
dense bone 1.53 1.456 1044 28
adipose 0.96 0.949 -69 20
lung (exhale) 0.50 0.489 -489 20
liver 1.07 1.052 56 21
trabecular bone 1.16 1.117 286 21
breast 0.99 0.976 -33 21
lung (inhale) 0.20 0.190 -792 21
muscle 1.06 1.043 48 21
Water 1.00 1.000 -5 56
Air 0.0012 0.0011 -998 10
Table 3.2 – The table shows the materials of the electron density reference phantom (model 062, CIRS), the
material parameters provided by the company81 and the HU measurement with the CT device at the AOI. DHU
states the standard deviation of the HU within the tissue equivalent inlets. Additionally air was added to the list.
From this Schneider et al. 45 derive the following HU-dependent scaling rules
ρ = (α+ β · 10−3HU) and (3.67)
ωi = γ · δ −HU
+ ηHU
(ωi,2 − ωi,1) + ωi,1. (3.68)
As supporting points for their interpolation they use in the bone domain between 100 and 1524
HU cortical bone (HU = 1524) and a mixture of red and yellow marrow (HU = -22). In the
soft tissue domain interpolation is carried out between adipose tissue (HU = -98), adrenal gland
(HU = 14), small intestine (HU = 23) and connective tissue (HU = 100). For HU below -98 the
material is treated as a mixture of air (-1000) and adipose tissue. These 7 tissues are the base
materials for the conversion.
Since the HU representation of tissues is CT-device dependent, a calibration of the material
conversion has to be carried out. For the first clinical pet trials at the ESRF CT scans will be
carried out at the "Animal Oncology and Imaging centre (AOI)"ix in Hünenberg, Switzerland. In
order to calibrate the CT an electron density reference phantom (model 062, CIRS, Norfolk, USA)
was scanned by Elke Bräuer-Krisch and Barbara Kaser-Hotz at the facility. This phantom is a
330 mm wide an 270 mm high soft tissue equivalent epoxy resin slice with 19 inserts representing
various materials in the human body. Table 3.2 presents the insert materials, and the HU seen
in the CT. Furthermore density and the relative electron density to water (RED) are listed as
provided by the manufacturer.
From this measurement the HU of the seven base materials are selected to achieve a maximum
agreement in density and RED for the 10 materials in table 3.2. The calibration curve is presented
in appendix B. The calibration uncertainty is on average 8.8 HU and is always smaller than 18
HU. Here we analysed of course just a limited number of materials. Schneider et al. 45 performed
a more comprehensive analysis with a total number of 77 naturally occurring tissues. The
standard deviation in HU from the calibration curve is 17.3. We assume therefore an uncertainty
of approximately 20 HU, taking into account the uncertainty in calibrating the CT-device and
the scattering of materials around the calibration.
This HU uncertainty affects the determination of the absorption coefficients and thus the
absorbed dose. The uncertainty in the absorption coefficient depends heavily on the HU and
the energy and varies between 0.5 and 5%. It is higher for low energies, since the photoelectric
ixHomepage of the AOI: http://www.aoicenter.ch/
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absorption has a strong dependence on the element composition. In general the uncertainty is
decreasing with increasing HU. A graph of the uncertainties over HU for 50, 100 and 150 keV
photons is shown in appendix B.
What is the resulting dose uncertainty? As it is apparent from the last paragraphs it is not
a simple task to attribute a general uncertainty from the material conversion. This is even more
difficult for the dose, because it will depend on the structure of the phantom, the depth in the
phantom and the spectrum of the radiation. If we just assume an uncertainty of 2% for the
determination of the absorption coefficient, which is approximately the average uncertainty for
a material that deviates modestly from the calibration curve, than in a homogeneous phantom
the dose uncertainty is
∆D
D
=
(µ+ ∆µ)e−(µ±∆µ) − µe−µx
µe−µx
≈ ±∆µ
µ
∓∆µx. (3.69)
For an absorption coefficient of µ = 20m−1 the expected error in for example 10 cm depth would
be 2%.
3.5 Results
At this point we present results for our algorithms and compare the accuracy of the dose calcu-
lation methods with each other. Of course benchmarking to measurements at the beamline is
indispensable. Dosimetry will be discussed in the next chapter and so we present here only a
comparison of dose calculations for two problems discussed in the next chapter: Dose calculation
in a homogeneous water phantom and in a human head phantom. In the next chapter measure-
ment results will be compared to Monte Carlo simulations only. Monte Carlo simulations can
be expected to be the most accurate dose calculation method and so we justify this limitation
with the wish to minimize possible confusions in the data presentation. The reader is, however,
invited to return to this chapter for comparisons.
3.5.1 Homogeneous water phantom
The energy absorption of microbeams in a homogeneous water phantom was calculated with
Monte Carlo simulations and the point kernel algorithm. To that end a CT was synthetically
created with HU = 0 in a 32×32×12 cm3 cuboid. The size of the CT image was 512×512×200
voxels with a resolution of 1 mm in all directions. Around the cuboid air was simulated with
HU = −1000. A plan was created in VIRTUOS with a 20×20 mm2 field of 50 µm wide and 400
µm spaced beams. The beam was directed parallel to the small dimension of the water phantom.
Subsequently the dose was calculated with three dose calculation approaches: the convolution
based point kernel algorithm (CPKA), the point kernel algorithm based on superposition in
curved spaced (SPKA) and Monte Carlo simulations (MC). In the Monte Carlo simulations
2 · 107 photon histories were simulated.
Figure 3.8 shows a comparison between Monte Carlo simulations and point kernel algorithm
(PKA) for the depth dose curve and 2 profiles at 30 and 60 mm depth, respectively. In the
case of a homogeneous phantom the results of the convolution and the superposition algorithm
are essentially the same. The agreement between the peak doses is better than 2% for all
depth and therefore the deviation is not plotted. For the valley doses figure 3.8 presents the
relative differences between Monte Carlo and point kernel algorithm underneath the dose curves.
Monte Carlo simulations still show a not negligible level of noise, which is ignored for quantitative
comparison. Between 24 and 120 mm depth the agreement in the depth dose curve is better than
5%. For shallow depth the dose is systematically overestimated by the point kernel algorithm.
Between 0 and 8 mm depth the deviation is higher than 20%. In the 30 mm depth profile the
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Figure 3.8 – The graphs compare Monte Carlo simulations and kernel based dose calculation in a homogeneous
water phantom for a 20×20 mm2 microbeam field with 50 µm wide and 400 µm spaced beams. From left to
right the depth dose curve in the field centre, a profile at 30 mm depth and a profile at 60 mm depth are shown.
All figures show the peak and the valley dose on a logarithmic scale. Underneath deviations in the valley dose
between both dose calculation methods are provided. The peak dose deviations are less than 2%.
dose is overestimated by 2% and in the 60 mm depth profile it is underestimated by 4.8% on
average.
3.5.2 Human head phantom
The dose calculation methods were compared on a CT of an anthropomorphic human head
phantom (CIRS, USA). This phantom served also for dose measurements with radiochromic
films in the next chapter. Slices of the CT image of the phantom are shown in figure 4.2. The
phantom is irradiated from the back with a field sized 20×20 mm2 consisting of 50 µm wide and
400 µm spaced microbeams. The irradiation plan corresponds to plan 1 presented in chapter
4.2.6 where also further details on the phantom will be given. In order to facilitate an easy
comparison with the next chapter we normalised the beams to a beam entrance dose of 100 Gy.
Figure 3.9 shows the depth dose curve in the beam centre and dose profiles at two different
depths, 64 and 104 mm. These two depth correspond to the inlay position 1 and 4 for film
dosimetry. For all dose curves relative deviations from MC are plotted underneath. The peak
depth dose curve agrees very well between MC, CPKA and SPKA. Encountered differences are
usually below 5% and only at the skull close to the beam entrance there are higher deviations
of up to 10% which are very likely caused by resampling the phantom in the kernel based dose
calculation. This is necessary, because kernels were precalculated for 0.5 and 2 mm resolution,
only. In the valley dose the differences are higher. In the homogeneous part of soft tissue the dose
is underestimated by CPKA and SPKA by between 10 and 15%. Close to the beam entrance
the CPKA overestimates the dose by 30% and more. Here the SPKA has a clear advantage and
deviations between SPKA and MC remain below 15%.
In the beam profiles again the peak dose is in excellent agreement between MC and the
kernel based dose calculation. The reason for the observed deviations seem to be linked to
statistical uncertainties in the Monte Carlo rather than physical shortcomings in the models of
the point kernel algorithm. Valley doses show again a bit higher uncertainties. Within the field
uncertainties are below 15%. There is a tendency of dose underestimation inside the beam and
dose overestimation outside the beam. In the Monte Carlo simulation there are two dose spikes
visible at approximately 70 and 200 mm lateral position. These dose features are not resolved
in the kernel based algorithms. The CPKA assumes of course homogeneous material around
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Figure 3.9 – The figure shows a dose calculation comparison for a 20×20 mm2 microbeam field with 50 µm
wide and 400 µm spaced beams in a anthropomorphic human head phantom. The top row shows the peak doses
and the bottom row valley doses in a depth dose curve (field centre) and two profiles. The positions correspond
to those in the next chapter (e.g. in figure 4.8). Deviations underneath the dose curve state differences to MC
simulations.
the primary interaction points. Since this is a feature far outside the primary beam it does
not recognise these structures. For the SPKA the structures are outside the region where the
superposition in curved space is applied and therefore the algorithm similarly ignores material
inhomogeneities there. However, the dose is just approximately 10% of the valley dose inside the
field and deviations there are unlikely to have a biological implication.
3.5.3 Optimal photon energy for MRT
Finally we return to the problem addressed at the beginning of this chapter. What is the optimal
photon energy for MRT? We created a phantom made of homogeneous water and a thin bone
layer of 7 mm thickness imitating the skull in an MRT treatment of the brain. We modified the
Monte Carlo simulations presented in chapter 3.2.2 to simulate monoenergetic MRT-fields of 2×2
and 4×4 cm2 between 50 and 400 keV photon energy. In figure 3.10 the result of the calculation
is plotted for PVDRs and valley doses in dependence on the photon energy. Furthermore the
peak dose in 10 cm depth is shown. The dose calculation was normalised to 100 Gy peak dose
at 2 cm depth.
The PVDR is highest at 150 keV photon energy in water and at 200 keV in bone. Doubling
the field size from 2×2 to 4×4 cm2 drastically reduces the PVDR, but it only slightly shifts the
energy upwards at which the PVDR is maximal. The result for the valley dose is very similar.
3.6 Conclusions 63
20
30
40
ey
,d
os
e,
[G
y]
0
10
0 100 200 300 400
V
al
le
Photon,energy,[keV]
10
15
20
25
30
35
P
V
D
R
14,mm,(bone),,20x20
20,mm,,20x20
100,mm,,20x20
14,mm,(bone),,40x40
20 40 40
0
5
0 100 200 300 400
mm, x
100,mm,,40x40
Photon,energy,[keV]
Figure 3.10 – The graph on the left show the PVDR dependence on the photon energy for monoenergetic MRT
fields of 2×2 cm2 (solid lines) and 4×4 cm2 (dashed lines) at 14 (blue), 20 (red) and 100 mm (green) depth in
the phantom. On the right the valley doses are shown. Additionally the peak dose in 10 cm depth is plotted as a
black line. Doses on the right are presented for a fixed peak dose of 100 Gy at 2 cm depth.
A minimal valley dose is reached at 150 keV photon energy in water and at 200 keV in bone.
Lower photon energies (50 keV) lead to much lower PVDRs and higher valley doses. The effect
is particularly severe in bone, where the valley dose at 50 keV is by factor of 3.5 higher than at
100 keV.
The peak dose in 10 cm depth increases with the photon energy. At the current mean energy
of the spectrum at ID17 of 100 keV around 26 Gy would be reached in the peak, whereas at 200
keV the dose would be 34 Gy.
These results proof that from a physical point of view a harder photon spectrum would be
advantageous. A mean photon energy between 150 and 200 keV would be the best compromise
between large mean free path on the one hand and low valley doses in bone and water on the
other hand.
3.6 Conclusions
In this chapter we presented various techniques to calculate peak and valley doses in MRT.
These techniques are, accept for the semi-adjoint Monte Carlo simulations, linked to a treatment
planning system VIRTUOS where all irradiation parameters are set. After planning the dose
calculation can be performed in forward Monte Carlo simulations or with point kernel based
algorithms. These algorithms are all based on the model of the photon source, which was
introduced in chapter 2 and furthermore on the conversion of CT Hounsfield units to material
parameters of which methods and uncertainties were analysed in chapter 3.4. Uncertainties from
the CT conversion are expected to be around 2%.
Among the dose calculation methods linked to VIRTUOS the forward Monte Carlo technique
presented in chapter 3.2.2 can be considered most accurate. However, calculation times are in
the order of several weeks for a sufficiently low statistic noise level. Parallelisation can reduce
the calculation time. Nevertheless Monte Carlo simulations remain a time consuming approach.
For that reason kernel based dose calculation algorithms were developed and discussed in
chapter 3.3. A pure convolution based dose calculation method (CPKA) is the fastest alterna-
tive to Monte Carlo simulations. Dose calculations can be performed within 5 to 10 minutes.
However, close to material boundaries there are larger deviations observable. This is an intrinsic
disadvantage of the method. Around the primary interaction point homogeneous material is
assumed and this generates a blurring at material interfaces. Although the deviations are less
than 10% in homogeneous parts of the phantom, errors close to irradiation boundaries can be
30% and more (chapter 3.5).
We therefore introduced another method in chapter 3.3.3: Dose calculation in curved space
which was implemented as part of a master thesis80. The basic idea of this method is that kernels
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in first order have the same shape when distances are measured in units of the radiological
distance. A mapping from the curved to the physical space depends on the material and is
approximated from the total attenuation coefficient around the primary interaction point. This
mapping in combination with local and global scaling methods enables the transformation of
a homogeneous water kernel in the curved space to the kernel in inhomogeneous material in
physical space. The method reduces the error close to material interfaces to less than 15%.
Screenshots of the treatment planning system are provided in appendix B. The methods
presented will not finalise the development of dose calculation tools in MRT. There are many
improvements and expansions desirable. The kernel based dose calculation approach provides a
method to calculate within around 30 minutes the dose with uncertainties of less than 15% in the
dose valleys and less than 2% in the dose peaks. This is an acceptable result for the optimisation
of treatment parameters and also with respect to the larger uncertainties in biology. Nonetheless
the accuracy will not be sufficient for therapy planning in patients and after optimisation of
irradiation directions and beam parameters time consuming Monte Carlo simulations will be
essential.
What limits the accuracy of the point kernel dose calculations? Respectively, what slows down
the speed of Monte Carlo computations? The limiting point for the point kernel algorithms is
the computation of scattered photon dose, whereas the limitations of Monte Carlo simulations
are the small voxel and beam sizes. The simulation of the photon scatter dose on a macroscopic
grid is easy to perform. These considerations suggest a combination of Monte Carlo and kernel
based techniques. In a hybrid algorithm the photon scatter dose could be efficiently calculated
in Monte Carlo simulations. Several authors report about very fast Monte Carlo codes that run
parallelised on GPUs82–84. The electron kernel algorithm, however, seems to be accurate enough
for the calculation of peak and valley doses. This approach could have the potential to calculate
peak and valley doses within minutes and with the accuracy of Monte Carlo simulations that
run over several weeks.
Another limiting factor of the developed dose calculation method is the restriction to uni-
lateral ports. In principle the point kernel algorithms have the ability to calculate the dose for
any beam geometry. However, work has to be invested into the storage and visualisation of
treatment relevant information. For the forward Monte Carlo code presented in chapter 3.2.2
multiport irradiations present a more fundamental problem. Here again hybrid approaches with
a combination of Monte Carlo and analytic methods could have the potential to offer an efficient
solution.
Chapter 4
Dosimetry of microbeams
4.1 Introduction
Dosimetry for MRT remains a challenge. The use of commercially available detectors is limited
due to the extremely high dose rate of up to 16,000 Gy/s, the required micrometer resolution and
the dose sensitivity which needs to range from 5 Gy up to 1000 Gy. A further issue in dosimetry
is the material equivalence to water. For a future clinical application of MRT doses need to be
measured within 3% accuracy. Bräuer-Krisch et al. 85 present several means of dosimetry and
analysed their strengths and weaknesses. Among others, solid state detectors are discussed such
as flash memory MOSFET detectors, fluorescent nuclear track detectors (FNTD), thermolumi-
nescent dosimeters (TLDs) and silicon strip detectors. These detectors often show dose rate and
energy dependencies and the readout process can be difficult. In recent years silicon detectors
have become very accurate, though, showing a high resolution, linearity over a wide dose range
and allow a microsecond real-time readout86,87. However, solid state detectors are usually not
water equivalent and may induce distortions in the radiation field. Other more tissue equivalent
detectors are MRI Gel dosimeters88,89. They possess a high three dimensional resolution, but
are usually very sensitive to dose rates.
Radiochromic films that we use here are promising dosimeters in MRT that have shown to
be largely dose rate independent and are usable over a wide range of radiation doses. With
resolutions of a few micrometre radiochromic films are among the highest resolving dosimeters,
they are easy to handle and their use is already established in radiotherapy. Unlike conventional
radiographic films radiochromic films darken instantaneously after radiation exposure without
chemical processing. Usually the radiosensitive substance is a monomer that polymerizes after
exposure to radiation and changes the absorption of the film material at optical wavelengths.
As radiosensitive films we used in this work HD-810 and HD-V2 Gafchromic® films from
ISP (Nuclear Associates) and investigated their applicability for our purposes. In table 4.1 some
features of the used films are compared to EBT2 films which are most frequently used in the
clinical practice but are sensitive to lower doses. So far HD-810 films showed the best performance
in terms of sensitivity and resolution in MRT. However, these films are not available any more
and are substituted by HD-V2 films. We compare the performance of both film types.
The dynamic range of the films is limited. HD-810 films are sensitive to doses between 5 and
500 Gy HD-V2 films to doses between 10 and 1000 Gy. Hence it is necessary to measure peak
and valley doses separately by choosing adequate beam exposure times.
For Gafchromic® films no dose rate dependency was reported. However the independence of
the dose rate was only confirmed between90 0.34 and 80 Gy min−1. For photon energies beneath
100 keV the film sensitivity becomes energy dependent91. This should not impair measurements
as long as calibration and measurements use the same spectrum. However, deviations are ex-
pected due to beam hardening and differences in the photon energies between peak and valley
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Film HD-V2 HD-810 EBT2
Dose 10 - 1000 Gy 5 - 500 Gy 0.1 - 10 Gy
Resolution 5 µm 2.5 µm 5 µm
Uniformity ≤ 3% ≤ 8% ≤ 3%
Table 4.1 – Comparison of HD-V2, HD-810 and EBT2 Gafchromic® films. Information are taken from the
webpage of Radio Product Design, Inc., http://www.rpdinc.com/ (01/05/2014).
regions in MRT-fields.
For all of the used films the optical dose-dependent absorption is strongest in the red light.
HD-V2 films have the most sensitive absorption peak at around 675 nm92. Due to their crystal
structure, Gafchromic® films have polarising properties rendering the readout sensitive to the
film orientation91,93,94 if the read-out light or the detector have any polarization preferences. A
disadvantage of radiochromic films is the required time between film exposure and readout. After
exposure the films need about 10 hours to darken and only after around 24 hours no significant
changes in the optical density can be observed91. This renders them unsuitable for online dose
measurements.
The main difficulty, however, in using radiochromic films is the film inhomogeneity which
can be classified in a microscopic and a macroscopic part91. Microscopic fluctuations in the
optical density arise due to the granular structure, compositional variations, defects in the film
structure, scratches or dust particles. This non-uniformity is of particular concern in high reso-
lution dosimetry considered here. Macroscopic non-uniformity is caused during layer production
in the manufacturing process. The overall variations within a film sheet are listed in table 4.1.
However, there are also variations between films and between batches.
The readout of the films on a micrometer scale is delicate. In conventional radiotherapy film
scanners are used. However, the resolution does not suffice for MRT. Although the nominal
scanner resolution is sometimes stated to be higher than 10,000 dpi, the actual optical resolution
is much less. At the ESRF a Joyce Loebl microdensitometer which has a much higher spatial
resolution is used to resolve the microbeams. Nevertheless its resolution is limited. The modu-
lation transfer function (MTF) of the device was measured and the resolution estimated to be
around 25 µm95. This is too low for 50 µm wide beams and the measured peak doses may be
incorrect. Another disadvantage of the microdensitometer is the lack of reproducibility and its
sensitivity to individual adjustments that makes the outcome user-dependent85.
In this chapter we use a microscope for the readout of films after the exposure to microbeams.
Its performance is demonstrated for various phantoms at the beamline ID17 of the ESRF. The
results of the dose calculation methods presented in the previous chapter are used for compar-
isons. Microscopes were used before for dosimetry in MRT by Nariyama et al. 96 , who compared
HD-810 Gafchromic® film measurements with Monte Carlo simulations for 25 µm wide mi-
crobeams. The achieved agreement was better than 20%. For quantitative measurements an
appropriate image processing is required. Even for a very good optics the field of view defined
by the objective and the camera chip size will not be homogeneously illuminated and flattening
corrections are necessary. However, compared to the microdensitometer the microscope is easier
to handle and data acquisition over the complete microbeam field is feasible within a reasonable
amount of time.
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4.2 Methods
4.2.1 Calibration with ionisation chambers
Radiochromic films enable only relative dosimetry. In order to link relative dose measurements
to absolute doses a calibration was performed with broad beam irradiations. For these fields
conventional dosimetry with ionisation chambers is possible when saturation effects due to the
high dose rates are corrected62. This way the optical film absorption can be correlated to a
physical dose.
Dosimetry of broad beams was performed using a pinpoint chamber TW31014 with a sensitive
volume of 0.015 cm3 and a semiflex chamber T31010 with a volume of 0.125 cm3 in combination
with a Unidos Webline T10022 electrometer; all devices are from PTW Freiburg. The semiflex
chamber was chosen due to its response uniformity to the MRT relevant photon energies and the
pinpoint chamber due to its small sensitive volume and low dose rate dependency. Cross-checking
both dosimters gives confidence in the measurement and its accuracy.
Dose measurements followed the AIEA TRS 398 report61 guidelines where further calibration
details can be found. The absorbed water equivalent dose Dw,q is determined by correcting
the effective ionisation M∗q with the beam quality factor kq and the calibration factor ND,w,
a chamber dependent factor that converts charge to the associated dose at the reference beam
quality,
Dw,q = M
∗
q ·ND,w · kq. (4.1)
In order to obtain the effective ionisation the chamber is calibrated to normal pressure p0 and
temperature T0 and is corrected for recombination effects by krecomb and the chamber polarity
by kpol,
M∗q = Mq ·
p0T
pT0
· krecomb · kpol. (4.2)
The factor kpol can be determined by subjecting the chamber to opposite polarities and reading
out the charge M+ and M−. The mean charge is assumed to be correct and hence kpol is set
to (M+ + M−)/(2M) where M is the standard readout polarity. For x-ray beams the effect is
usually very small. The recombination correction factor krecomb is obtained from the two voltage
method. Further details can be found in Andreo et al. 61 .
We are very grateful to Elke Bräuer-Krisch who conducted all the chamber measurements
and was an indispensable help due to her knowledge and experience with the ID17 beamline at
the ESRF.
4.2.2 Film handling
The 20.32×12.7 cm2 film sheets were carefully cut into pieces of around 3×3 cm2 size and were
marked with an "R" in the upper right corner to mark the film orientation. For the exposure and
the readout the orientation of the films was always kept constant. Film pieces for calibration and
measurement were usually taken from the same column of the film sheet since layer variations
are usually more prominent perpendicular to the coating application97.
Except for exposure and readout films were kept in darkness and wrapped in aluminium foil
to avoid the absorption of UV light. Films were carefully handled with nitrile gloves to avoid
contamination with oil and mechanical damage of the surfaces. However, we did not take extra
effort to control temperature or humidity.
4.2.3 Optics, Microscope
Instead of the microdensitometer we used a Zeiss Axio Vert.A1 microscope with EC Plan-Neofluar
objective lenses (magnification/numerical aperture of the objective lenses: 5x/0.16, 10x/0.3 and
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20x/0.5). In order to guarantee a stable illumination over time the microscope was equipped
with an LED light source. The spectral range of the LED extends from 400 to 750 µm and
is temperature independent. However, the output is low at longer wave lengths. Since the
Gafchromic® films have the highest readout sensitivity in the red light we added a RG 665
Schott low pass filter in the light path that is transmissive for wavelengths over 675 nm. As
detector we used an AxioCam MRm Rev. 3 FireWire camera (from Zeiss) with 1388×1040
pixels of 6.45×6.45 µm2 size. The dynamic range of the 12 bit camera is larger than 1:2200. The
quantum efficiency exceeds 20% between 350 and 900 nm and reaches its maximum between 500
and 550 nm.
The microscope was equipped with a scanning table (130×85 mot P) that allows a repro-
ducible positioning within 1 µm accuracy.
A linear response between light intensity and camera signal is very important for quantitative
measurements. We therefore validated the linear response of the camera with a photographic
step table (Kodak, Photographic Step Table No. 2).
4.2.4 Readout and image processing
The resolution of the smallest objective (NA=0.16, resolution of 1.29 µm with the camera) was
sufficient for all film readouts. The objective provides a relatively large field of view of 1.79×1.34
mm2 and also limits the amount of data acquired per scan. The field of view can be extended
by stitching images together. For this purpose we used the Zeiss MosaiX software. To ensure
that the film is flat in the focal plane it was clamped between two object plates. An important
adjustment at the microscope is the condensor aperture that determines the depth of focus. For
the Axio Vert.A1 the depth of field varies approximately between 2 and 45 µm. An optimal
setting would mean an illumination of the film’s sensitive layer only. We found that the contrast
is best if the aperture is 80% opened. Unfortunately the aperture also has a strong influence
on the light intensity and thus once adjusted the aperture should not be touched during the
measurement. Image brightness can be reproducibly regulated via LED voltage and exposure
time of the CCD-camera.
The image intensity is obtained as an integer value (grey value G) between 0 and 4095 (12-
bit). Measuring the intensity as a function of LED-voltage or camera exposure time always
yielded a linear behaviour up to a grey value of around 2800 (see figure 4.1). Above, the grey
value started to saturate. For this reasons we ensured that in all measurements the camera
readout did not exceed this value. On the other hand the grey value should be large enough to
reduce the noise. If the dynamic range is not sufficient, different exposure times or LED voltages
can be used for acquisition and the results be calibrated to each other.
Unfortunately the illumination of the field of view is never completely homogeneous. After
image acquisition all single images were shading corrected and imperfections in the film caused
by dust and scratches were eliminated. The latter was achieved by excluding pixels that lay
outside 5 standard deviations of the surrounding pixels. For the shading correction a reference
image R was taken from an unirradiated film and a dark image D where the illumination of the
microscope was turned off to account for the average background noise level. The raw image
Braw was corrected with the equation
Bcorr(i, j) =
Braw(i, j)−D(i, j)
R(i, j)−D(i, j) 〈R−D〉 . (4.3)
The argument (i, j) denotes the pixel position in the images. The angle brackets indicate an
averaging over the image. If the exposure time was changed between dark image, reference
image and sample image the brightness needs to be calibrated. Due to the linear response of the
CCD camera grey values taken at a exposure time t can easily be converted to the grey value at
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Figure 4.1 – Grey value response of the camera depending on the exposure time for different LED voltages.
There is a clear linear behaviour observable. Up to a grey value of 2800 the deviation from the linear response is
less than 1%. Above this value the response saturates. In all cases the grey value off-set at exposure time 0 ms
is 43.5 presumably due to the dead time of the system and background light/noise.
exposure time t0 by linear scaling,
G0 =
αt0 + β
αt+ β
G. (4.4)
Here a and b represent the regression parameters for the grey value dependence on the exposure
time (figure 4.1).
The microscope resolution was higher than the resolution actually required and images were
averaged over several pixels. Parallel to the microbeams where spatial resolution is not as
important averaging took place over 775 pixel (= 1.000 mm) and perpendicular to the microbeams
always 4 pixel were summarised (= 5.16 µm).
4.2.5 Calibration curves
For quantitative data the actual measurement films always need to be accompanied by calibration
films. It is advisable to take measurement and calibration films from the same row parallel to
the coating application.
Calibration films were exposed with homogeneous 2×2 cm2 fields at a reference depth of 2
cm in a 30×30×12 cm3 solid water phantom. Under these conditions also the measurements
with ionisation chambers were performed. Nevertheless the dose is not completely homogeneous
across the field. It is highest in the centre and lowest at the field edges. Therefore after the
scan of the calibration films the central, minimal grey value G0 was approximated by fitting a
quadratic function
G = G0 + α(i− a)2 + β(j − b)2; (4.5)
to the acquired image, where i and j are the image coordinates and a, b, a, b are fitting constants.
A calibration curve between film grey values and the dose measured with ionisation chambers
was obtained by identifying the parameters p1, p2 and p3 in equation
D(G) = p1 +
p2
G− p3 , (4.6)
that fitted the measurement best. Herein we follow the rational fit approach that Lewis 98
proposed.
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Figure 4.2 – The left two figures show a transversal and a sagittal view of the human head phantom CT scan.
On the right a sketch of the inlay and the film positions used for the measurements are shown.
4.2.6 Phantoms and experimental set-up
A homogeneous water phantom
The method was applied at ID17 of the ESRF to measure the dose in a 30×30×12 cm3 solid
water (RW3) phantom, where the short axis was parallel to the beam direction. Both, HD-V2
and HD-810 films were used for the measurement and their performance was compared. Films
were positioned at 3, 5, 10, 20, 30, 40, 60 and 80 mm depth and exposed to a 20×20 mm2
microbeam field formed by the multislit collimator (MSC)11. The collimator had 50 µm wide
slit apertures with 400 µm pitch. For all measurements the vertical slit upstream the MSC had
a 520 µm wide opening. At a storage ring current of approximately 200 mA the irradiation was
carried out by moving the target at a constant speed through the beam.
The measurement was done with two different beam set-ups, the preclinical and clinical. For
safety reasons and as part of the PASS system (see chapter 1.1.1) additional ionisation chambers
were added in the clinical set-up to online monitor the dose rate during irradiation. These
additional chambers affect mainly the dose rate but also the spectrum. In the preclinical modus
the dose rate per storage ring current was measured as 69.91 Gy/mAs and in the clinical modus
39.37 Gy/mAs.
In order to meet the most sensitive range of the radiochromic films peak doses and valley
doses were determined in separate irradiations. Films for the valley dose measurements were
irradiated with an 8 times higher peak entrance dose than films for the peak dose measurements.
An anthropomorphic human head phantom
A more realistic set-up was used to validate the therapy planning system. An anthropomorphic
human head phantom (CIRS, USA) was first scanned with a CT-scanner and afterwards used
for therapy planning in VIRTUOS (see chapter 1.2). The phantom consists of epoxy materials
imitating the brain, spinal cord, vertebral disk and soft tissuei. CIRS claims that the attenuation
coefficients of the materials match those of the real tissue within 1% accuracy between 50 keV
and 1 MeV. Figure 4.2 presents CT-scan slices of the phantom. The phantom has got an inlay of
63.5×63.5×104 mm3 size made up of one 63.5 mm, one 20 mm and two 10 mm high blocks with a
width and thickness of 63.5 mm. Between these blocks films can be positioned for measurements.
Two irradiation directions were planned for an exposure with 20×20 mm2 MRT fields with 50
µm wide and 400 µm spaced microbeams (plan 1 and plan 2). For both exposures the isocentre
was in the centre of the inlay in x and y and in z just behind the 63.5 mm high block (see figure
iThe details can be found on the web page of the company: http://www.cirsinc.com
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4.2). Four film positions were used as illustrated in figure 4.2. In plan 1 the field was irradiated
from the back and in plan 2 the head was horizontally rotated by 45° compared to plan 1 to
obtain a beam entrance from the back left.
Measurements were performed in the preclinical set-up. Calibration and measurement films
were always taken from the same row on one film sheet parallel to the coating direction to
minimize the effect of the film inhomogeneity. A maximum number of 8 film pieces can be
obtained in a row from a single film sheet. The calibration curve was measured with four films
at the doses 90, 120, 150 and 180 Gy. The other four films were used to measure peak and valley
doses at different depths (positions 1-4, figure 4.2). The peak entrance dose was adjusted in a
range between 300 and 10,000 Gy such that the dose to measure was always in the range of the
calibration. By varying the scanning speed of the goniometer the different peak entrance doses
were obtained (see chapter 1.1). The choice of a rather small calibration range was made to
increase the calibration accuracy.
Similar to a real treatment scenario the alignment of the head phantom was carried out on
the basis of lead markers located at different positions on the phantom surface. These markers
can be identified on the CT image. Prior to the MRT exposure projection images are acquired in
situ. On these projections the markers can also easily be located. Mattia Donzelli implemented
an algorithm that computes from this information the gantry angles required to deliver the
treatment plan.
4.2.7 Measurement of output factors
The dose absorbed in the phantom (patient, animal or sample) is determined by the dose rate
and the exposure time. The dose rate for a micrometre wide beam, however, is not directly
accessible by absolute dosimetry. Only the dose rate of large field sizes can reliably be measured
with ionisation chambers. Output factors link the dose rate of a small beam to that of a large
reference field.
The dose calculation of the treatment planning system only provides relative dose values. For
a treatment the exposure time (or goniometre speed) needs to be determined from the prescribed
dose at a certain depth in the target (usually given as a peak entrance dose at a certain depth),
the dose rate measured with ionisation chambers for a large reference field and the output factor
that relates both quantities with each other. Furthermore many MRT experiments use non-
standard irradiation geometries. One example are pencil beam irradiations71. At the moment
there is no treatment planning system that allows treatment planning for all possible irradiation
patterns. Other standard MRT experiments with mice and rats are lacking complete CT scans.
Nevertheless the dose given to the brain of the laboratory animal should be estimated. In all these
cases output factors are of outstanding importance. Their measurements with film dosimetry
and computation with Monte Carlo methods is, however, delicate.
Due to the small vertical field size and the impossibility to move the source, larger fields can
only be created by scanning the sample vertically through the beam (compare chapter 1.1). The
dose is determined by the scanning speed v, the slit height h, the electron current I in the storage
ring and the specific dose rate D˙. D˙ is vastly determined by the gap size of the magnetic field of
the wiggler, the measuring point in the phantom and the field size. For a certain geometry and
field size the dose can be calculated from the equation 1.1
D =
D˙ · I · h
v
.
The linear relationship between dose and ring current is well established99,100. D˙ needs to be
determined at the beginning of an experiment. For that reason a reference dose rate D˙ref is
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Figure 4.3 – Left: The figure shows a grey value histogram of a homogeneously irradiated film. In comparison
to a Gauss distribution (red) the distribution is clearly asymmetric and therefore peak, mean and median grey
value differ. Right: The mean grey value exhibits the most linear behaviour over the transmission intensity of a
photographic step table, and was hence used in all measurements.
measured under reference conditions for a 20×20 mm2 field, at 2 cm depth in a largeii solid
water phantom. The dose for any other field size and depth in a homogeneous phantom can be
calculated by multiplication of the reference dose rate with an output factor OF, i.e.
D =
D˙ref · I · h
v
·OF(field size, depth). (4.7)
Here we measure output factors for 25, 50, 75, 100, 500 and 1000 µm wide and 20 mm high
beams at 2 cm depth in a solid water phantom under preclinical conditions.
The Monte Carlo simulations were carried out with the semi-adjoint approach presented in
chapter 3.2.3. The source was defined as a point emitting photons in a single direction. Dose
was scored at 2 cm depth in a homogeneous water phantom on a grid with 10 µm bin side length
perpendicular to the beam and 1 mm parallel to the beam. As a whole the mesh grid covered
an area of 30×30 mm2 around the beam at 2 cm depth. 108 linearly polarised photons were
simulated and the interactions were handled as for most other simulations in this work with the
Livermore low energy libraries. The photon energy distribution followed the MRT spectrum.
For the determination of output factors the semi-adjoint Monte Carlo approach has the
advantage that the calculation for field sizes between 10×10 µm2 up to 30×30 mm2 can be
handled with a single simulation.
4.3 Results
4.3.1 Calibration curves
Grey values of the microscope film scans scatter over a broad range. A typical histogram of a
homogeneously irradiated film is presented in figure 4.3 (left). The grey values do not follow a
normal distribution (red curve) but are asymmetrically distributed; mean and maximum do not
coincide. We scanned a photographic step tablet (KODAK, Photographic Step Tablets No. 2)
with the microscope and plotted the logarithm of the grey value against the optical density. The
optical density (OD) is defined as
OD = − log10(I/I0), (4.8)
iiIdeally would be a solid water phantom of infinite size. In this sense "large" refers to a size where the change
in the backscattering contribution due to the phantom limitations can be neglected.
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Figure 4.4 – Left: Calibration curves for HD-V2 and HD-810 films in the clinical and preclinical set-up are
shown. The differences between the clinical and preclinical set-up are probably due to the energy dependence of
the film sensitivity. Right: The relative calibration uncertainty is higher for HD-810 films than for HD-V2 films.
Measurements should be carried out at higher doses.
with I0 as the incident and I the transmitted beam intensity. The best linear behaviour was
found between the mean grey value and the optical density (figure 4.3, right). Deviations from
linearity are smaller than 7%.
Calibrations curves for the dose measurement in a homogeneous water phantom are presented
in figure 4.4A. Deviations between the fit and the data are below 1.5 Gy for HD-V2 films and
below 2 Gy for HD-810 films. In figure 4.4B the resulting relative calibration uncertainty is
plotted over the dose. To keep the calibration uncertainty below 3% measurements should be
performed at doses above 50 Gy for HD-V2 films and above 70 Gy for HD-810 films.
Interestingly the calibration curves for the clinical and preclinical set-up are not identical.
The reason is probably the spectral shift towards lower energies when additional material is
added into the beam path. The response of Gafchromic® films is energy dependant at low
photon energies. Alternatively an inaccurate absolute dose measurement with the ionisation
chambers could be considered. However, the shift from the clinical to the preclinical set-up has
different directions for HD-810 and HD-V2 films. HD-V2 films seem to become more sensitive
moving towards lower energies, the HD-810 films become less sensitive. The problem will be
further discussed in section 4.4.3.
4.3.2 Measurement of an MRT field in a homogeneous solid water phantom
The microscope scans taken from films exposed to MRT fields had a resolution of 1.29 µm. For
further processing we reduced the resolution to 5 µm perpendicular and 1 mm parallel to the
beams and hence averaged over 4×775 = 3100 pixels. Doses of the clinical and the preclinical
irradiation were not significantly different. The modification done to the photon spectrum by
the additional ionisation chambers does not cause changes in the dose absorbed beyond the
measurement uncertainties of the films. Hence averaging was performed over both measurements.
In figure 4.5 (left column) peak and valley doses are shown as depth dose curves. A value
at a certain depth is obtained by averaging over the central 13 beams and 7 mm parallel to the
beams. The result of the Monte Carlo calculation is shown as a solid line. The average over
all 4 measurements (both films in the clinical and preclinical set-up, respectively) are presented
by blue crosses. Except for the peak dose at 80 mm depth Monte Carlo calculations are within
the measurement uncertainty which is determined as standard deviation from the 4 data points.
Although there is no systematic difference between the clinical and preclinical beam setting,
HD-V2 films measure a higher peak dose while HD-810 films measure a higher valley dose.
Consequently the deduced peak to valley dose ratios (PVDRs) are higher for HD-V2 films and
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Figure 4.5 – The figures show comparisons between film dosimetry and Monte Carlo dose calculations for a
20×20 mm2 MRT field in solid water. The beam spacing and beam width at the collimator were 400 µm and
50 µm, respectively. The left column presents depth dose curves and the right column profiles perpendicular to
the microbeam planes through the field centre at 30 mm depth. From top to bottom peak dose, valley dose and
PVDR are shown.
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Figure 4.6 – The centre to centre distance was measured at different depth and reflects the small but measurable
divergence of the synchrotron beam.
lower for HD-810 films. The differences are probably caused by different film sensitivities at low
photon energies.
In contrast to the microdensitometer measurements the microscope allows a two dimensional
readout of the entire microbeam fields. Therefore we were able to acquire peak dose, valley
dose and PVDR as profiles across the MRT field. In the right column of figure 4.5 profiles of
the microbeam field at 30 mm depth are shown. The profiles are taken from the centre of the
microbeam field by averaging over 7 mm parallel to the microbeams and over both film types in
the clinical and preclinical set-up (4 films). Error bars present 95% confidence intervals which
were deduced from the statistical noise in the data. However, they do not include systematic
errors due to calibration uncertainties or film inhomogeneities. In the field centre there are
photon scattering contributions from all directions. Valley doses are therefore higher in the field
centre than at the field edges. Changes in the peak dose on the contrary do not depend on the
photon scattering but are only determined by the primary photon fluence and inclined incidence
of the photons to the collimator (see chapter 2). Therefore the relative peak dose changes are
smaller across the MRT field and the PVDR gets higher at the field edges. The measured profiles
match the Monte Carlo simulated doses within the measurement uncertainties. The peak dose
variations across the MRT field seen in the Monte Carlo result are less than 5% and could not
be verified by film dosimetry.
Due to the high resolution of the microscope it was also possible to measure the beam
divergence in the solid water phantom. To this end the average beam to beam distance was
determined for the 4 measurement series in all depths. The result is plotted in figure 4.6.
Error bars are gain 95% confidence intervals. Linear regression gives a beam divergence of
tanα = (1.01 ± 0.06) · 10−5, where we denote the opening angle as α. A value of 1.02 · 10−5 is
expected from the 39.3 m distance between wiggler source and MSC and the slit spacing of 400
µm at the MSC. The measured ctc of the microbeams at the beam entrance is (412.04±0.02)µm.
The distance between sample and MSC is 1.2 m and consequently ctc at the goniometer should
be 412.21µm. The difference encountered can be attributed to an improper alignment of the
phantom surface with the isocentre of the goniometer.
4.3.3 Dose measurements in a human head phantom
The dose calculation in the human head phantom was handled similar to that in a real treatment
scenario. The peak entrance dose DPE for 50 µm wide beams at 2 cm depth in a water phantom
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Figure 4.7 – Calibration curves for peak and valley dose measurement in plan 1 and plan 2 in the human head
phantom.
determined the choice of the goniometer scanning speed v from equation 4.7. The dose calculation
algorithms deliver relative dose values only and hence they need a calibration.
For the Monte Carlo dose calculation the dose of the MRT-field was initially simulated in a
homogeneous solid water phantom to determine the number of photon histories required for a
Monte Carlo dose of 1 Gy at 2 cm depth. This quantity α was found to be
α = 6.526 · 1024Gy−1
in the simulation and was used to scale the simulated dose DMC in the human head phantom
with N photons by
D =
α ·DPE
N
·DMC , (4.9)
to obtain the dose D that was actually delivered in the exposure.
Figure 4.7 shows for each of the measurements (two plans with separated peak and valley
measurement) calibration curves. The fitting error for all calibration data is below 2%, which
is acceptable but not surprising in view of just four data points and three fitting parameters in
equation 4.6. Large deviations are between the different calibration curves. If we had used a
single calibration curve for all measurements the calibration error would have been roughly in
the order of 10%.
A comparison between film dosimetry and dose calculation is presented in figure 4.8. Depth
dose curves and profiles for peak and valley dose are presented. Measurements were unfortunately
only possible in the limited depth range of the inlay in the phantom. Dose calculations are,
however, performed on the whole phantom. Doses were calibrated to 100 Gy peak entrance
dose. Depth dose curves were taken from the centre of the microbeam field by averaging over
the central four microbeams (valleys) and 7 mm parallel to the beams. In plan 1 the agreement
between measurement and Monte Carlo simulation is in the peak doses better than 4% difference
and in the valley better than 9% difference. For plan 2 the peak dose at 26 and 44 mm is in the
measurement 14 and 12% lower than in the Monte Carlo simulations. At the other two depths
the agreement is better than 2%. Valley dose differences between measurement and Monte Carlo
are below 10%.
The profiles shown in figure 4.8 were taken at the centre of the microbeam field averaging over
7 mm parallel to the microbeams. The uncertainties indicate 95% confidence intervals derived
from the statistical variations on the film. They do not account for systematic errors such as
calibration uncertainties or film inhomogeneities. For treatment plan 2 there are considerable
deviations in the profiles at positions 1 and 2. The dose measurement was performed with an
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Figure 4.8 – The graphs show the measured and computed dose distribution of treatment plan 1 on the left and
treatment plan 2 on the right. At the top the depth dose curves for peak and valley doses, in the middle peak dose
profiles and at the bottom valley dose profiles are shown. The plotted uncertainties are 95% confidence intervals
obtained from the statistical variations on the film.
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Figure 4.9 – Left: When measuring output factors the peak dose was determined ignoring the reflection at
the edge of the microbeam. Right: Output factors determined by measurement and Monte Carlo simulations
depending on the aperture size are shown.
angle of 45° oblique to the beam. Therefore the radiological depth for the beams at one film edge
was significantly lower than for beams at the other film edge. This is reflected by a dose gradient
in the data. As illustrated in figure 4.2 (right) the centre of the field at measurement position
1 was exactly at the inlay boundary and hence the measurement could only be performed from
beam 20. Furthermore the measurements of the first 4 beams have larger uncertainties which
were very likely caused by strain and damage when the film sheet was cut.
4.3.4 Measurement of output factors
To calibrate the measurement four films were exposed to homogeneous fields of 100, 200, 250
and 300 Gy. Equation 4.6 was used to fit these values with a calibration uncertainty of up to
3%. In the microscope scans of the microbeam films an additional dose peak is observed at one
side of the microbeam. This peak was very likely caused by total external reflection (see chapter
2.4). Therefore it was subtracted in the determination of the microbeam dose as illustrated in
figure 4.9 (left).
The output factors were two times independently measured. The average difference between
both measurements was 0.08. The result is presented in figure 4.9 (right). The output factors
for 20 mm high fields are given with respect to a 20×20 mm2 reference field at 20 mm depth.
Therefore the Monte Carlo simulation approaches one at 20 mm aperture size. The Monte Carlo
result shows an increase of the output factors from 0.67 at 20 µm aperture size to 1 at 20 mm.
Between 100 and 1000 µm the slope flattens creating a turning point at approximately 300 µm.
4.4 Discussion
4.4.1 Uncertainty analysis
There are three main components that contribute to the measurement uncertainty.
1. Statistical noise caused by microscopic variations in the film and detector noise of the
microscope CCD camera.
2. Macroscopic Film inhomogeneities and not corrected inhomogeneous illumination.
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3. Calibration uncertainties leading to systematic errors. These errors influence the whole
series of film measurements that rely on the calibration. The error may express itself in a
dose off-set in a certain dose-range.
We estimated the influence of the first and second uncertainty by analysing the broad beam
irradiated calibration films. In the measurement films averaging was carried out over an image
subset S of N = 3100 (4×775) pixels to reduce the statistical noise. A random statistic noise
should consequently lead to an error of the mean µS of
σµS =
std(S)√
3100
. (4.10)
If a film is completely homogeneous and homogeneously irradiated, than for a set of subsets {Si}
with N pixels from the image it is to expect that the standard deviation of means equals the
mean of standard deviations, i.e.
std(mean(Si)) ≈ mean(std(Si)/
√
N). (4.11)
It follows directly from the law of large numbers when all the Si are independently and identically
distributed random variables. If there are inhomogeneities in the film than
std(mean(Si)) > mean(std(Si)/
√
N). (4.12)
Here we can identify the statistical noise with
σStat = mean(std(Si)/
√
N) (4.13)
and the total uncertainty with
σtotal = std(mean(Si)). (4.14)
The difference σinhom is caused by inhomogeneities and can be deduced from
σ2total = σ
2
inhom + σ
2
Stat. (4.15)
Unfortunately the dose is even for the broad beams not quite homogeneous, which was the reason
why we fitted the scanned dose with equation 4.5. How can we overcome this problem?
If the actual profile of the grey values in the film was known the problem could easily be
solved. The dose profile seen by the calibration films should have several symmetries. It should
have a four fold rotational symmetry and also a mirror symmetryiii. Therefore the information
in the film contains in fact an eight fold measurement of the broad beam profile. We exploited
this knowledge by averaging over all 8 orientations of the dose distribution. The resultant grey
value profile was subtracted from the film scan and the statistical analysis outlined above yielded
the influence of inhomogeneities, and statistical noise. Of course the method is not very accurate
and yet it allows a quantitative estimate of the uncertainty contributions.
The calibration error was estimated before as ∆D ≈ 2Gy for the HD-810 films and ∆D ≈
1.5Gy for the HD-V2 films. The calibration uncertainty depends of course on the dose separation
of the calibration doses and whether the calibration films stem from the same film sheet. The
observation made in figure 4.7 highly recommends to take the calibration and measurement series
from the same row along the coating direction.
The dose dependent contribution of all the errors is depicted in figure 4.10. The graphs
suggest that measurements should be carried out at higher doses. At low doses calibration errors
iiiWe ignore here an influence of the beam polarisation, which is very small when the field edges are excluded.
(see chapter 2)
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Figure 4.10 – The figures show the measurement uncertainties of radiochromic film dosimetry in MRT at a
resolution of 5000 µm2 for HD-810 (left) and HD-V2 films (right) classified according to the contributions of
statistical noise, film inhomogeneities and calibration uncertainties.
have a large influence. At higher doses the effects of film inhomogeneities dominate. Statistical
noise due to microstructure and granularity of the film is of minor importance. Overall the HD-
V2 and HD-810 films are not very different in their performance. In HD-V2 films inhomogeneities
and statistical noise are a bit higher than in HD-810 films. This is however balanced by a higher
calibration accuracy. In principle 5% accuracy in dosimetry is possible when measurements are
carried out at doses above 100 Gy. For that reason we chose for the dosimetry in the human
head phantom a dose range of 90 to 180 Gy.
The error analysis does not take into account film-film variations or dose inhomogeneities on
larger spatial scales. In view of the large variations in the calibration data presented in figure
4.7 these effects should not be underestimated. The error induced by statistical noise appears
to be very small in this analysis. It should be noted, however, that this strongly depends on the
resolution and scales with
σStat ∼ A−1/2, (4.16)
where A is the area of averaging which was 5 µm×1000 µm = 5000 µm2 for all measurements
in this work. If a high resolution of 5 µm is required in both directions than the statistical error
is going to be between 5% at 150 Gy and 28% at 10 Gy for the HD-V2 film and between 3% at
150 Gy and 6% at 10 Gy for the HD-810 film. Here the HD-810 film has got a clear advantage
over the HD-V2 film.
4.4.2 Grain Size
The resolution of the presented technique depends on the microscope and the grain size of the
films. The microscope resolution is better than 1 µm and does not present a limitation. The film
resolution, however, is limited by the crystal grain size. The manufacturer guarantees a resolution
of at least 5 µm. We estimated the grain size by calculating the two dimensional autocovariance
function as suggested by Buscombe et al. 101 for granularity measurement in sediments which
was implemented in the bachelor thesis of Katrin Welsch102 at our institute. For this purpose we
Fourier transformed the mean subtracted image of a homogeneously irradiated film. The absolute
value of the Fourier transform is squared to obtain the variance spectrum. The autocovariance
function is normalised by its maximum. As suggested by Buscombe et al. 101 we defined the grain
size as the area where the normalised autocovariance function exceeds 0.5. This led for the HD-
810 films to an average grain diameter of 1.95 µm and for the HD-V2 films to a grain diameter
of 2.02 µm. The autocovariance function is radially symmetric, meaning that the grains are
isotropic (circular) and also isotropically spread. It can therefore be expected that the physical
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imitations of the presented method is reached at around 2 µm. Both film types are comparable
in terms of their granularity.
4.4.3 Energy dependence of the films
It was reported previously that Gafchromic® films are sensitive to the photon energy for energies
lower than approximately 100 keV91,103. Butson et al. 91 investigated the energy dependence of
MD-55 Gafchromic® films and observed a drop of sensitivity to 60% at 30 keV compared to 120
keV effective photon energy.
In order to assess the energy dependence of the used Gafchromic® films we exposed them to
20 Gy photon dose of an x-ray tube at tube voltages of 100, 150, 200 and 250 kV and scanned
the films with the microscope. The dose rate was monitored with a semiflex and a soft x-ray
chamber. Both chambers agreed within 2%. Grey values were converted to dose using the
calibration curves and are plotted in figure 4.11 (left). More interesting is, however, the spectral
sensitivity.
We simulated the spectrum of the x-ray tube in Monte Carlo simulations in Geant4, version
9.3.p02. Unlike in all other Monte Carlo simulations we used the PENELOPE physics libraries
with an energy cut-off of 1.7 keV because they turned out to be more accurate for the simulation of
the characteristic x-ray spectrum. The anode material was tungsten and the beam was filtered
with an 0.1 mm copper filter. The simulated spectra can be found in appendix C. The film
sensitivity ηS towards an intensity spectrum g(E) can be calculated from the monochromatic
sensitivity h(E) via
ηS =
Emax∫
E=0
g(E)η(E) (4.17)
Without additional assumptions an infinite amount of measurements would be necessary to
determine h(E). However, the energy dependence of the film sensitivity is mainly influenced by
differences in the energy absorption between water and the film material. Since the polymeric
film consists of light elements only there are no discontinuous sensitivity changes to be expected
in the considered energy range.
Hence we approximated η(E) as a quadratic function. From the four measurements a system
of 4 linear equations with 3 variables (the coefficients of the polynomial) is formed. It can be
used to calculate both, the coefficients of the polynomial and also the uncertainties.
Since it was shown previously that Gafchromic® films have no energy dependence above 100
keV, we normalised the efficiency at 100 keV to 1 and show the result for the spectral sensitivity
in figure 4.11 (right). The HD-810 film shows a strong sensitivity decrease with decreasing
energy which was also reported for MD-V2-55 films91. The HD-V2 film, however, has a much
lower spectral dependency that slightly increases with decreasing energy. However, the increase
of about 10% towards 40 keV is not significant in our data. The result corresponds to the
weak energy dependence of EBT2 films which was shown by Butson et al. 104 . They found a
sensitivity increase of 5% when reducing the photon equivalent energy from 95 keV to 36 keV.
The different behaviour might be explained by the differences in the active materials of the two
film types. Both, HD-810 and MD-V2-55 films have pentacosa-10,12-dyinoic acid (PCDA) as
active material105 whereas EBT2 and HD-V2 films use the lithiumsalt LiPCDA.
Of course the result for the spectral sensitivity is far from being accurate and only intended
to give a general trend and proof of principle. Nevertheless it shows that HD-810 films have
a strong sensitivity drop at low energies. At 40 keV the sensitivity is just about 50% of the
sensitivity at 100 keV photon energy. HD-V2 films on the other hand are much less sensitive to
photon energies. At 40 keV the sensitivity has increased by about 10% compared to 100 keV. In
this respect HD-V2 films should be preferred when measuring doses at low photon energies.
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Figure 4.11 – The left graph shows the sensitivity of HD-810 and HD-V2 films to the energy spectrum of an
x-ray tube operated at 100, 150, 200 and 250 kV acceleration voltage. On the right the inferred spectral sensitivity
is shown.
4.5 Conclusions
In this chapter it was shown that film dosimetry in combination with microscopy is a dosimetry
tool that meets the requirements set by MRT. However, the method is error prone and special
care must be taken when evaluating the data. We analysed in detail the uncertainties and
compared Gafchromic® HD-V2 and HD-810 films. As an example dosimetry was performed in
a solid water phantom, a human head phantom and for the determination of output factors.
As three main components of measurement uncertainties we identified and quantified statisti-
cal noise, film inhomogeneities and calibration uncertainties. Calibration uncertainties dominate
especially at low doses for both films and fall below 3% at doses above 50 and 70 Gy for HD-V2
and HD-810 films, respectively. Inhomogeneities are the second largest source of uncertainties.
Measurement and calibration should be done on the same film sheet and ideally in one row paral-
lel to the coating direction in the fabrication process. Otherwise uncertainties of up to 10% have
to be expected. With respect to these parameters HD-V2 and HD-810 films are very similar.
Differences were, however, observed in the energy dependence and the statistical noise. HD-
810 films show a strong drop of sensitivity when moving towards lower energies. At 40 keV the
sensitivity is just half of that at 100 keV photon energy. HD-V2 films, on the other hand, have
just a very weak energy dependence in the range between 40 and 100 keV and their sensitivity
seems to slightly increase with decreasing photon energy. The effect of different film sensitivities
was for example observed in the calibration curves at the clinical and preclinical set-up of the
solid water phantom measurements.
The statistical noise in HD-V2 films is significantly higher than in HD-810 films. At the
resolution of 5×1000 µm2 used in this chapter the statistical noise is of minor importance and
usually much less than 1%. If the resolution of 5 µm is required in two directions than the
statistical noise will impair the measurements and may render the use of HD-V2 films impossible.
The dose of a microbeam field was determined in a solid water phantom. Within the measure-
ment uncertainties the peak and valley dose measurements agree with Monte Carlo calculations.
The Peak dose was determined with an accuracy of better than 5% and the valley dose with
an accuracy between 10 and 15%. Problematic was, however, a systematic difference between
HD-V2 and HD-810 film measurements. While valley doses were higher on HD-810 films, peak
doses were higher on HD-V2 films. The additional dosimeters in the beam line in the clinical
set-up did not measurably influence the dose in the phantom.
To validate doses predicted by our treatment planning system two plans were created and
delivered to a human head phantom. To this end we went through the entire treatment procedure:
CT scan with lead markers, planning in VIRTUOS, adjustment of orientation according to the
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acquisition of projection images and finally exposure with a certain peak entrance dose. The
comparison between the dose of the treatment planning system and dosimetry yielded agreement
within 10% in the valley doses and 4% for 6 of 8 measuring points in the peak dose. In one of
the plans two measuring points in the peak dose showed, however, differences of 12 and 14%
respectively.
The dose calculation in the human head phantom exhibited a strongly enhanced dose in the
skull. Especially in the valley dose the dose is increased by more than a factor of two. This may
be a severe problem in a future treatment of human patients.
Finally we determined output factors and compared them to Monte Carlo simulations. Un-
fortunately the measurement uncertainties are still in the order of 10% and further repetitions
are necessary to show that computation and measurement agree with smaller uncertainties. The
dependence of the output factor on the beam size is very sensitive to the underlying physical
processes. The polarisation has for example an influence of up to 2.5% (data not shown here).
Two regions in the output factor course can be distinguished. For apertures that are smaller
than around 300 µm electron scattering dominates the reached maximum dose. The smaller the
beam the more electrons scatter out of it and thus reduce the dose in the beam. At larger field
sizes the reached maximum dose is dominated by photon scattering. An equilibrium is not reach
at the reference field size of 20×20 mm2.
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Chapter 5
Towards a biological understanding of
MRT
5.1 Introduction
5.1.1 Basics of radiobiology
Effects of ionising radiation
iIonising radiation can be classified into directly ionising radiation and indirectly ionising radi-
ation. Directly ionising radiation such as proton or electron beams have the ability to directly
ionise atoms and molecules. Indirectly ionising radiation such as x-ray or g-rays produce sec-
ondary particles (usually electrons) that in turn ionise. In biological targets they may knock
out electrons in molecules on their path and affect in particular water, as the most prevalent
compound in living organisms,
H2O
g−−−→ H2O + + e−. (5.1)
This primary water ion has a very short lifetime and will react with water molecules to form a
hydroxyl radical
H2O
+ + H2O −→ H3O + + OH·. (5.2)
Free radicals are atoms or molecules with an unpaired electron. They are very reactive and will
induce damage in other molecules such as proteins and the genetic material.
Deoxyribonucleic acid (DNA), the carrier of the genetic information has been proven to be
the most sensitive target with respect to ionising radiation. During evolution various protection
and repair mechanisms developed to shield the DNA from alteration and damage. Nevertheless
already low doses of ionising radiation are able to cause, either by direct hits or indirectly by the
production of free radicals, unrepairable damage to this molecule. This may lead to cell death
or the inability of the cell to divide and proliferate.
The dose D0 that creates on average in every cell 1 lethal lesion takes for most mammalian
cells values between 1 and 2 Gy. D0 creates on average 40 double strand breaks (DSBs), around
1000 single strand breaks (SSBs) and over 1000 base damages per cell. Still, most of these lesions
are tackled by various DNA repair mechanisms and 37% of the cells survive this dose (Poisson
statistics). Base damages and SSBs are almost completely repaired. The much more complex
double strand breaks, however, were shown to decide upon cell survival.
iThis section follows in large parts Hall and Giaccia 106 .
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Figure 5.1 – Top: Base excision repair repairs mutations of single bases in four steps. Bottom: Nucleotide
excision repair replaces for example pyrimidine dimers and other damages affecting more than one base. The
figure was adapted from Hall and Giaccia 106 .
DNA repair pathways
There are different DNA repair pathways working in parallel in the cell and not all of them are
completely understood. Most of our knowledge on DNA repair mechanisms stems from mutations
in certain genes and how they change the radiation sensitivity. Base damages are fixed by the
base excision repair pathway (BER) or the nucleotide excision repair (NER).
In the base excision repair a single base mutation is repaired (see figure 5.1). These single
base mutations can arise after chemical alteration of bases, e.g. depurination of guanin or adenin
and desamination of cytosin. The repair process works in 4 steps. First the base is removed
by glycosylase or DNA lyase. Afterwards the sugar residues are removed by APE1 (apurinic
endonuclease 1) and the correct nucleotide is inserted by DNA polymerase b. In a last step
ligation is accomplished with DNA ligase III-XRCC1 (X-ray repair cross-complementing protein
1). In the case that more than one mutation occurred the repair synthesis is performed by
RFC (replication factor C), PCNA (proliferating cell nuclear antigen) or DNA polymerase d/e.
Overhanging structures are removed by flap endonuclease 1 (FEN) and the strands are joined
by ligase I.
Nucleotide excision repair (NER) removes adducts such as dimers from the DNA strand
(see figure 5.1). Typical lesions tackled by this repair pathway are dimers of two bases, e.g.
pyrimidindimers or covalent bonds between bases and large carbohydrates. The repair can be
divided in two types, NER related to transcription (TCR, transcription coupled repair) and a
general repair (GGR, general genome repair). The process is for both types very similar. The
lesion is recognised and the damaged DNA strand is cut on two positions bracketing the lesion.
The damaged region which typically counts between 24 and 32 nucleotides is removed and repair
synthesis and DNA ligation replaces the removed part and rejoins the insert.
DNA double strand repair has two basic processes, homologous recombination repair (HRR)
and nonhomologous end joining (NHEJ). Which pathway is preferred depends on the phase in
the cell cycle, and they do not exclude each other. In both cases ATM (ataxia-telangiectasia
mutated) and ATR (Rad3-related) are recruited to the DNA strand breaks. The proceeding of
the cell in the cell cycle is stopped. HRR requires for its function a copy from an undamaged
homologous chromatid or chromosome. Therefore it does only work after DNA replication in the
late S- or G2-phase of the cell cycle. Its primary function is to repair and restore the functionality
of replication forks with DSBs. ATM phosphorylates BRCA1 (breast cancer tumour suppressor
protein) which is recruited to the DSB. The enzyme MRE11 (and perhaps others) resects one
strand resulting in a 3’ single strand end of the DNA which becomes the binding site for Rad51.
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Endonuclease resection produces two RPA-coated single strand overhangs. BRCA2 is attracted
to the DSB by BRCA1 and facilitates loading of Rad51 onto RPA-overhangs. Rad51 forms
nucleofilaments and catalyses strand exchanges with the complementary strand in the undamaged
chromosome. Further paralogues of Rad51 bind to RPA-coated single stranded region and recruit
Rad52, which is protecting against exonucleolytic degradation. Rad54 unwinds the double strand
molecule. One of the broken strands is clamped between the intact homologous strands forming
so called "holiday junctions". Afterwards DNA-synthesis starts. In nonhomologous endjoining
(NHEJ) ATM and ATR activate an NBS/MRE11/Rad50s protein complex for the resection of
the DNA ends. This complex can be blocked and controlled by 53BP-1. At the same time
H2AQ is phosphorylated to gH2AX. The lesion is recognised by the KU-proteins that bind to
the DNA DSB ends. DNA-PKcs (protein kinase catalytic subunit) is recruited. The ends are
processed, overhangs and hair pins are removed by protein complexes summarised in the term
"Artemis". Polymerases (µ or l) bridge the DNA-ends and synthesise to fill the gaps. Finally
ligation follows by the PNK/XRCC/DNA-ligase IV/XLF complex. NHEJ is a very error-prone
signalling pathway. However, misrepaired double strand breaks do not necessarily affect the cell.
Most of the DNA molecule consists of non-coding parts, i.e. parts that do not contain genes, or
genes that are not actively expressed in the cell. Changes in these regions will not impair cell
survival.
Apart from the described repair pathways there exist also crosslink repair pathways, that deal
with DNA-DNA or DNA-protein cross links and mismatch repair (MMR) that remove base-base
mismatches or insertion mismatches.
Cell death and cell survival curves
Un- or misrepaired DNA can cause cell death. For radiotherapy the dose dependent cell survival
probability is an important quantity. However, cell death is ambiguous and can be defined in
various ways. Cell dying can occur via different processes and not all of them lead consequently
to a removal of the cell from the tissue.
A very controlled cell death mechanism is apoptosis. The word apoptosis comes from the
Greek verb "apopiptein" meaning falling off. It is a mechanism for a tissue to control tissue
growth and is for example involved when tadpoles lose their tail. Cells round up and detach
from neighbouring cells. The chromatin is condensed at the nuclear membrane and the nucleus
is fragmented. The cell shrinks and separates forming membrane-bound fragments ("apoptotic
bodies"), a process which is often termed "blebbing" . Many stress related signals are involved
in apoptosis activation. Especially p53 was identified as a key protein in apoptosis signalling.
Bcl-2 (B-cell lymphoma) is a suppressor of apoptosis.
Another stress related and very controlled mechanism that can lead to cell death is autophagy .
The term autophagy is derived from the Greek word "autoc", meaning self and "fagein", eating.
This process degrades long-lived proteins and organelles in lysosomes to sustain cells under
nutrient depletion. The cytoplasm and organelles are chopped and enclosed by membrane vesicles
("autophagosomes") that finally fuse with lysosomes. However, recent research has revealed that
autophagy has not only a protective character but is also related to cell death. It is therefore
sometimes referred to as programmed type II cell death. The mechanism is equal for all living
cells and was conserved during evolution.
The most common type of cell death after radiation, however, is mitotic death. Un- or
misrepaired lesions in the DNA manifest in different forms of chromosome aberrations. They
deprive the cell from the ability to adequately distribute the DNA content to the daughter cells
during cell division. Especially asymmetric exchange type aberrations seem to be the principle
mechanism for radiation-induced mitotic cell death.
Other mechanisms may just lead to silencing of the cell. Senescence is a cellular stress
88 Chapter 5 Towards a biological understanding of MRT
0.01
0.1
1
vi
vi
ng
 f
ra
ct
io
n
0.0001
0.001
0 1 2 3 4 5 6 7 8 9 10 11
Su
rv
Dose [Gy]
Figure 5.2 – The graph shows a typical cell survival curve.
response caused by DNA damage and oxidative stress that shortens the telomeres of the DNA.
p53 and retinoblastoma proteins signal the silencing of genes required for cell cycle progression
from the G1- to the S-phase. Senescence leads to permanent cell cycle arrest, however, the cell
lives on and takes part in intercellular signalling pathways.
For tumour control after radiotherapy it is sufficient to achieve that tumour cells are not
longer able to divide, i.e. the loss of reproductive integrity. Therefore cell survival is studied by
examining the clonogenic potential of cells after irradiation. In so called clonogenic assays cells
are collected after irradiation, counted and plated individually on a dish. The dish is incubated
for one or two weeks. The cells divide and start to form colonies, if they maintained reproductive
integrity. The outcome needs to be corrected by the plating efficiency. Even unexposed cells
do not have a 100% probability to form a colony. The plating efficiency is the percentage of
cells that forms colonies under control conditions in the absence of radiation. For low LET
radiation the cell survival starts as a straight line on a log-linear plot, shown in figure 5.2. Then
it is bending down over a range of a few Gray. At higher doses the cell survival is a straight
line again. Many biophysical models have been suggested to describe the observed behaviour.
However, the accuracy of the biological data is not high enough to discriminate the models. A
very popular and widespread model is the linear quadratic model (LQM). It assumes that there
are two forms of radiation actions, one leading to a linear and one to a quadratic form. The
surviving fraction can be described by
S = e−αD−βD
2
. (5.3)
This description goes back to early work with chromosomes and the idea that the most lethal
chromosome aberrations need two separate breaks, since two breaks introduce the chance of
crosslinks between different parts of the DNA. This frequently leads to mitotic cell death, be-
cause the homologous chromosomes cannot be pulled apart in the anaphase of mitosis. Hence
a quadratic term is added to the linear describing simple Poisson statistics. Both dose contri-
butions are equal for a dose equal to a/b. However, the curves do not quite coincide with the
observations, as the dose response becomes straight again at very high doses.
Measuring DNA strand breaks
DNA strand breaks are a measure for the damage done to a cell and especially double strand
breaks can be seen as an accurate estimate for cell survival. However, as we will review in the
next chapter, recent findings indicate that DSBs do not only appear as direct radiation damage
but also as signalling effects from the environment.
Different techniques have been developed to measure DNA strand breaks. A standard tech-
nique is pulse-field gel electrophoresis (PFGE). Cells are lysed and bedded in agarose plugs. DNA
5.1 Introduction 89
fragments are separated according to their size by electrophoresis. Another technique is the comet
assay , also known as single cell gel electrophoresis. Unlike PFGE the Comet assay studies DNA
damage on a single cell level. Cells are embedded in agarose and are lysed. The DNA forms
loops that are linked to the nuclear matrixii. In the following electrophoresis, comet like tails
appear under the microscope in the presence of strand breaks. A completely different approach
is the observation of DNA damage-induced nuclear foci. These assays use immunofluorescent
staining against certain proteins employed in the DNA damage repair system. The advantage
of these assays is an easy protocol and a possible application to both, tissue sections and cell
culture. Most commonly the proteins gH2AX and 53BP1 are analysed.
gH2AX which was used as a damage marker throughout this work is the phosphorylated ver-
sion of the histone protein H2AX. Unphosphorylated the histone is already part of the chromatin
in the cells. In response to radiation (see the DNA double strand repair pathway above) the
histone is phosphorylated in the vicinity of DSBs and shapes foci at the DSB.
53BP1 is also phosphorylated in response to stress and similarly forms nuclear foci. The
phosphorylated and the unphosphorylated part of the histone agglomerate around DSBs. Apart
from these frequently used proteins, others form foci as well (e.g. ATM, RPA, RAD51 and
BRCA1).
5.1.2 Challenges and experimental contradictions
In the last years the existing radiobiological models have been challenged by several in vivo
and in vitro findings. Although DNA DSBs seem to be the most relevant factor impairing cell
survival, their initiators can be various. Life has developed a variety of mechanisms to react when
facing life threatening situations and thus to protect the organism. Most likely these pathways
are not dedicated to deal with radiation damage. However, ionising radiation affects numerous
metabolic processes in cells and disturbs cellular equilibria such as that of oxidant production
and scavenging. A cell hit by ionizing radiation will answer to these changes by counter-reactions.
The expression of proteins may change, the progression in the cell cycle may be stopped and
stress response signals may be released into the intra- and intercellular medium. The cell may
undergo controlled cell death, neighbouring cells receiving signals from the hit cell may react and
eventually systemic processes may activate inflammatory pathways and immune response. Since
high doses of ionizing radiation are an unnatural source of endogenous hazard for a cell and an
organism it is unclear whether these reactions will in the end help the cell and corresponding
organism to survive or lead to further damage.
Certainly the paradigm of radiobiology – taking individual cell survival as a measure for
organ survival – needs to be regarded as a strongly simplified model. The organism, intercellular
signalling but also the inflammatory system play an important role. MRT is one example that
shows that existing models can be misleading and are insufficient to explain all observations
and treatment outcomes. In recent years overwhelming evidence has been gathered that even
conventional radiotherapy might be poorly described by current radiation-damage models.
Butterworth et al. 108 have categorised biological effects that are related to irradiation but are
not direct consequences of radiation damage in three groups, abscopal effects, bystander effects
and cohort effects. Abscopal effects are defined as radiation-induced effects in unirradiated tissue
outside the irradiated volume. The term summarises all radiation impacts observed in organs
distant to the radiation side. Bystander effects are radiation induced effects in the same tissue
but in cells that were not directly irradiated. These effects are mediated by different signalling
pathways. The term "bystander" has been used by many authors. Some have, however, pointed
out that the term might be misleading since not only bystander cells but also directly hit cells
iiThe nuclear matrix is similar to the cytoskeleton a network of fibres but inside the cell nucleus. For more
information see e.g. Nickerson 107 .
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are likely to be affected by intercellular signalling108,109. Therefore a third category of effects
is introduced, cohort effects, that summarises biological responses in irradiated cells that are
not directly evoked by energy deposition but rather intercellular communication. Plenty of
experimental evidence, in vivo and in vitro indicates that these cell-signalling effects are crucial
for cell and tissue survival110–112.
Bystander effects manifests in several ways. Reported are DNA damage, cellular transforma-
tions, chromosomal aberrations and mutations108,113,114, micronuclei113–115 and changes in gene
expression108. Therefore endpoints of radiation and bystander damage can be diverse, rendering
comparisons problematic as remarked by McMahon et al. 109 . A commonly used endpoint is the
foci formation of gH2AX and 53BP1 (e.g. Trainor et al. 112) as a measure of DNA DSBs and
the activation of double strand repair pathways. Intriguingly DSB formation is not only seen in
directly hit cells, but also in bystander responding cells. Another endpoint is cell killing which
is measured in clonogenic assays. This endpoint has probably the closest relation to clinical
outcomes. Moreover micronuclei formation can be an endpoint (e.g. Prise 116). The formation
of micronuclei predominantly arises from non-rejoined DNA DSBs and is associated with cancer
development115. Other authors examine the expression of stress factors such as p53 or related
proteins115.
When irradiating only a part of sparsely plated DU-145 (human prostate cancer) and AGO-
1522 (human fibroblast) cells in a single culture flask with an X-Rad 225 x-ray generator, But-
terworth et al. 117 observed a much lower out-of-field survival in clonogenic assays than predicted
by the linear quadratic model. Only if less than 10% of the cells were exposed, the cell survival
out-of-field went back to the level expected by the amount of scattered dose. Otherwise the
fraction of cells irradiated did not impact the out-of-field survival. Interestingly they found that
DU-145 cells show an increased in-field survival, when the in-field fraction decreases. This effect
could be related to the dose volume effect seen in MRT.
Trainor et al. 112 investigated the 53BP1 and γ-H2AX foci formation with the same cells and
source applying 1 Gy radiation dose. They found that in the in-field region of a modulated
radiation field 30 minutes after irradation less foci can be seen than at the same dose in a ho-
mogeneously irradiated sample. A transition zone formed between irradiated and non-irradiated
part, covering 8 mm in-field and 10 mm out-of-field, although the dose edge was much steeper.
After 24 hours there was no difference between irradiated and unirradiated cells observable, how-
ever, in- and out-of-field the foci number remained above unirradiated controls. In statistical
analysis of the foci number 24 hours post irradiation they could demonstrate that the index of
dispersion σ2/µ is larger than one. In statistics the index of dispersion or variance to mean ratio
measures the dispersion of probability distributions and is one for Poisson processes. Due to the
statistical nature of ionisation events one would expect that the number of DSBs per cell are
Poisson distributed. Indices of dispersion which are larger than one often occur if the data is
clustered suggesting here that there are two distinct entities of cells. Trainor et al. 112 inferred
that these entities correspond to the bystander responding and bystander non-responding cell
population. 32% of the cells were bystander responding with on average 3.1 additional foci per
cell as compared to control and 68% were not responding with additional 0.82 foci per cell when
irradiated.
A very remarkable observation was reported by Camphausen et al. 118 . They injected LLC-
LM or T241 tumour cells to the midline dorsum of mice and irradiated the legs of the animals
with 5 times 10 Gy on 5 consecutive days. Already the first day after the last fraction there was
a growth difference between sham irradiated controls and irradiated animals. 3 days later the
tumour size of non-irradiated mice was 3 times larger than in irradiated animals, although none
of the mice received a significant dose at the tumour site. They also showed that this abscopal
effect could be negated by blocking p53 or by taking p53-mutant mice.
Possibly related are dose rate and temporal fractionation effects. Although the dose rate does
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not seem to have an influence on cell survival as for instance shown by Butterworth et al. 117
for dose rates between 0.25 to 4 Gymin−1, interruptions during irradiation or periodic irradi-
ations appear to be of importance. While breathing motion does not influence cell survival in
homogeneous irradiations119, significant changes occurred in the survival when only parts of the
cells were irradiated. Cole et al. 120 examined survival of H460, H1299 and DU-1455 cell lines in
clonogenic assays in a half-irradiated cell culture flask where they imitated respiratory motion
by either moving the absorber or the cell flask. The motion perpendicular to the absorption
edge had 14 to 21 cycles per minute with 3 cm amplitude and described a cos2 waveform. Only
cells outside the 3 cm dose transition zone and a safety margin were taken for clonogenic assays.
When comparing the survival with static conditions an increased cell survival in- and out-of-field
was obtained. The out-of-field bystander effect was partially negated by the motion of the edge.
Mixing effects and cell migration could be ruled out. It was also refuted that the dose gradient
caused the increase in cell survival.
Clastogenic factors
The signalling mechanisms underlying the bystander effects are to date not revealed. It was
suggested that soluble clastogenic factors are one mediator of these effects. Clastogenic means
DNA breaking and clastogenic factors were first mentioned in 1954, when damage in the bone
marrow was observed in children whose spleen had been irradiated because of leukaemia113,121.
Supernatants of the blood in exposed humans and animals and the intercellular medium of
exposed cells in cell culture can induce DNA damage when transferred to healthy cells. These
clastogenic factors persist for a long time in the blood. They were still detected two months after
an accidental gamma radiation exposure122 and in atomic bomb survivors they were found even
31 years after exposure113. At the same time clastogenic activity of blood plasma from irradiated
rats was already seen 15 minutes after irradiation113,123, implying that clastogenic factors can
be generated very quickly.
Transferring the medium to unexposed (undamaged) cells causes DNA DSBs, which can for
example be detected with gH2AX fluorescent antibody staining. Han et al. 124 showed that the
maximum fraction of cells with gH2AX foci in cells receiving medium from irradiated cells is
already reached 10 minutes after irradiation. However, the clastogenic factors do not exist for
long in the extracted medium or plasma. The clastogenic activity of the medium rapidly de-
creases124. Cells seem to be the origin of the clastogenic factors and they actively emit them
into the intercellular medium. That is supported by the observation that blood plasma irradia-
tions122 or irradiations of cell culture medium124 alone do not lead to clastogenic factors. Upon
the dose dependence of clastogenic factors different observations were made. On the one hand
Emerit 122 did not see any dose dependence between 4 and 50 Gy when irradiating blood in vitro.
Clastogenic effects were still detectable at doses as low as 0.5 Gy. On the other hand Emerit
et al. 125 observed that the amount of clastogenic factors in the blood of Chernobyl clean-up
workers was dependent on the dose the workers were exposed to.
Radiation is not the only source of clastogenic factors in the organism. Clastogenic factors
were also found in patients with chronic inflammatory diseases122 and are considered to be at
the origin of the accompanied spontaneous chromosome instability observed. Again it is possible
to induce cell damage by transferring the supernatants of the blood of these patients to healthy
cells. Very likely these clastogenic factors also explain the increased risk of cancer in patients
with inflammatory diseases, e.g. a 20 times higher risk of colorectal cancer for Crohn’s disease
and an increased risk of liver cancer for hepatitis patients122. Likewise clastogenic factors are
created in contact with certain chemicals. One example is asbestos. Ingestion of asbestos or its
contact with the cell membrane leads to superoxide and hydrogen peroxide production126.
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Figure 5.3 – Reactive oxygen species, their transformations and degradation in cells. In red the important ROS
factors (oxidants) of the cell are shown: the superoxide anion, hydrogen peroxide and the hydroxyl radical. By
SOD (superoxide dismutase) catalysation superoxide is transformed into hydrogen peroxide. Hydrogen peroxide
in term can be eliminated by catalase or by glutathione (GSH) catalysed with the enzyme glutathione peroxidase
(GPx). The latter reaction leads to the products water and glutathione disulfid (GSSG). However, Fenton like
reactions can transform hydrogen peroxide into the very reactive hydroxyl radical. The graph is based on Robbins
and Zhao 129 .
Oxidative metabolism and reactive oxygen species
The exact mechanisms and chemicals underlying the clastogenic activity are still unknown.
Abundant evidence links clastogenic factors with oxidative stress and oxidants. A connection be-
tween bystander effects and reactive oxygen species was presumed by several researchers108,127,128.
A variety of oxidants is generated and handled by cells. Being capable of transforming and dam-
aging proteins and DNA, they present an acute hazard to the cell and some oxidants could work
as intracellular stress signals as well. One of the most important oxidants is hydrogen peroxide, a
comparably long lived and widely diffusible compound that possesses a life time of more than 100
s127,128. Hydrogen peroxide (H2O2) is rather weak oxidizing, it can cross biological membranes
and acts as an intracellular messenger. In the presence of transition metals it can create ex-
tremely reactive and toxic reactive oxygen species (ROS). For example hydroxyl radicals (OH·)
are produced from hydrogen peroxide in Fenton reactionsiii. Glutathione peroxidases (GPx) act
as hydrogen peroxide scavengers at low concentrations128. Another abundant, very unstable and
short lived oxidant with a life time of a few seconds is the superoxide anion (O−·2 ). It is mutated
by superoxide dismutase (SOD) in the reaction113,122
2 O−·2 + 2 H
+ SOD−−−−−−→ H2O2 + O2. (5.4)
The relation of ROS to each other is schematically shown in figure 5.3.
The main natural source of ROS in a cell is the oxidative metabolism127. 90% of superoxide
anions are produced within mitochondria3. Normally there is a balance between oxidant pro-
duction on the one and antioxidant defence on the other hand. If this balance is disturbed the
cell falls under oxidative stress, a pathological condition that can lead to degenerative senescence
and cancer. An altered redox state ("ROS level") affects the regulation of most stress-response
genes, it alters the growth rate, induces the expression of specific genes and modulates ion chan-
nel activities127. The ROS level can be affected by various exogenous impacts. Ionising radiation
is one of them.
Narayanan et al. 130 suggested that the plasma membrane bound NADPH oxidase becomes
activated in response to ionising radiation and produces large amounts of O−·2 . The mechanisms
that activate NADPH are not yet elucidated. However, selective blocking of NADPH oxidase by
diphenyleneiodonium inhibited the generation of H2O2 and O−·2 . This would mean that direct
iiiIn Fenton reactions transition metals donate or accept free electrons and help to form free radicals. Es-
pecially iron is often involved and can for example produce hydroxyl radicals from hydrogen peroxide in
Fe 2+ + H2O2 −−→ Fe 3+ + HO · + OH – .
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irradiation of the DNA is not necessary to induce mutations, which is supported for example by
Wu et al. 131 , who observed mutations after plasma irradiation with a-particles.
When cells are treated with DMSO (dimethyl sulfoxide), a potent hydroxyl radical scavenger,
the mutation frequency is strongly reduced127 and the number of observed DSBs, detected by
measuring gH2AX foci, is halved124 in irradiated cells. In bystander cells DMSO reduced the
number of gH2AX foci back to the level of non-irradiated cells. Further evidence, emphasizing
the role of oxidative stress in radiation damage, provide experiments in which glutathione (GSH)
depleted cells show an increased mutagenicity. Glutathione is an important thiol that acts as a
redox buffer in the cytosol and thus prevents oxidative stress127,132 (see figure 5.3).
ROS participate in the expression regulation of stress-inducible proteins, for example p53
signalling and the MAPK (mitogen-activated protein kinase) pathways. They also activate su-
peroxide dismutase (SOD) and certain catalyse enzymes127. SOD, given additionally up to 24
hours after irradiation, can inhibit the clastogenic factor formation. However, if SOD is added
later, it does not prevent or reduce clastogenic factors. ROS were also hypothesised to stimulate
cell growth by the redox-activated tumour growth factor b1 (TGF-b1) cytokine133.
Hypothetical clastogenic factors
There is a strong link between clastogenic factors and oxidative stress, but they are not identical.
Oxidative stress seems to be the precursor of clastogenic factors, since blocking ROS by SOD
or DMSO prevents their formation. Once present, SOD does not influence clastogenic factor
activities, though. Presumably cells amplify ROS production when irradiated and self-sustain
high ROS levels afterwards by clastogenic factor signalling. Oxidants can damage the DNA
molecule. They also initiate several stress related signalling processes. There is growing evidence
that acute and chronic oxidative stress initiates late radiation-induced effects as well.
Clastogenic factors were found to have a low molecular weight, to be unstable at room tem-
perature and to lose their activity overnight in a refrigerator. However, frozen they are preserved
over years. Clastogenic factors induce DNA damage in living cells, but not in isolated DNA.
HPLC (high-performance liquid chromatography) analysis suggests that they are comprised of
several components122. Clastogenic factors are most effective during the S- or G2-phase of the
cell cycle113. Three distinct groups of substances have been proposed as clastogenic factors:
cytokines108,122 (for example GF-b, interleukin-8, TNF-a), unusual nucleotides such as inosine
triphosphate (ITP)113,122 and molecules released from cell membranes by lipid peroxidation122.
Membranes have probably an important role in bystander and ROS signalling. By acti-
vation of phospholipase A2 arachidonic acid is released from the membrane and the genotoxic
4-hydroxynonenal is formed. For example this compound was found in most of the patients with
chronic inflammatory diseases. Membranes also play an important role for the release of TNF-a.
Gap junction mediated signalling
Gap junctions are plasma membrane structures forming low resistance channels that link neigh-
bouring cells. They consist of two connexons from each contributing cell. These connexons are
multimeric assemblies of connexins127. Gap junctions are widely spread among most animal
tissues and it is supposed that they play a central role in bystander signalling. After low dose
a-particle irradiations cell populations were found to respond rather as integrated units of adja-
cent cells than as separate individual cells127. Azzam et al. 115 irradiated confluent Ag1522 cells,
normal human skin fibroblasts and HLF1 cells, normal human lung fibroblasts with very low
doses of a-particles and assessed the expression of p21Waf1, a stress factor similar to p53. They
found that more cells showed an increased p21Waf1 expression than actually hit at doses as low
as a few mGy. Furthermore cells with p21Waf1 induction appeared in aggregates and lindane,
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an effective gap junction inhibitor, let these aggregates disappear. Furthermore lindane reduced
the number of micronuclei between 1 and 3 cGy significantly. At higher doses it didn’t have
a significant impact. There is also evidence that ionising radiation and ROS play a role in the
activation of gap junctions and the expression of gap junction proteins such as connexin43127,134.
5.1.3 Motivation and criticism of the experiments in this work
There are further explanations for the observed bystander effects. For example the inflammatory
system was suggested to play a role. Lorimore et al. 135 report that the recognition and clearance
of radiation induced apoptotic cells can activate macrophages and lead to neutrophil infiltrations.
The reaction of an organism to ionising radiation is very complex and involves many signalling
pathways and systemic reactions. Probably none of these has specifically evolved to protect
from radiation. A lot of further research is required to reveal the biological impact of ionising
radiation in its full depth. This will complicate the optimisation of treatment strategies in
radiotherapy. However, understanding might also help us to develop new, much more effective
treatment strategies. MRT is a first step, showing that we can do more than classical models
suggest, although we do not really understand why it works.
Apart from systemic reactions discussed for the explanation of MRT, a molecular biological
explanation may also be possible. Probably the tissue sparing property of MRT is the result
of a combination of various not yet understood factors. From the beam geometry in MRT
it is reasonable to suppose that bystander effects play a part. In a series of experiments we
analysed the response of pancreatic cancer cells to modulated radiation fields at different times
after radiation exposure. As biological markers we used gH2AX staining and DNA staining with
Hoechst 33342. We examined the gH2AX signal in homogeneous fields, at radiation boundaries,
in exposures with dose gradients and in MRT fields. Furthermore we looked at changes in the cell
cycle by analysing the Hoechst 33342 DNA-stain. We used in our experiments large screenings
of cells with ten and hundred thousands of cells, with an automatised cell and foci detection
system. This method yields good statistics and provides a kind of "flow cytometer" with spatial
resolution. The results are surprising. We found evidence for positive and negative bystander
response and some of these findings may explain the principles of MRT.
All our experiments were done in vitro only and we have to face related criticism. When
working with cell cultures one has to deal with the legitimate comment of looking at a very
artificial system that does not resemble at all a real organism. When the first clonogenic assays
were performed in 1956, the significance of in vitro experiments were questioned and criticised.
In 1957 F.G. Spear expressed his doubts in the MacKenzie Davidson Memorial Lecture to the
British Institute of Radiology by saying "An isolated cell in vitro does not necessarily behave as
it would have done if left in vivo in normal association with cells of other types. Its reactions
to various stimuli, including radiations, however interesting and important in themselves, may
indeed be no more typical of its behaviour in the parent tissue than Robinson Crusoe on his desert
island was representative of social life in York in the midseventeenth century."106 However, cell
culture results are successfully applied in radiotherapy today. For example the in vitro measured
cell survival curves agree very well with those obtained in vivo. Hence our results need to be
confirmed in living organisms. Nonetheless, with this work we hope to add a small piece to the
extremely fascinating puzzle of modern radiobiology.
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5.2 Methods
5.2.1 Cell culturing and antibody staining
Throughout our experiments human pancreatic cancer cells, Panc1 were used. These cells stem
from an epithelial carcinoma. They are adherent and grow in single layers. Cells were kept in a 1
g/l glucose DMEM mediumiv (from Life Technologies) with 10% fetal bovine serum (FBS, from
Life Technologies), 11% penicillin Pen/Strep Amphotericin B (from Lonza), 1% MEMNEAA non
essential amino acids (from PAN Biotech GmbH) and 1% GlutaMAX (from LifeTechnologies).
FBS was necessary to provide the cells with certain growth factors. The cells were grown in cell
culture flasks and kept in an incubator at 37 °C, 100% humidity and 5% CO2 level for buffering.
Cells were splitted ideally every second day. That means they are treated with trypsin for 5
minutes, a peptide breaking enzyme that is found for instance in the small intestine. If cells are
treated with trypsin for a short time the enzyme will not harm the cells but only break peptide
bonds between cells and between the cells and the dish surface. Thus it solves and separates cells.
After treatment a part of the cells is discarded, whereas the other is reseeded in the cell culture
flask. For irradiation cells were grown on iBidi µ-slidesv (iBidi GmbH, Planegg/Martinsried,
Germany) or in small cell culture flasks. In most experiments confluent cells were used. The
idea was to enable both, gap junctions and soluble factors mediated signalling effects. However,
the cell density varies a bit from experiment to experiment. The medium was changed directly
before irradiation. After irradiation the medium was kept until fixation in order to allow free
diffusion of potential soluble factors in the medium.
Fixation of the cells was performed 15 minutes in 4% paraformaldehyde (PFA) solution at
room temperature. Paraformaldehyde is the polymer of formaldehyde with chain lengths of
up to around 100 monomers. At low pH the polymer can be decomposed in water to form a
formaldehyde solution. Formaldehyde links proteins by forming methylene bridges and thereby
inactivates proteins and enzymes. At the same time functional groups remain and can be recog-
nised by antibodies during subsequent histochemical staining. After fixation cells were washed
3 times in PBS (phosphate buffered saline) to thoroughly remove the PFA again.
Immunostaining , immunohistochemical or antibody staining is a method that uses antibod-
ies to detect certain proteins, enzymes or functional groups in tissue sections or fixed cells in
cell culture. We used the indirect immunostaining method with a primary antibody, specific for
an antigen of interest (in our case gH2AX) and a binding site for a secondary antibody. As
primary antibody we used the Phospho-Histone H2A.X (Ser13) Rabbit (Alexa Fluor 488 Con-
jugate) antibody from Cell Signalling. Although this primary antibody is already coupled to
a fluorophore we counterstained with a fluorophore coupled secondary anti-rabbit antibody to
increase the signal strength. We followed the immunostaining protocol of the laboratory of Dr
Nathan Brady.
In the first step of this protocol cells are permeabilised with 0.3% Triton X-100 (from Sigma
Aldrich) solution in PBS for 10 minutes. Triton X-100 is a surfactant and is able to permeabilise
cell membranes. This is necessary to allow antibodies to penetrate the cell membrane.
Specificity of antibody staining is improved by a blocking step with 3% bovine serum al-
buminum (BSA, from Sigma Aldrich) in a 0.3% Triton X-100 solution for 45 minutes. BSA
prevents unspecific binding of antibodies. After blocking the cells are incubated over night with
the primary antibody in Triton X-100 solution. The primary antibody is thoroughly removed by
washing three times with PBS and the secondary antibody is added in Triton X-100 solution.
Incubation time for the secondary antibody is 1 hour. By washing with PBS the secondary
antibody is removed afterwards. Cell nuclei can be stained in this step by adding Hoechst 33342
ivFor the experiments at the synchrotron 3.7 g/l glucose DMEM medium was used.
vProduct details can be found on the company webpage, ibidi.com, catalogue number 80826 (August, 2014).
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Figure 5.4 – This figure shows the experimental set-up for the step exposure (left) and gradient exposure (right)
at the x-ray tube. The step exposure was achieved by exposing different parts of the two first iBidi wells for
different times.
(from Sigma Aldrich) to PBS. Hoechst 33342, similar to Hoechst 33258 is an organic compound
that specifically stains DNA fluorescently136. The molecule binds to the minor groove of double-
stranded DNA and preferably to adenine and thymine rich regions137. The excitation of Hoechst
33342 is at 352 nm with an emission in blue light, whereas the secondary has an excitation max-
imum at 488 nm with an emission in green light. With appropriate excitation light and filters
both signals can be analysed separately.
5.2.2 Beam application and dosimetry
Irradiation was carried out with a conventional x-ray tube and at the biomedical beamline ID17
of the European Synchrotron Radiation Facility (ESRF) in Grenoble, France. The following
experiments are presented in this work:
1. Homogeneous irradiation of cells in iBidi µ-slides at the x-ray tube with doses of 1, 2, 8,
16 and 32 Gy. Cells were fixed 3 hours after exposure. The aim of this experiment was to
measure the dose response of H2AX phosphorylation.
2. Homogeneous irradiation of cells in a cell culture flask at the x-ray tube with a dose of 32
Gy. Cells were fixed 24 hours after exposure. This experiment was intended to measure
changes in the cell cycle after homogeneous exposure.
3. Irradiation with a dose gradient in iBidi µ-slides at the x-ray tube. The maximum dose
was 48 Gy. Cells were fixed 3 and 24 hours after exposure. This experiment was carried
out to investigate the cellular response in the gH2AX signal to a radiation field with a
gradually changing dose.
4. Irradiation with 4 different doses in a single iBidi µ-slide well at the x-ray tube. Doses
were 0, 5, 16 and 32 Gy in an approximately 3 mm wide region. Cells were fixed 3 and
24 hours after exposure. In MRT strong dose gradients play an important role. Therefore
this experiment was aimed to explore the cellular reaction close to radiation boundaries.
5. Irradiation with a microbeam field (MRT-field) at the ESRF in iBidi µ-slides and in cell
culture flasks. Peak entrance doses were 50, 100 and 250 Gy and cells were fixated 1 and
6 hours after exposure. Finally in this experiment we investigated the cell response after
exposure in an MRT set-up.
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Figure 5.5 – The photon spectrum of the x-ray tube used for the cell irradiations (left) and the dose profile
behind the copper wedge (right) are shown. The dose is compared between measurement and calculation.
Experiments with an x-ray tube
For experiments 1 to 4 a Siemens Powerphos medical x-ray tube was used which was operated
at 4 mA cathode current and 120 kV acceleration voltage. The tube has a tungsten anode
and there is an intrinsic copper filter of 500 µm. The spectrum is presented in figure 5.5. It
was calculated with Monte Carlo simulations in Geant4.9.3.p02 and the PENELOPE physics
libraries56, neglecting the heel effect. The distance between sample and tube was approximately
12 cm. Absolute dosimetry was performed with a 0.125 cm3 semiflex chamber T31010 (PTW,
Freiburg). It was calibrated for photon beams between 66 keV and 5 MeV. Due to its comparably
small detector volume this chamber is suitable for the small field sizes of the x-ray tube which
have just a few cm in diameter. The chamber was connected to an UNIDOS electrometer (PTW).
The dose rate at the position of the cells was measuredvi as (17.9± 0.6) mGy/s.
Different dose distributions were achieved with different collimators and varying irradiation
times. To shield parts of the cells from radiation an absorber with 5 mm lead and 10 mm copper
was employed. Just 3 ·10−7 of the original dose rate is transmitted by the collimator (figure 5.4).
A copper wedge was used to create dose gradients. The length of the wedge was 48 mm and
the opening angle was 14.9° (figure 5.4). The dose profile created by the wedge was calculated
from the x-ray tube spectrum and with the x-ray absorption data from Berger et al. 64 . These
results were complemented by dosimetry with MDV Gafchromic® films. The read out was done
as described in chapter 4.2. The comparison between measurement and calculation is presented
in figure 5.5.
For the experiments 1 and 2 doses of 1, 2, 8, 16 and 32 Gy were achieved by varying the
exposure time from 56 s for 1 Gy to 30 minutes at 32 Gy. In experiment 3 cells were irradiated
45 minutes across the copper wedge. The dose steps of experiment 4 were again achieved by
varying exposure times of 0, 5, 15 and 30 minutes. Due to the set-up and variations in the dose
rate all dose values have an uncertainty of around 15%.
Experiments at the ID17 of the ESRF
The beam set-up for experiment 5 at the ID17 in Grenoble is shown in figure 5.6. The MSC
(multislit collimator) shapes 50 µm wide parallel beams with a centre to centre distance (ctc) of
400 µm. At the sample position beam width and ctc have increased to 51.5 and 412.3 µm (see
chapters 2.3.3 and 4.3.2). In order to create realistic peak and valley doses a PMMA block of 5
cm thickness was placed in front of the cells into the beam. This increases the scattered dose in
the valley.
viThe measurement was carried out by Katrin Welsch, BSc Physics student at that time.
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Figure 5.6 – The figure illustrates the experimental set-up used for dosimetry of the MRT cell exposure. The
bottom of the cell culture flask is elevated by a 1 mm stand at the flask edge. This creates a small air-gap which
needs to be considered in the dosimetry set-up. The 1 mm PMMA layer, imitating the flask bottom was separated
1 mm from the PMMA block.
Film dosimetry was performed with HD-V2 Gafchromic® films. Calibration films were ex-
posed to homogeneous doses between 10 and 400 Gy. Three independent measurements for both
peak and valley doses were carried out. The films were scanned according to the dosimetry
methods discussed in chapter 4.2. We fitted the function
D = −51.36Gy + 1.137 · 10
5
G− 130.1 Gy (5.5)
to the calibration data with doses D and pixel grey values G. Except for the 300 Gy value the
fitted calibration deviates by less than 5 Gy from the measurement. The dose was measured in a
set-up as similar as possible to the cell exposure (see figure 5.6).The results of the measurement
for the peak doses, valley doses and PVDRs at the three peak entrance doses used for the cell
exposure are summarised in the following tablevii:
Peak entrance dose [Gy] Peak dose [Gy] Valley dose [Gy] PVDR
50 16.0± 0.8 0.73± 0.04 22.0± 1.6
100 32.1± 1.6 1.46± 0.08 22.0± 1.6
250 80.2± 4.0 3.64± 0.18 22.0± 1.6
Monte Carlo simulations were performed in Geant4.9.5 in the semi-adjoint modus incorpo-
rating the developed source models (see chapters 2.3.3 and 3.2.3). 109 photons were simulated
with the ESRF spectrum and 107 with the collimator leakage spectrum. In figure 5.7 the Monte
Carlo results and the measurement of the peak and valley doses are plotted across the MRT field
for 100 Gy peak entrance dose. The peak dose is in excellent agreement between measurement
and calculation. However, the valley dose measurement is approximately 15% higher than the
Monte Carlo result. A likely explanation is the lack of electronic equilibrium at the film position.
For the evaluation of the cell irradiation presented in the next chapters the Monte Carlo results
were used.
5.2.3 Image acquisition and image processing
Microscopy was carried out with a fully automated, inverted Nikon Ti microscope for high content
screening (Ti-HCS) at the Nikon Imaging Centre of Heidelberg Universityviii. The microscope
was equipped with four objectives with 10, 20, 20 and 40 times magnification and a numerical
viiAccording to chapter 4.4.1 5% uncertainty was assumed for peak and valley dose measurement.
viiiWebpage of the Nikon Imaging Centre: http://nic.uni-hd.de/
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Figure 5.7 – Peak and valley doses (left and centre) measured by film dosimetry and computed in Monte Carlo
calculations are shown. A dose profile across the entire MRT field was obtained by Monte Carlo simulations and
is shown in the right figure.
aperture of 0.3, 0.75, 0.75 and 0.6 respectively. One of the 20x objectives was an immersion
objective. In all our experiments either the 10 or the 20x objective was used without immersion
oil. As camera served an Andor Clara high-sensitive interline-CCD-camera with a resolution of
1392×1040 pixels. The pixel size was 6.45×6.45 µm2. Several wavelength for excitation were
provided by a Lumencor SpectraX light engine. Available wavelengths were 395, 440, 475, 508,
560 and 640 nm. A scanning table and automatic focus allowed acquisition of large images. For
some experiments they extended to a region of several cm inferring scanning times of a few hours
and image sizes of up to 25 GByte.
Even the best optics cause artefacts with a negative impact on the image quality. The image
acquired will suffer from aberrations, for example astigmatism or chromatic aberration by an
imperfect objective. Furthermore it is very difficult to achieve a homogeneous irradiation of the
sample, which is mainly a problem of the illumination system of the microscope. But also an
ideal illumination and objective will only produce a sharp projection of a plane of the sample. If
there is a small tilt in the sample plane, there will be some areas in the image that are sharp and
others will appear blurred. To account for this problem z-stacks were acquired, i.e. the image
was acquired at different sample-objective distances. For each region in the image the sharpest
representation was chosen. This can easily be achieved by taking for all points the maximum
intensity of the z stack. The problem is illustrated in figure 5.8. For three points in the sample
the light paths and the focus created by the objective lens are shown. The highest light intensity
on the image side is obtained at the image position of a sharp projection, because there the light
is concentrated in a single point.
Image processing was performed in Matlab 2013. Correction of the image-illumination is
usually done by acquisition of a "flat" or "white" image. This white image is acquired without a
sample in the light path. We have, however, opted for another technique. Removing the sample
has the disadvantage that there is no scattering or emitting object in the focal plane. This leads
to dark images and the illumination inhomogeneities are poorly represented. Since we usually
acquired large mosaic images made up of many acquisitions at different lateral sample positions it
can be assumed that objects are on average statistically equally spread. Therefore all images from
an experiment were superimposed and averaged. The result still contains some remainders of
structures of the individual images as can be seen in figure 5.9 (left). Illumination inhomogeneities
are expected to appear on larger scales than structures seen in the samples. Therefore the white
image was filtered with a Fourier filter eliminating high frequency contributions. The filtered
white image is also shown in figure 5.9 (right). This process is repeated for all fluorescent channels
separately.
After image acquisition, each image is corrected by dividing the pixel grey values by the value
of the corresponding pixel in the white image. Each image in the mosaic has a small overlap
with its neighbouring images. This overlap needs to be regarded when fitting and stitching all
images together. The overlap is calculated via autocorrelation and assumed constant all over
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Figure 5.8 – An inclined sample plane leads to various image distances. Depending on the objective-sample
distance (z) different regions of the image appear sharp. A z-stack can help to increase the depth of field.
the mosaic. The resulting mosaic is normalised to its maximum intensity value for all acquired
channels and split into images of 2000×2000 pixels size (except for the edges).
The number of cells reached in some of the experiments 5 · 105 cells. Therefore it was
impossible to manually count gH2AX foci or to individually segment cells in the images. Instead
we used the software Cell Profiler138 to perform the segmentation of the cell nuclei and to identify
gH2AX foci. For nuclei recognition the Kapur method was used139. This method exploits the
histogram of the image. It determines the grey value threshold that maximizes the sum of the
entropy of a dimmer background and a brighter foreground. The entropies of the foreground F
and the background B are defined as
H(F ) = −
s∑
i=1
ni
NF
ln niNF
H(B) = −
m∑
i=s+1
ni
NB
ln niNB
(5.6)
where i is the index of the grey level, m the total number of grey levels, ni the number of pixels
with grey level i, NF the number of pixels in the foreground, i.e. NF =
s∑
i=1
ni, and NB is the
corresponding number of pixels in the background. The threshold value s was determined on a
global base. Because of the image correction and homogeneous staining level across the image
there was no need to adapt the threshold across the image.
Automated detection of gH2AX foci
Recognition of the gH2AX foci was more subtle. Whereas the cell nuclei were well separated
and did not overlap since the cells were growing in a monolayer and not piling up, gH2AX
foci agglomerated in the nuclei. They were distributed in the cell nucleus in three dimensions.
Foci below and above the focal plane contributed to a background noise and therefore a simple
thresholding method, such as the Kapur approach was not appropriate.
The z-stack acquisition was not extensive enough to get a sharp image of the whole cell. Some
of the gH2AX foci were situated outside the focal regions and would thus not be recognised as
foci throughout analysis. Nonetheless the number of detected foci will statistically be correlated
to the total number of foci in the cells. As long as the focal plane is more or less at the centre of
the cell nucleus the number of detected foci Ndetected will on average be the total number of foci
Ntotal multiplied by a detection rate η,
Ndetected ≈ η ·Ntotal. (5.7)
Not resolved foci lead, however, to a background signal. Some foci overlap or cannot be dis-
tinguished because of there close distance. Furthermore many cells exhibit a rather uniform or
fibrous gH2AX background signal. These background effects should not be identified as foci,
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Figure 5.9 – The shading correction of the fluorescence images was performed by averaging over all images of a
mosaic acquisition. The result of the averaging is shown on the left. The texture is a remainder of structures in
the single images. Smoothing with a Fourier filter gives the white image (right). Shading correction is essential.
The sensitivity fluctuates by approximately ±20% around the average.
though. The size of gH2AX foci varies depending on the lesion created and also on the radiation
type as observed for example by Bracalente et al. 140 . They found the diameter of the gH2AX
foci to vary approximately between 400 and 900 nm. Hence with a camera pixel pitch of 6.45 µm
and a 20x optical magnification the foci size would be between 1.2 and 2.8 pixels. However, the
limited optical resolution will blur the foci. The optical resolution Dx can be calculated from the
fluorescence wavelength l of the secondary antibody of about 500 nm and a numeric aperture
NA of 0.75,
∆x =
1.22λ
2 ·NA ≈ 400nm. (5.8)
Some of the foci may still be detectable, although they are slightly out of focus. Therefore it
can be expected that the foci have in the acquired images between 2 and 5 pixels diameter.
Furthermore they should be more or less circular in shape and have an approximately Gaus-
sian intensity profile (optical blurring). A selective filter would be appreciable that selectively
eliminates all structures that do not meet these requirements. The wavelet transformation is
an integral transformation that performs this kind of filtering. Unlike a Fourier transform the
wavelet transform contains both frequency and spatial information. The continuous wavelet
transform g˜ of a function g is defined in one dimension as
g˜(a, x) =
∞∫
−∞
[
g(x′)
1√
a
W ∗
(
x− x′
a
)]
dx′ (5.9)
and the back-transformation
g(x) =
1
CW
∞∫
−∞
∞∫
0
[
g˜(a, x′)
1√
a
W
(
x− x′
a
)]
da
a2
dx′. (5.10)
Here the parameter a defines the size or wavelength of the wavelet. W and W ∗ are the wavelet
and its complex conjugate that have to obey the admissibility condition in Fourier space,
CW =
∞∫
0
|Wˆ (ω)|2 dω|ω| <∞. (5.11)
This condition also determines the factor CW in the back-transformation and is fulfilled if the
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Figure 5.10 – The one dimensional Mexican hat function (A) with its spectrum (C) was used to identify
gH2AX foci in the fluorescence microscope images. (B) shows the green fluorescence signal of a cell in which the
phosphorylated H2AX histone was stained with an antibody emitting in green light. Whereas foci detection was
difficult in (B) it was straightforward in the wavelet filtered image (D).
integral in normal space disappears, i.e.
∞∫
−∞
W (x) dx = 0.
It is simple to extend this transformation to two dimensions. The transform has four dimensions,
2 spatial and 2 wavelength dimensions. There are several wavelets in use and the wavelet trans-
formation plays an important role in image compression and modern data processing. For our
purposes a wavelet that is similar to the foci shape would be ideal. A wavelet that is fulfilling
the admissibility condition and is closest to the normal distribution is the Mexican hat function.
It ensues from the Laplace derivative of the two dimensional Gauss function,
f(x, y, σx, σy) =
1
2piσxσy
e
− 1
2
(
x2
σ2y
+ y
2
σ2y
)
(5.12)
and reads
W (x, y, σx, σy) =
σ2xσ
4
y + σ
4
xσ
2
y − σ4yx2 − σ4xy2
2piσ5xσ
5
y
e
− x2
2σ2x
− y2
2σ2y . (5.13)
In the isotropic case when σ = σx = σy the Mexican hat simplifies to
W (x, y, σ) =
1
2piσ4
(
2− x
2 + y2
σ2
)
e
− 1
2
(
x2+y2
σ2
)
. (5.14)
The advantage of using the Mexican hat wavelet is that it is localised in frequency and space.
For one dimension the Mexican hat function and its wavelength spectrum is shown in figure 5.10
with the wavelength which was also used in the foci analysis. An example of a damaged cell in
the 500 nm GFP-channel is also presented in figure 5.10 together with the Mexican hat transform
and the subsequently identified foci positions.
It is difficult to estimate the error-rate of this automatic detection method. A comparison
with eye-based foci counting gave a detection rate of (85± 5)%. However, manual foci counting
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Figure 5.11 – The four images present the four different morphology types of radiation damage in the GFP-
channel. The images were acquired of fluorescent stained Panc1 cells. gH2AX labelling appears in green light
and the DNA (the nucleus) in blue light. From left to right examples of type I, II, III and IV cells are presented.
Some cells have a mixture of type II-IV properties. The white scale bar has a length of 10 µm.
cannot be a reference since it also exhibits uncertainties. In another test we synthetically created
foci in Matlab that had sizes and shapes similar to those seen in the microscope images. In these
synthetic tests the detection rate tended towards 80% at high foci densities.
5.3 Results
5.3.1 Morphology of gH2AX-fluorescent stained cells after irradiation
Cells are not identical. Although the cells in a cell culture are monoclonal, i.e. they stem from a
single ancestral cell, they differ in the state of the cell cycle, in age, oxidative state, mutations in
the genome and many other parameters. Therefore the response of cells to a stimulus or stress
such as ionising radiation will also cause individual reactions. Phosphorylation of gH2AX is a
very rapid process. We fixed cells 30 minutes to 24 hours after irradiation depending on the
experiment and the highest fluorescence signal was obtained shortly after irradiation. However,
the signal is still measurable 24 hours after exposure. The rapid reaction of the H2AX histone
following double strand break formation was observed in many experiments. The morphology of
gH2AX staining varies. At doses of up to 5 Gy some cells showed no reaction at all and others
were completely filled with the fluorescence signal. The distribution of the fluorescent marker
can also differ from cell to cell. In some cases the marker was more or less homogeneously spread
over the entire cell, in other cases foci formed in different sizes. We tried to classify the cellular
reaction to radiation by gH2AX foci formation and found 4 groups (figure 5.11).
• Type I cells show no reaction at all. The gH2AX level is low and there are no foci visible.
• Type II cells have several small gH2AX foci. The foci diameter is smaller than 1.5 µm
diameter. The background signal in the nucleus is low.
• Type III cells have a few large gH2AX foci. The foci diameter is larger than 1.5 µm and
can measure up to 3 µm. The background signal in the nucleus is small.
• Type IV cells are completely filled with gH2AX speckle and foci. Some cells seem to emit
a homogeneous, strong signal or have a high background signal.
The groups do not exclude each other. There are cells that have small and large foci at the same
time with varying levels of background signal. The fraction of cells belonging to the different cell
types depends on the dose. In very rare occasions apoptotic cells can be observed recognisable
by blebbing and fragmentation of the cells (see chapter 5.1.1). These cells usually have a strong
gH2AX fluorescence signal.
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Figure 5.12 – Left: The gH2AX signal intensity histogram is shown for homogeneous irradiations with various
doses 3 hours after exposure. With increasing dose the distribution becomes wider and is shifted towards higher
doses. Right: gH2AX foci number histograms are shown for the same data. A shift to larger foci number is
observed with increasing dose. The distributions are broader than for the signal intensity. Some cells do not show
gH2AX foci at all. Especially at low doses there is a larger fraction of "non-responding cells". Peak positions and
averages are plotted against dose in figure 5.13.
5.3.2 Exposure to homogeneous doses
Intensity and foci number are not linearly correlated
To assess the response of cells to homogeneous doses we plated cells in an experiment (experiment
1) 48 hours prior to irradiation onto iBidi µ-slides with a cell area density of 300 cells per square
millimetre. Upon fixation 3 hours after irradiation the cell density was (630±50) mm−2. Applied
radiation doses were 1, 2, 8, 16 and 32 Gy. The cells were stained after fixation. The images
were processed and analysed as described above. The number of gH2AX foci and the gH2AX
intensity were determined for all of between 25,000 and 55,000 identified cells per dose. Figure
5.12 shows the cell frequency spectra over the gH2AX intensity and the number of gH2AX foci.
In the gH2AX fluorescence intensity histogram a single peak occurs. It becomes broader and is
shifted towards higher intensities with increasing dose. The foci number spectrum also shows a
peak. Similarly it becomes broader and is shifted towards higher foci numbers with increasing
dose. However, at low doses there is also a number of cells that do not have any foci at all. If the
creation of foci was just a reaction to DSBs and each focus relates to a single DSB, one would
expect a Poisson distribution of foci. All of the distributions are much broader than Poisson
distributions. This can be tested by calculating the variance to mean ratio (VMR), which is 1
for Poisson distributions but between 10 and 15 in the measurement (compare Trainor et al. 112).
The differences here may be explained by counting uncertainties. Unexplained remains, however,
the group of cells with no or very few foci. At low doses there seem to be responding and non-
responding cells. These two types of cells are not distinguishable in the gH2AX intensity spectra.
However, we found that the non-responding cells were at the low intensity end of the gH2AX
intensity spectrum.
In figure 5.13 the gH2AX fluorescence signal and the average number of gH2AX foci are
plotted against the applied dose. The mean and the most frequent value (peak position) are
shown in the same graph. The latter is less sensitive to outliers. The uncertainty bars illustrate
the peak width, which was arbitrarily defined as the set of values where the frequency is larger
than 70% of the peak frequency. As described by others the number of gH2AX foci saturates at
high doses. The gH2AX intensity, however, grows approximately proportional to
√
D (compare
black fit) and does not saturate. The reason for foci saturation could either be detection problems
at high foci densities or the formation of repair centres141. The phosphorylation of the histone
H2AX does apparently continue. A
√
D behaviour could have its origin in the reaction kinetics.
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Figure 5.13 – gH2AX fluorescence intensity (on the left) and gH2AX foci numbers (in the centre) are plotted
against the absorbed homogeneous dose. The distribution of foci and signal intensity is not symmetric and hence
the most frequent intensity/foci number (red square) and the mean intensity/foci number (blue diamond) do not
coincide. The mean is easier to compute. The peak position is, however, less sensitive to outliers. The peak
position of the fluorescence intensity is approximately proportional to
√
D and does not saturate with dose. The
foci number saturates with dose. Hence there is no linear relationship between both quantities as shown on the
right.
Although there is not enough data to reliably confirm this relation.
Radiation influences the cell cycle
Radiation has also an influence on the progression in the cell cycle. In order to study the
cell cycle distribution we used the Hoechst 33342 stain and analysed the fluorescence intensity
of cells in the blue channel (experiment 2). The fluorescence intensity is proportional to the
amount of DNA in the cells. Cells in the G2-phase that have already replicated their DNA can
be distinguished from cells in the G1-phase by a higher fluorescence intensity. The cells used for
the experimental data shown in figure 5.14 were plated 48 hours before and fixed 24 hours after
treatment. Some of the cells were irradiated homogeneously with 32 Gy, some of the cells were
sham irradiated and some kept in the incubator throughout the whole experiment. When the
cells were fixed the cell density was between 400 and 450 mm−2 in the irradiated iBidi wells and
between 600 and 700 mm−2 in the unirradiated iBidi wells.
For the unirradiated cells 2 peaks at intensities I1 and I2 can be recognised. The ratio of I2
to I1 is slightly smaller than 2, which is very likely caused by a non-linearity of the microscope
camera. The peak areas are approximately equal, i.e. cells are more or less equally distributed
between G1- and G2-phase. Cells between both peaks can be attributed to the S-phase of DNA
synthesis. After irradiation, however, the peak at intensity I1 has almost disappeared. Instead
another peak arises at an intensity I3 which is approximately 1.8 times I2. These are cells that
have copied their DNA content 2 times. This may happen to cells that suffer from chromosome
aberrations and that are consequently unable to pull the homologous pairs apart in the anaphase
of mitosis. Some cells continue nevertheless with the S-phase and replicate the DNA. Probably
related to the altered cell cycle distribution is an increase in the average nucleus size by around
31% from 90 to 119 µm2.
In reaction to ionising radiation cells in the G2-phase have a stronger gH2AX signal and
more foci than cells in G1-phase. At very low dose the factor is approximately 2. However it
decreases with increasing dose. This is not an unexpected observation. G2-phase cells have more
DNA and offer a 2 times larger target than G1-phase cells.
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Figure 5.14 – Changes in the cell cycle visualised with Hoechst 33342. The Hoechst intensity (abscissa) is
proportional to the DNA content of the nucleus. Cells in the G1-phase have a single DNA content and are
represented by cells with the lowest Hoechst intensity (at 0.2). During S-phase the DNA is replicated and cells
reach the G2-phase with an approximately doubled Hoechst intensity (at 0.35). Unirradiated and sham-irradiated
cells distribute more or less equal between G1 and G2. Irradiated cells have almost no G1-phase cells 24 hours
after irradiation with 32 Gy. Instead some cells have a signal intensity which is approximately twice the G2-phase
signal. These are presumably cells which have after unsuccessful cell division doubled their DNA content twice.
5.3.3 Irradiation with modulated doses and bystander response
The gH2AX signal increases in low and decreases in high dose regions with time
We then turned towards inhomogeneous irradiations and tried to explore the role of cell-to-
cell signalling in radiation fields with varying doses and finally in MRT fields. To this end we
irradiated Panc1 cells through a copper wedge with a wedge angle of 14.9° to create a dose
gradient across the cell population (experiment 3, see figure 5.15, left). The cells were plated 24
hours prior to irradiation. There are always two wells of the iBidi receiving the same dose. One
of these wells was fixed 3 and the other 24 hours after irradiation. Cells were confluent when
irradiated and had a cell density of 700 to 750 mm−2 3 hours after radiation and 600 to 700
mm−2 24 hours after radiation, respectively.
During irradiation a film was attached to the bottom of the iBidi µ-slide. Unfortunately there
was no direct mapping between fluorescence microscopy images and dose possible. Allocating
the cell position and the position on the x-ray film had an uncertainty of up to 0.5 mm.
The cells were immunostained, scanned with fluorescence microscopy and the images analysed
according to the methods described before. Figure 5.15 (centre) shows the gH2AX fluorescence
intensity over the position from the wedge edge. The four wells closest to the wedge edge were
analysed. There is a 4 mm gap in the data at around 10 mm from the wedge edge. This is the
location of the separator between the analysed wells. With growing distance from the wedge
edge the intensity of gH2AX fluorescence becomes weaker. This is true for both, cells fixed 3
hours and cells fixed 24 hours after radiation exposure. However, the slope is steeper 3 hours
post-irradiation. Intriguingly the two intensity curves intersect in the first well and in the second
well from the wedge edge. All of the iBidi wells were stained with the same marker concentrations
and imaged with the same settings of the microscope. Apparently the gH2AX activity does not
simply decay with time, but they become equal. In high dose regions the activity is reduced,
in low dose regions it is enhanced. In contradiction to observations by others (e.g. Schmid
et al. 142) the signal has hardly decayed after 24 hours. Equalling can also be observed in the
gH2AX foci number. As seen for the homogeneous irradiations there seem to be two groups of
cells – responding and non-responding cells. The fraction of these cells was dose dependent in
the homogeneous case. This is also observed for the dose gradient. In figure 5.15 (right) the
fraction of non-responding cells is plotted against the distance from the wedge edge. 3 hours
after irradiation this fraction grows from 0.5% at the wedge edge to approximately 9% at 20
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Figure 5.15 – Left: The experimental set-up to produce a dose gradient with a copper wedge is shown. The
gH2AX fluorescence signal intensity is plotted in the centre as a function over wedge edge distance 3 and 24 hours
after exposure. On the right the fraction of non-responding cells is shown. The gap at 10 mm is caused by the
well separator. The right and the left parts of the curves stem from different wells and the medium could not
mix.
mm distance from the edge. 24 hours after radiation there is, however, no dose dependency
observable anymore. The fraction of non-responding cells is between 1 and 2%.
Evidence for a spatially propagating bystander signal at radiation boundaries
In another experiment we investigated the behaviour of gH2AX fluorescence intensity and num-
ber of foci at sharp irradiation boundaries (experiment 4). Cells were plated 48 hours before
irradiation into iBidi µ-slides. Two wells of the µ-slide were irradiated with doses of 0, 5, 16
and 32 Gy in 4 parallel stripes (see chapter 5.2.2). The cells in one of these wells were fixed 3
hours and the cells in the other well 24 hours after radiation. 3 hours after radiation the cell
density was 510 mm−2 and 24 hours after radiation 360 mm−2. The number of foci and the
gH2AX fluorescence intensity are both plotted in figure 5.16. The doses are 32 Gy from 0 to 2.1
mm, 16 Gy from 2.1 to 4.2 mm, 5 Gy from 4.2 to 7.0 mm and 0 Gy from 7 to 10 mm. Three
hours after radiation the mean number of gH2AX fluorescence intensity and also the number
of gH2AX foci show a step-like behaviour and there is a significant drop at each dose edge.
Neither the fluorescence intensity nor the number of gH2AX foci respond, however, in a linear
fashion. The number of gH2AX foci is more noisy than the fluorescence intensity data and the
saturation effect of the foci number can be observed at high doses: The step size drastically
increases towards lower doses. 24 hours after radiation treatment the steps have decreased in
size, in both, number of gH2AX foci and gH2AX fluorescence intensity. However, the mean
level of fluorescence intensity and the mean level of foci per cell has not diminished for all doses.
The average number of gH2AX foci has increased in the 0 Gy step from 7 to 10 mm and the
fluorescence intensity has raised in the 0 and 5 Gy steps from 4.2 to 10 mm. After 24 hours the
fluorescence level of the 0 Gy step has reached the level of the 5 Gy step after 3 hours. As in the
gradient dose experiment we have also analysed the fraction of cells with no foci (bottom row
of figure 5.16). After 3 hours there is a strong drop observable from the 0 Gy to the 5 Gy step
where the number of non-responding cells falls from 60% to approximately 10%. The fraction
further decreases with increasing dose. However, there is no step-like behaviour visible anymore.
This may possibly be caused by the low fraction of non-responding cells and the consequently
poor statistics. More interesting is, however, the 0 Gy step itself. There is a remarkable increase
of non-responding cells with increasing distance from the radiation edge from 60% to 80%. 24
hours after radiation there is not much of a difference in the non responding cells for the 5, 16
and 32 Gy steps to 3 hours post-irradiation. However, in the 0 Gy step the number of cells with
no foci has fallen to 20%.
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Figure 5.16 – The top left and the top right graph show the gH2AX signal intensity and foci number over the
position perpendicular to the radiation boundaries 3 hours and 24 hours after exposure. The edges are indicated
by lines at 2.1, 4.2 and 7 mm, separating 32, 16, 5 and 0 Gy zones. The bottom row shows the fraction of
non-reacting cells with no foci: On the left 3 hours after radiation with a logarithmic ordinate. A strong drop
occurs between 0 and 5 Gy. The part from 7 to 10 mm is plotted with a linear ordinate in the central plot and
shows that the non-reacting cells are less frequent closer to the radiation boundary. The right graph shows the
fraction of non-responding cells 24 hours after radiation exposure. In the radiated part the graph is similar to 3
hours after exposure. The fraction of non-responding cells in the 0 Gy-region has strongly decreased.
5.3 Results 109
104 105 106
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
γH2AXfsignalfintensity
Fr
eq
ue
nc
yf
[a
.u
.]
50fGy,fafterf1fhour
50fGy,fafterf6fhours
100fGy,fafterf6fhours
250fGy,fafterf6fhours
0 100 200 300 400
105
Position [µm]M
ea
n
γH
2A
X
flu
or
es
ce
nc
e
in
te
ns
ity
[a
.u
.] 50 Gy after 1 hour
100 Gy after 1 hour
250 Gy after 1 hour
50 Gy after 6 hours
100 Gy after 6 hours
250 Gy after 6 hours
5.105
5.104
Figure 5.17 – The graph on left shows the gH2AX signal intensity histogram in the peak dose region of a 2×2
cm2 MRT field. 6 hours after exposure for all doses and 1 hour after exposure for 50 Gy peak entrance dose, two
distinct cell entities emerge. On the right a gH2AX profile (averaged over all peaks) is shown for all exposures
and fixation time points.
5.3.4 Irradiation with an MRT field
Finally we investigated the gH2AX signal after irradiation with a microbeam field at the biomed-
ical beamline ID17 of the ESRF in Grenoble. The experimental set-up for the application of
microbeams is described in chapter 5.2.2. We irradiated Panc1 cells in cell culture flasks and
iBidis with a 20×20 mm2 MRT field. The adjusted beam entrance dose in water was set to 50,
100 and 250 Gy, leading to peak doses of 16, 32 and 80 Gy at the position of the cells. The
PVDR (peak to valley dose ratio) in the field centre was 22 (details given in chapter 5.2.2). The
cells were fixed 1 hour and 6 hours after exposure. Image acquisition for the cell culture flasks
after staining was performed in a 22.5×26 mm2 region with a resolution of 0.645 µm covering
the whole MRT field. The iBidis were irradiated with the same experimental set-up, although
the size of an iBidi well is just 9.4×10.7 mm2 in size. However, we wanted to give two times the
same doses. The centre of the field was aligned with the centre of the iBidi well. By imaging the
central 7.6×7.6 mm2 of the iBidi with a resolution of 0.322 µm we analysed approximately the
central one seventh of the MRT field.
The lower resolution of 0.645 µm was not suitable for foci detection and only the gH2AQ
fluorescence intensity was evaluated. The cell densities in the culture flasks lay between 500
and 600 mm−2. The higher resolution for the iBidi wells was used for foci analysis. Due to
experimental difficulties the cells in the iBidis were much less homogeneously plated and the cell
density was only between 220 and 280 mm−2.
In the peak region a responding and a non-responding cell-entity exists
The Monte Carlo results (see chapter 5.2.2) were used to assign a dose to each cell. This way it
was possible to analyse the fluorescence signal depending on the absorbed dose. In figure 5.18
gH2AX fluorescence intensity histograms are plotted against the absorbed dose in heat maps.
Both, the dose and the GFP intensity are plotted on a logarithmic scale. 1 hour after irradiation
cells receiving a dose smaller or equal to the valley dose show only a weak gH2AX fluorescence
intensity dependence on dose. From the valley dose to approximately 2 times the valley dose the
gH2AX intensity strongly increases and reaches a saturation level. Above 2 times the valley dose
there is no dose dependency observable. This observation is independent of the peak entrance
dose. However at 50 Gy peak entrance dose with a peak dose of 16 Gy, some cells above 1.5
Gy show a high and some a low fluorescence intensity. 6 hours after radiation there is no dose
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Figure 5.18 – Histograms over gH2AX fluorescence intensity and dose 1 hour after exposure (top row) and 6
hours after exposure (bottom row). The first, second and third column show the results for 50, 100 and 250 Gy
peak entrance dose, respectively.
dependent behaviour observable up to approximately 2 times the valley dose. Above this dose
two cell entities exist, the one having a low gH2AX fluorescence intensity (entity 1) which is
only marginally higher than in the valley region and one having a high fluorescence intensity
(entity 2). Figure 5.17 (left) shows the gH2AX intensity histograms for the peak region. While
the gH2AX signal of entity 1 is almost dose independent, that of entity 2 depends on the dose
and is higher at higher peak doses. The fraction of entity 2 cells is approximately 60% for 100
and 250 Gy 6 hours after radiation and also for 50 Gy 1 hour after radiation. This fraction falls
down to approximately 30% 6 hours after radiation for 50 Gy peak entrance dose.
The gH2AX signal decay depends on the dose
The gH2AX fluorescence intensity beam profiles blur with time whereas the intensity differences
in the valley dose regions decrease. A profile of the gH2AX signal intensity across a single
microbeam is shown in figure 5.17 (right). The time course of the gH2AX signal intensity
depends apparently on the dose. 6 hours after radiation the gH2AX signal in the valley at 50 Gy
peak entrance dose has increased, whereas that of the cells in the valley at 100 Gy peak entrance
dose has slightly decreased. This leads to almost equal levels of gH2AX signal in both cases.
The strongest decrease of the gH2AX fluorescence is observed for the cells in the valley region
at 250 Gy peak entrance dose.
The peak dose influences the cell response in the valley and vice versa
From the images with higher resolution gH2AX foci were counted. As expected the foci number
per cell increases with increasing dose. Dose is not its only determining factor, though. At the
same dose the number of foci in the valley region depends on the peak dose as well. 1 hour after
radiation an average number of 40 foci per cell is achieved with 4 Gy at 50 Gy peak entrance
dose, with 7 Gy at 100 Gy peak entrance dose and with 12 Gy at 250 Gy peak entrance dose (see
table in figure 5.19). An increasing peak dose seems to make the cells in the valley more resistant
to radiation. Histograms over the number of gH2AX foci are presented in figure 5.19. 1 hour
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Figure 5.19 – The figure shows gH2AX foci number histograms in the valley and peak region 1 and 6 hours
after exposure with a 2×2 cm2 MRT field. The numerical values are tabulated on the right.
after radiation the fraction of cells with no foci is 17, 22 and 26.5% in the valley at 50, 100 and
250 Gy respectively. Surprisingly the number increases with increasing dose. For the fraction
of responding cells the frequency maximum is at 25, 30 and 35 foci per cell at 50, 100 and 250
Gy. In the peak region there is still a fraction of not responding cells which is around 11% for
50 and 250 Gy and around 8% at 100 Gy peak entrance dose. The frequency maximum is at 50
foci per cell at 50 and 100 Gy. At 250 Gy the maximum number of cells is reached at around 30
foci per cell, similar to the valley dose region. The number of foci per cell is still around 50 at
100 Gy peak entrance dose in the peak dose region after 6 hours, whereas the number of foci at
250 Gy, although it has increased a bit, is still smaller at around 40 foci per cell. At 100 and 250
Gy the fraction of non-responding cells is approximately 7%. In the valley region the fraction
of non-responding cells is 21% after 6 hours for 100 Gy (22% after 1 hour) and 10% for 250 Gy
(26.5% before). For 100 Gy peak entrance dose there is no frequency peak over the foci number
visible. For 250 Gy there is a peak at 35 foci per cell.
Two effects can be concluded from these observations. First, the time scales of foci production
and degradation and also of the gH2AX signal time-lapse depend on the peak entrance dose.
Secondly, there seems to be a signal from the valley region that leads to a reduction of gH2AX
signal in the peak regions of the microbeams. The time scale of the latter effect is again dose
dependent which can be deduced from the observation that after 50 Gy peak entrance dose the
two cell entities have already formed 1 hour post-exposure. For 100 and 250 Gy this needs more
time and is observed after 6 hours only. Vice versa the peak dose region seems to influence the
valley as well and leads to less foci at the same valley dose with an increasing peak dose. 1 hour
and 6 hours after irradiation there is clearly no linearity between gH2AX signal or foci number
and dose. This might be different at time points closer to the irradiation as reported by others
(e.g. Rothkamm et al. 143).
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Figure 5.20 – The left graph shows the change in the fraction of G2-phase cells as an averaged profile across the
microbeams for 50, 100 and 250 Gy peak entrance dose. The boundaries of the microbeam are indicated as black
lines. The graph on the right shows the average foci diameter as an averaged profile across a microbeam for 100
and 250 Gy peak entrance dose 1 and 6 hours after exposure. Foci in the microbeam are much larger than in the
valley. 1 hour after exposure the edges of the microbeam show the highest average foci sizes.
Irradiation changes the cell cycle distribution in the valley, but not in the peak
There is another interesting phenomenon in the cell cycle distribution. As described previously
in chapter 5.3.2 cells accumulate after irradiation in the G2-phase and the fraction of G2-phase
cells increases. 1 hour after radiation, independent of the peak entrance dose and cell position in
the peak or valley region, (19.0±1.5)% of the cells were in G2-phase, (48±3)% in G1-phase and
(17.8 ± 1.4)% in the S-phase. A few cells had more than the doubled DNA content. However,
this fraction counts just (5.0 ± 0.9)% of the cells. 6 hours after radiation treatment the G2
fraction has grown by (28± 3)% for all peak entrance doses in the valley region (see figure 5.20).
However, the increase in the G2-phase fraction in the peak region is, despite the higher dose,
much smaller at around (8 ± 3)% for 100 and 250 Gy peak entrance dose. This reduction of
G2-cell cycle accumulation is not constraint to the beam region, but extends to 100µm into the
valley region approaching the valley dose value. At 50 Gy peak entrance dose the reduction is
less pronounced at around 15%.
The exact quantification is difficult for several reasons. The delineation of the cell cycle
phases was done by eye and is in this sense arbitrary (see appendix D). Furthermore the cell cycle
distribution depends on many factors, including cell density and the culture medium. Therefore
comparison between different flasks is of limited meaning although the cells were plated at the
same time, with the same medium and reached a similar cell density. Even more difficult are
links to other experiments. Nevertheless the reduction of a G2 fraction close to the beam is
evident. Whether this means an increased cell cycle arrest in the valley or a reduced cell cycle
arrest close to the peak cannot be decided.
Foci sizes vary between peak and valley and are highest at beam penumbras
Another intriguing observation indicates that the high-to-low dose interface plays an important
role. It was reported by others that not only the number and intensity of foci is a useful
information on DNA damage, but also the size of the foci141. We have therefore analysed the
foci size with autocorrelation and determined a mean foci-size of the cells (for details see appendix
D). In figure 5.20 (right) the mean foci size is plotted as a profile across a single microbeam. The
average foci size in the valley region is (1.6± 0.1)µm and (1.4± 0.1)µm 1 and 6 hours after 100
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Gy peak entrance dose and (1.8 ± 0.1)µm both, for 1 and 6 hours after 250 Gy peak entrance
dose. In the peak region the average foci size is higher. In the centre of the peak the mean foci
diameter is (2.6 ± 0.1)µm and (2.0 ± 0.1)µm 1 hour and 6 hours after 100 Gy peak entrance
dose and (3.1± 0.1)µm, both 1 hour and 6 hours after 250 Gy peak entrance dose. 1 hour after
irradiation the foci size is at the beam penumbra much higher than in the microbeam centre. 6
hours after radiation these spikes at the beam penumbra have disappeared.
Evidence for gap junction mediated signalling
Two ways of signal transmission are discussed that may induce bystander reactions, soluble
factors and gap junctions (see chapter 5.1.2). The cell cycle changes are observed in a region
around the microbeam which is much broader than a single cell. Also the observed signalling
in the step irradiation and equalising of gH2AX signals seen in the radiation experiments with
inhomogeneous fields promote the hypothesis that a soluble signal is involved. But there is
also evidence for gap junction mediated signalling in MRT fields. Figure 5.21 (left) shows the
gH2AX signalling strength in dependence on the distance to the closest neighbour. The average
cell nucleus diameterix is (21.3 ± 4.0)µm. The gH2AX signal strength is on average lower for
cells with a close neighbour. Especially for nuclei that are closer to each other than the average
nucleus diameter, there is a strong decrease in the average gH2AX fluorescence level.
Does the signal of neighbouring cells lead to a continuous response or is it binary, triggered
by the signal of the neighbouring cell? In figure 5.21 (right) gH2AX signal strength histograms
are shown for nuclei distances of 14 to 17 µm, 18 to 28 µm and 29 to 50 µm in the valley
region 6 hours after treatment with a 100 Gy peak entrance dose MRT field. These histograms
suggest that the response is binary. Responding cells have a lower gH2AX signalling strength
and non-responding cells have a higher signalling strength. With increasing distance from the
closest neighbour the fraction of cells with a higher fluorescence grows.
Unfortunately there is a large overlap of the two gH2AX intensity spectra. This is, however,
not surprising looking at the method. Its main drawback is that it does not differentiate be-
tween two isolated cells and a cell which is situated in a confluent part of the cell culture flask.
Furthermore it does not consider the gH2AX level of the adjacent cells. The first problem can
be circumvented by analysing the gH2AQ signal in dependence on the local cell density. The
result is very similar. The second problem can be avoided by analysing the distribution of the
difference of H2AX phosphorylation ∆i,j between two cells i, j exposed to the same dose with
fluorescence intensities Ii and Ij ,
∆ij = |Ii − Ij |. (5.15)
If cells are not influencing each other, the distribution of ∆i,j with arbitrary cells i, j and the
distribution of ∆ni,j with neighbouring cells i, j should be the same. This is, however, not the
case. The distribution of ∆ni,j is more concentrated at the origin than ∆i,j which is broader. It
can be concluded that the H2AX phosphorylation state is signalled to neighbouring cells and
adapted by the cells. A comparison of the distributions ∆i,j and ∆ni,j also allows to estimate the
percentage of cells that move into line with close neighbours. In appendix D the two distribution
are plotted for 100 Gy, 1 hour and 6 hours after radiation exposure for all cells receiving a valley
dose between 1.5 and 1.6 Gy. 1 hour after exposure 9.2% of the cells are closer to their neighbours
in H2AQ phosphorylation levels than to other arbitrarily chosen cells receiving the same dose
and 6 hours after exposure 42.7%.
ixThis diameter was obtained by the automated cell nucleus segmentation of the Cell Profiler. The area of the
detected nucleus is usually marginally larger than the actual nucleus. The diameter was calculated by assuming
circular nuclei.
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Figure 5.21 – The graph on the left shows the mean gH2AX signal intensity of cells depending on their distance
to the closest neighbour. The signal intensity is lower for closely adjacent cells. The right figure shows histograms
over the gH2AX signal intensity in dependence on the distance to the closest neighbour. The histograms reveal
that the signal intensity does not only increase with distance, but that there is a kind of binary behaviour – either
they have a low or a high signal.
5.4 Discussion
Some of the results described in the last chapter are astonishing, but an interpretation with
our present knowledge on DNA DSB repair is a challenging task and cannot be satisfactory
accomplished in this chapter. For sure the presented data will challenge certain paradigms and
it proves our limited knowledge on cell biology. The investigations and experiments in this work
are by far not exhaustive and were not intended to be. Everything they can achieve is encouraging
further intensive work on the field of cell-cell communication and DNA damage repair because
both will probably have a strong influence on radiotherapy outcomes.
The histone H2AX was discovered in 1980 as an isoform of the H2A histone. Its role in DNA
damage repair was first suggested by William Bonner144. A linear dose response between foci
creation and absorbed dose of ionising radiation was shown several times for low doses140,141,143
and a direct correlation of foci with double strand breaks has been inferred. Hence gH2AX has
frequently been used as a biomarker for DSBs. It was shown to be 100-fold more sensitive than
the comet assay142,145. A matter of debate is whether the gH2AX signal intensity is similar to
the number of gH2AX foci a measure of DNA damage. Several studies report linear relationship
between both quantities and use the fluorescence intensity instead of the foci number142,146,147.
Measuring fluorescence intensity is easier to accomplish and can be used in flow cytometry.
Furthermore the detection of foci is not straightforward especially at high doses when several
foci overlap. Very likely the here observed saturation of foci number at high doses has in part
its origin in the lack of foci resolution. In particular small and dim foci are often missed in both
automated and manual foci counting. The intensity of gH2AX binding per cell, however, does
not only depend on the number of DSBs, but also on the H2AX substrate and the H2AX kinase
activity144. Moreover a lower expression of gH2AX in unirradiated G1-phase cells was observed
in these experiments and by others147. Nonetheless gH2AX was proposed as a biodosimeter with
some success even in the valley region of MRT fields143.
Phosphorylation of gH2AX
In order to judge upon the best method to evaluate cell damage and to interpret the experimental
data a good knowledge of gH2AX functionality would be desirable, but is only partially present.
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H2AX contributes, depending on the cell line, to 2-25% to the H2A histone pool148. It differs from
other histones by a serine residue 4 amino acids from the COOH terminus. After DNA damage
this serine becomes rapidly phosphorylated. The causes can be various, e.g. external damage,
replication fork collisions, apoptosis and dysfunctional telomeres148. Phosphorylation itself may
occur via different pathways. ATM (ataxia telangiectasia mutated) seems to be most important
after ionising radiation. But there are others, such as ATR (ATM and Rad3-related) and DNA-
PK (DNA dependent protein kinase). However, H2AX phosphorylation is not necessary for
DNA break recognition149. H2AX deficient cells are still able to gather repair and signalling
proteins at the DSB site. Lu et al. 150 therefore supposed that the presence of a gH2AX focus
does not necessarily reflect a DSB. They showed that gH2AX is involved in apoptosis after
UVA exposure and investigated the JNK-mediated phosphorylation of H2AX. They found that
JNK inhibition reduces both, H2AX phosphorylation and caspase-3 activation, a hallmark of
apoptosis. Although H2AX was not required in their experiments for caspase-3 activation, it
was necessary for the DNA fragmentation ("ladder formation") in apoptosis. In fact H2AX
deficient cells were significantly more resistant to apoptosis than wild type cells. This fits well to
the observation that H2AX acts as a tumour suppressor150,151. The lack of H2AX in p53 deficient
mice considerably accelerates the onset of lymphomas and other cancers148. It was also observed
that H2AX deficient cells fail to arrest in the G2-phase after ionising radiation148,152. This is a
very interesting observation with respect to our own findings. Is there a connection between the
reduced percentage of cells in the G2-phase close to the microbeams and the large gH2AX foci
that only occur at the microbeam site but not in homogeneous fields? Genome instability and
increased radiosensitivity is both accompanied with a lack of H2AX153,154, although its role in
DNA-repair remains unclear.
Signal decay of gH2AX
Although H2AX is not essential for DNA DSB repair one observes dephosphorylation of gH2AX
after DNA repair140. The time course of foci decay is very similar to the kinetics of DSB repair
after intermediate doses155 and an impaired DSB repair pathway leads to persistence of foci
as shown in DNA-PKcs deficient140, Ku80 deficient156 and DNA ligase IV-deficient cells155.
Therefore Olive and Banáth 157 proposed the use of gH2AX to measure radiosensitivity of cell
lines. They measured the disappearance of gH2AX during the first few hours after exposure
and found that radioresistent cell lines lose gH2AX faster than radiosensitive cell lines. From
pulse field gel electrophoresis (PFGE) analysis it was found that DSBs decay exponentially with
time after exposure141,158. Schmid et al. 142 demonstrated that the gH2AX signal decay has two
exponential decay contributions, one with a halftime of 13.9 hours and one with 24 minutes.
They observed that the contribution of both processes depended on the radiation type. With
low LET radiation treated cells had a lower slow decay contribution than cells exposed to high
LET radiation. The decay of gH2AX is also slower for p53 deficient than in p53 wt cells (5.9
vs. 3.8 hours)153, probably because p53 is involved in the regulation of DNA repair. In our
own experiments we fixed cells 1, 3, 6 and 24 hours after radiation. In contrast to the described
findings we didn’t see a decay half time in the order of 6 hours. The decay was much slower
and sometimes even an increase was observed for gH2AX foci and H2AX phosphorylation. In
the case of the gradient irradiation there was just a minor difference between the gH2AX levels
after 3 and 24 hours. Furthermore the decay kinetics is dependent on the dose and the dose
given to neighbouring cells. For the experiments carried out in this work doses were, however,
much higher than for the majority of other experiments using gH2AX staining protocols. Several
authors confirm that the number of foci per cell decreases with repair time only at low doses but
not at higher doses144,155,156,159. Bouquet et al. 156 investigated the dose dependence of gH2AX
signal loss after calicheamicin g1 (CLM) and x-ray treatment and found that at higher doses the
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level of H2AX phosphorylation remains high for hours. What is different at high dose exposures?
Is the remaining high gH2AX level an indication of cellular stress and stress signalling?
The exact meaning of the gH2AX signal remains a matter of debate. The one-to-one corre-
lation with DSBs is also questionable since most of the DSBs join within a few minutes which
completely contradicts gH2AX loss half-times in the order of several hours157. 24 hours after
a 2 Gy radiation exposure Banáth et al. 153 were not able to detect any residual DNA damage,
challenging again the association of gH2AX foci with physical breaks.
Linearity of the gH2AX signal with dose
Critical for seeing a linear correlation between dose and gH2AX reaction (e.g. number of foci)
seems to be the time of observation after exposure. Many experiments suggest a linear dose
response up to 2 or 3 Gy (e.g. Bracalente et al. 140 , Rothkamm et al. 143) and most of them
measure shortly after radiation exposure. Rothkamm and Löbrich 155 even claim linearity from
1 mGy to 100 Gy between foci count and dose. However, they count foci as early as 3 minutes
after radiation exposure. Our experiments are far beyond the typical dose scale and 1 hour
time between irradiation and fixation seems to be already too long to see a one-to-one response
between dose and gH2AX reaction. Linearity might exist at low doses (D < 10 Gy, see figure
5.13) in the experiments described here. Also the level of background foci is quite high. An
explanation could give foci repair centres. It was suggested that close by foci merge to form a
single focus141. At high LET radiation less foci were observed than DSBs predicted by Monte
Carlo simulations. This clustering happens before the formation of radiation induced foci, be-
cause it was not observed in the first 30 minutes. Foci merging after longer time periods was,
however, noticed giving a possible explanation of larger foci at longer time periods after radiation
exposure141.
The meaning of gH2AX foci size
The meaning of different foci sizes is another unsolved problem in gH2AX analysis. Higher foci
sizes were observed after high LET radiation140,141. For low and intermediate LET Neumaier
et al. 141 measured on average 0.64 µm diameter (FWHM) 30 minutes post-irradiation. At high
LET small and large foci were found in experiments by Bracalente et al. 140 . Furthermore foci
in the primary track appeared larger (0.8 µm) than those of delta rays (0.6 µm)141. With time
after radiation foci sizes were observed to increase140,153. Observations in this work also suggest
that foci can be classified in large and small foci. In chapter 5.3.1 we classified cells depending on
the foci size into 4 groups, cells without foci, cells with small foci, cells with large foci and cells
that were completely speckled and filled with gH2AX. The fraction of the different types were
found to be dependent on the radiation dose. With autocorrelation we estimated the foci size.
Foci sizes that we estimated with this method are larger than sizes found in the literature. This
is very likely rather a methodological than empirical difference. Furthermore the autocorrelation
method yields an average for all foci.
The creation of larger foci was attributed to complex non-repairable DNA damage and Bra-
calente et al. 140 supposes that larger foci persist whereas small foci resolve. These findings can
partly be confirmed by our own observations. The higher the dose becomes the larger the av-
erage foci size gets. In the peak region much larger foci were found than in the valley region.
Contradictory is, however, the reduction of the mean foci size from 1 to 6 hours after exposure
and even more the observed extremely large foci at the microbeam edges. Foci size seems to
indicate more than the complexity of DNA lesions. Their appearance could be connected to
signalling and bystander effects at the edges of the microbeam path.
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Bystander signalling by gap junctions
Rothkamm et al. 143 observed, when trying to use gH2AX foci counting for biodosimetry, that
there is a higher number of foci close to the absorption edges and that this effect cannot be
explained by cell movement. In fact Crosbie et al. 160 did not observe a significant cell motility
after MRT exposure. They therefore already hypothesised a inter-cellular signalling between
neighbouring cells. We also observed these increased gH2AX levels in the step irradiation ex-
periments close to the step edges (see figure 5.16). There is an increase of the level close to the
edge on the low dose site, at the 16 to 32 Gy and the 5 to 16 Gy edge. Between 0 and 5 Gy
this increase is not observed, however we see a reduction of non-responding cells with decreasing
distance to the radiation boundary. But there are also several observations in the microbeam
field that indicate cell communication. An increasing peak dose leads to the same number of
foci at higher doses in the valley and there is a slight increase in the number of foci in the valley
dose 6 hours compared to 1 hour after radiation. The latter observation seems to be typical for
inhomogeneous radiation fields: While high dose regions lose gH2AX levels, levels raise in low
dose regions.
What mediates the signal transduction between cells then? Banáth et al. 153 observed that
neighbour cells often show similar foci numbers and sizes and inferred that these are daughter cells
from one irradiated mother cell and that the damage is inherited. In our observation we also see
equal damage in adjacent cells. After 1 hour 9.2% and after 6 hours 42.7% of neighbouring cells
have a more similar H2AX phosphorylation level than two randomly selected cells at the same
dose. It is unlikely that this originates in cell division and inherited damage. The importance
of cell-to-cell contact was emphasised by experiments of Mitchell et al. 161 . In their experiments
they irradiated C3H 10T1/2 mouse fibroblast cells with a high and a low plating density by a
5.3 MeV a-particle microbeam. Bystander effects were observed for both, low and high density
cells. However, the effects were several times stronger in densely plated cells.
Changes in the cell cycle two cell entities
Remarkable is the change in the G2-phase fraction of the cell population across the microbeam.
That the cell cycle is influenced by cell-cell communication after radiation exposure is not new.
Shao et al. 162 demonstrated that the G1 cell cycle arrest is influenced in bystander cells and
that cell-cell contact is important. In view of these observations the question is whether the
reduced G2-phase fraction in and close to the microbeams results from an induced G1-arrest.
This, however, is unlikely, because it is well known that the G1 arrest is mediated by p532. Panc1
cells are p53 mutants and should therefore not arrest in G1-phase. This is also confirmed by the
presented experimental results of homogeneous irradiations, where the G2 fraction is increased
24 hours after exposure (see figure 5.14). Another hypothesis would be that the cells get stuck
in the S-phase due to the high damage caused in the peak. However, there is an increase in the
G1-phase observable compared to the valley (data not shown) and the S-phase fraction remains
more or less unaffected. Furthermore the change in the cell cycle distribution is also seen at 50
Gy peak entrance dose. Here the peak dose is even lower than for the homogeneous exposure
with the cell cycle distribution shown in figure 5.14.
A possibly related observation is the formation of two cell entities with very different levels of
H2AX phosphorylation. In case that the cell cycle progression is accelerated in the microbeams,
one could argue that the entity 1 (with a lower H2AX phosphorylation level) is generated by
fast proliferation and quickly created daughter cells that were not exposed to radiation. The
fraction of entity 1 cells after 6 hours at 100 and 250 Gy is 40%. Hence within 6 hours 25% of a
cell population that received a very high dose would have divided, which is very unlikely. Even
more astonishing would be that 25% of the cell population in the peak region of the 50 Gy peak
entrance dose MRT field would have already replicated within 1 hour. Although cell density is
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a difficult measure, because it cannot be measured prior to irradiation, there is no evidence that
there was an increased cell density at the microbeam site which would support the theory that
enhanced proliferation created the low gH2AX level cell entity. Fact is that the splitting of the
cell population in a high and low gH2AX signal fraction happens at the microbeam edge (see
appendix D). Furthermore there is a time dependence observable. Apparently the splitting is
delayed by higher doses and occurs faster at low doses, since we see the two cell entities already
after 1 hour at 50 Gy peak entrance dose but not before 6 hours after irradiation for 100 and
250 Gy peak entrance dose. In the case of 50 Gy peak entrance dose the fraction of high gH2AX
level cells has decreased 6 hours after exposure. Does that imply a repair process? Further
experiments are required to probe this hypothesis.
Bystander signalling by a small soluble factor
Apart from observations indicating a gap junction mediated signalling there is also evidence in the
performed experiments for bystander signalling by soluble factors. The equalisation of gH2AX
response after a dose gradient and dose steps irradiation is one of them and the increased levels
of gH2AX signal in the valley 6 hours compared to 1 hour after MRT field irradiation another.
Also the changing fraction of non-responding cells with the distance to the radiation edge in the
0 Gy step of the step-irradiation experiment indicates signalling by soluble factors. McMahon
et al. 109 suggested a model for bystander response assuming a diffusible small molecule. The
basic points of their model are:
• Hit cells and responding cells generate a signal for a certain time to reach a local equilib-
rium. The time depends on the DNA damage.
• The signal decays with a certain decay constant l.
• Not the intensity of the signal, but the time of influence above a certain concentration
threshold on a bystander cell decides upon reaction probability.
• The response is binary.
• The propagation of the signal with concentration r is described by the diffusion equation
with a decay term, where D is the diffusion coefficient:
∂ρ
∂t
= D∆ρ(r, t)− λρ(r, t).
They presume that diffusion is usually much faster than signal production. Therefore we consider
the stationary problem with ∂ρ/∂t = 0 and try to find a solution for an experiment where half
of the cells are irradiated and half of the cells are shielded. The stationary solution for r in the
unirradiated half space, if the irradiated half space has a constant concentration c0, sustained
by the cells after damage detection and if the unirradiated half space does not have any signal
production at all, is
ρ = c0e
−
√
λ/Dd, (5.16)
where d is the distance from the radiation boundary. Mastro et al. 163 measured the diffusion
coefficient of small molecules in the cytoplasm and found on average 3.3·10−4 mm2/s. McMahon
et al. 109 found for l a value of 3.2 · 10−4s−1 when fitting experimental data. This implies that
the spatial signal decay is in the order of 1 mm. That fits well to the ranges observed in our
experimentsx.
xImportant in the model of McMahon et al. 109 is of course the time a cell is subjected to a certain signal
strength. However, the cells in the irradiated part will at a certain point stop emitting a signal. Because of
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Of course the data presented here is still too sparse and subjected to too high uncertainties for
a quantitative evaluation. However, our results do in principal support a soluble factor mediated
bystander effect. Definitely this bystander effect is important in MRT, where valley dose regions
have just a few hundred micrometre distance from the closest dose peak.
5.5 Conclusions
In this chapter we tried to find explanations for the principles behind MRT tissue sparing by
looking at effects in the double strand break repair and changes in the cell cycle in pancreatic
cancer cells under cell culture conditions, i.e. in vitro. The attempt to exhaustively explain the
rational behind MRT with these experiments was not intended. Cell culture can hardly simulate
the complex processes in real tissue as part of an even more complex organism. Inflammatory
response, immune reaction, cell migration and the effects of the vascular system are not present in
this simple model. Cell culture is another model in science that has its strengths and weaknesses.
Scientific models do not represent the reality they are just reflecting some parts of it. The strength
of a model is at the same time its weakness: the simplification of reality. It is the principle of
science to simplify and abstract and at the same time not to forget about the differences to
reality. Still, the model of cell culture is very complex and we understand but very little about
the cellular response towards ionising radiation.
Within the model of cell culture we were, however, able to show that the secret of tissue
sparing in MRT is likely to be found in molecular biology. This shall not exclude other ex-
planatory approaches. We showed that at high doses neither the creation of gH2AX foci nor
the phosphorylation level of H2AX are proportional to dose. Furthermore both measures are
not proportional to each other. As already observed by others we confirm that at high doses
the reduction of the gH2AX level with time does not follow the DNA-repair kinetics any more.
Instead we demonstrated an adjustment of gH2AX fluorescence levels and foci numbers with
time after exposure. High dose regions decrease, low dose regions increase their H2AX phos-
phorylation. We attributed these adjustment to bystander responses and provided evidence for
both, cell-to-cell communications via gap junctions and soluble factors. It was shown that our
results are in agreement with the idea of a dispersive propagating signal molecule transferring the
bystander information. We were also able to show that close neighbours react alike as opposed
to arbitrary cells receiving the same dose.
In an MRT field we were able to reveal that the distribution of the cell cycle is changed at and
close to the microbeams. This presumably promotes cell proliferation replacing damaged cells.
Accompanied with these changes in the cell cycle is the appearance of a group of less damaged
cells in the peak region between 1 and 6 hours after exposure. Furthermore large gH2AX foci
go along with these changes at the edges of the microbeams. Hitherto associated with more
complex DNA double strand breaks this observation raises the question whether these larger
foci are rather involved in a faster repair process. They appear at the edges of the microbeams
close to low dose regions. To risk an adventurous hypothesis one could suggest a support in the
DNA repair from less damaged adjacent cells. Unlike most reports on bystander effects we do
not only observe negative effects, i.e. damaging of unirradiated cells, but particularly bystander
positive effects, in the sense of a reduction of H2AX phosphorylation levels. Although we must
admit that our observations question the conventional interpretation of the gH2AX signal after
radiation exposure.
build-up and decay, cells with a lower stationary signal will experience different durations with a signal over
the threshold value. Therefore the static signal concentration is in our case a suitable measure of bystander
probability.
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Chapter 6
Conclusions
MRT is a multidisciplinary research field and involves a complex interplay between physical and
biological factors. The main focus of this work was pointed at the prediction of dose in an MRT
treatment, its dosimetric validation and the biological effect of an MRT dose distribution on a
cellular level.
Treatment planning is an essential component of radiotherapy. In MRT it is assumed that
the peak dose determines the tumour control and the valley dose the normal tissue sparing. An
accurate prediction of dose prior to an MRT treatment is indispensable when moving on to a
clinical application. One of the main outcomes of this work was therefore an MRT treatment
planning system (TPS) based on the interface VIRTUOS, a planning software which is currently
used at the German Cancer Research Centre (DKFZ) for conventional therapy planning. The
dose calculation is based on the definition of treatment parameters in VIRTUOS, a CT image of
the patient acquired prior to the treatment and a model of the radiation source in the form of
phase space information. To the latter a separate chapter, chapter 2, was dedicated.
The source phase space is distinctly different to that of other radiation sources. In particular
the photon beams are polarised and highly parallel. In chapter 2 we investigated the effect of
polarisation and developed a simple source model.
The polarisation sensitive Compton effect preferentially scatters photons perpendicular to
the polarisation direction and leads to an unisotropic energy absorption. It was found that the
polarisation has a strong influence on the scattered dose outside the radiation field, but little
effect on the dose inside the radiation field. Within the microbeam field the linear polarisation
perpendicular to the microbeams reduces the valley dose by less than 3%. The effect on the
peak dose is even less and does not exceed 0.1%. Therefore the assumption of unpolarised beams
leads to reasonable dose estimates. Nonetheless polarised photon interactions were regarded for
all Monte Carlo simulations throughout this thesis.
From the simulation of the entire phase space by Martínez-Rovira et al. 13 we extracted
a couple of essential parameters to create an accurate, but simple source model. The model
is tailored for the ID17 biomedical beam line at the ESRF in Grenoble, but may be adapted
to beamlines at other synchrotrons as well. The most important feature of the model is that
the beams can be assumed as parallel when the change in the beam width and ctc (centre to
centre distance) from the MSC to the sample caused by the tiny beam divergence is regarded.
Collimator scattering can be neglected, but there is a considerable amount of leakage radiation
which increases the dose by around 10%. The photon flux varies slightly from beam to beam due
to the broad synchrotron beam profile and geometric absorption at the collimator edges. Some
effects are not regarded by Monte Carlo simulations, such as total external reflection, diffraction
and rough collimator surfaces. In chapter 2.4 we showed that total external reflection at the
MSC walls affects more than 4% of the photons entering a 50 µm wide slit at the edge of a
20×20 mm2 MRT field. Reflections from the collimator walls were also experimentally observed
121
122 Chapter 6 Conclusions
while measuring output factors.
Apart from the source model the material composition of the phantom (or patient) serves as
an input for the dose prediction in MRT. The conversion of Hounsfield units (HU) to material
parameters is presented in chapter 3.4 and based on the method of Schneider et al. 45 . Unfor-
tunately the transformation is not unique and two different materials can have the same HU
representation in a CT. The resulting uncertainties were estimated to be between 0.5 and 5% for
the attenuation coefficient µ and around 2% for the dose absorption in the tissue.
Three different dose calculation methods, forward Monte Carlo, convolution (CPKA) and
superposition point kernel algorithm (SPKA), were presented in chapter 3 which are linked to
VIRTUOS. The forward Monte Carlo dose calculation method in chapter 3.2.2 can be assumed
as most accurate. However, it requires a considerable amount of computation time. Without
parallelisation the calculation time is in the order of weeks. Therefore two kernel based dose
calculation methods were developed and integrated into the TPS. In these methods analytically
calculated photon and electron dose kernels are used to estimate the scatter dose around primary
interaction points on the microbeam paths.
The fastest and most simple point kernel approach is the convolution based algorithm (CPKA)
which calculates the dose by convolving the scatter kernels with the primary interaction density
(“interaction strength”) on the beam. The dose calculation took in calculations on a standard
PC 5 to 10 minutes. The disadvantage of the method is that homogeneous material is assumed
around the interaction point. At material interfaces considerable deviations between CPKA and
Monte Carlo simulations arise.
This disadvantage is compensated by a superposition point kernel algorithm in curved space
(SPKA). Material inhomogeneities are regarded by deforming the point kernel in a projection
into curved space. The metric is derived from the absorption coefficient around the primary
interaction point. The differences between Monte Carlo and SPKA are considerably reduced
close to the material interfaces. The price for this modification is a two to three times longer
calculation time than for the CPKA depending on the irradiation geometry.
Overall the CPKA, forward Monte Carlo and SPKA agree within 15% accuracy with the ex-
ception of regions close to material boundaries in CPKA dose calculations. The first veterinarian
patient was already planned with the new TPS.
For lateral homogeneous detector geometries we presented another very efficient dose calcu-
lation method: semi-adjoint Monte Carlo. The accuracy is comparable to that of forward Monte
Carlo, but much less particle histories are required for the same statistical noise level.
In chapter 4 we presented an MRT dosimetry procedure with radiochromic films associated
with a readout at an optical microscope. Unlike film scanners this method has a sufficiently
high resolution and in contrast to readouts with a microdensitometer the method has a better
reproducibility, provides two dimensional dose maps and is still higher resolving. Moreover the
microscope scanning time is much shorter than with the microdensitometer. However, care must
be taken with inhomogeneous illuminations.
An uncertainty analysis was carried out and two film types, Gafchromic® HD-V2 and HD-
810 films, were compared to each other. It turned out that the total uncertainty results from
a combination of film inhomogeneities, statistical noise and calibration errors. The total uncer-
tainty decreases with dose. At low doses the calibration uncertainty dominates, while at high
doses inhomogeneities are most important. The statistical noise contribution was small for the
resolution of 5×1000 µm2 required for the planar microbeams in this work. However, for higher
resolutions these uncertainties become significant. The physical limitation for the resolution is
the grain size which is 2 µm in both film types.
Gafchromic® HD-V2 and HD-810 films are in principle very similar in their performance.
However, HD-V2 films exhibit a higher statistical noise rendering them less suitable if higher
dose resolutions are required than the 5×1000 µm2 examined here. HD-810 films are on the
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other hand sensitive to the photon energy. The film sensitivity at 50 keV photon energy is
approximately half of the sensitivity at 100 keV.
The dosimetry method was applied to measure the dose in a homogeneous water phantom,
an anthropomorphic human head phantom and for the determination of output factors. The
measurements were compared to the TPS predictions and semi-adjoint Monte Carlo simulations.
In the case of the anthropomorphic human head phantom the complete treatment planning
process was carried out from the acquisition of the CT image, over the calibration with ionisation
chambers, alignment with projection images and exposure. Planning and measurement agreed
within 10% measurement uncertainties in the valley region and except for two outliers within
4% uncertainty in the peak region.
We finally tried to connect the dose to a biological damage inflicted on cells in cell culture
in chapter 5. To this end human pancreatic cancer cells Panc1 were cultivated and exposed at
an x-ray tube and at the ID17 beamline of the ESRF in Grenoble. Cells were irradiated with a
homogeneous, a gradient and a step dose pattern at the x-ray tube with doses of up to 48 Gy.
At the synchrotron the cells were irradiated with microbeam fields with peak doses between 16
and 80 Gy and valley doses between 0.7 and 3.6 Gy.
For analysis cells were fixed between 1 and 24 hours after radiation. They were stained for the
phosphorylated histone gH2AX and with the DNA stain Hoechst 33342. Under gH2AX staining
various cell morphologies were observed. Cell nuclei with smaller or larger foci and different levels
of background staining could be distinguished. Large screening with fluorescence microscopy in
combination with automated foci counting and nuclei contouring allowed a spatially resolved cell
signal analysis with a large number of cells. The technique is comparable to flow cytometry but
provides also spatial information.
From these cell irradiations we found a non-linearity between fluorescence intensity, foci
number and dose. A binary cell response was measured for the number of formed foci – either
cell nuclei contained a high number of foci or no foci at all. This observation contradicts the
theory that there is a one to one correlation between double strand breaks and foci formation.
Apart from the dose the cell response crucially depends on the dose given to neighbouring
cells. A levelling off with time was observed in all conducted experiments with spatially varying
dose. In the gradient and step exposure the number of foci and the gH2AX signal intensity
increased in low and decreased in high dose regions from 3 to 24 hours after exposure. In
microbeam exposures the dose in the valley that lead to an equal level of gH2AX signal was
peak dose dependent. If the peak dose is increased, the same number of foci is reached at a
higher valley dose.
The experimental results support the idea of a small diffusing molecule that conveys a by-
stander signal. In the step exposure at the interface between unirradiated and irradiated cells
we found that the fraction of non-responding cells in the unirradiated part depended on the
distance to the radiation boundary and that this fraction decreased with time. The signal decay
observed would match that of a diffusive signal. However, the data did not suffice for a detailed
quantitative analysis.
Comparing the gH2AX signal differences between adjacent cells and arbitrarily selected cells
receiving the same dose in the valley region of a microbeam field revealed that close neighbours
tend to react alike. A quantitative analysis showed that over 40% of the cells were influenced by
close neighbours. This observation would support a gap junction mediated bystander signalling.
In future experiments one could test this dependence by inhibiting gap junctions, for example
with lindane.
There were remarkable findings in cells exposed to MRT fields. Within the microbeam paths
there are cells with a low (entity 1) and with a high (entity 2) level of gH2AX. The formation of
these two cell entities was observed to be time and dose dependent. Only the response of entity
2 cells depended on the dose. Potentially associated to these two responses is the formation of
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large foci at the beam penumbras observed shortly after radiation exposure. The foci size in the
penumbras exceeded that of the anyway increased foci size in the peak region by 15 to 20% 1
hour after exposure but went back to an unobtrusive level 6 hours after exposure.
Apart from gH2AX we also analysed the Hoechst 33342 staining signal which allowed con-
clusions to be drawn about the cell cycle distribution. In homogeneous irradiations we observed
the well known fact that radiation influences the cell cycle distribution. The fraction of G1 cells
is reduced and that of G2 cells increased. Furthermore some multiploid cells appeared. Panc1
cells are p53 mutants and do not arrest in G1. In a microbeam field we observed that the change
in the cell cycle distribution did mainly affect the valley regions. From 1 hour to 6 hours after
exposure an 28% increase in the G2 fraction of valley region cells was measured, but in peak
region cells the increase was just between 5 and 15%.
Dose is obviously not the only determining factor in MRT. Our results suggest that intercellu-
lar signalling is a crucial factor in tissue survival and especially dose interfaces could be extremely
important for the cell survival. While most research in the field of bystander signalling supported
a negative bystander effect, i.e. a signalling that causes damage, we conclude from our observa-
tions that it is not easy to predict whether bystander effects are protective or detrimental. Most
likely the bystander response is a protective mechanism that is activated in response to hazard,
against which it did actually not evolve. Probably it is one explanation for the tissue sparing
effect of MRT. Further basic research may unravel the importance of intercellular signalling in
MRT. Moreover there is a chance to effectively use the knowledge on bystander effects in cancer
therapy and medicine.
This way MRT presents a fascinating research field which may contribute to radiotherapy
in general by unveiling the influence of cell signalling and refining the still simple dose-damage
relationships as they are in use in clinical practice today. MRT as a treatment modality itself is
promising. However, its use is limited by the dependence on large synchrotrons. The clinical use
in a research facility is difficult, expansive and can therefore only be provided to a very small
number of patients. Hence an important focus in MRT research should be on the development
of compact and powerful x-ray sources.
Inverse Compton compact light sources164 present one alternative to synchrotrons, where
x-rays are created by inverse Compton scattering of photons in a laser field at electrons that
have a few tens of MeV kinetic energy and are produced in small storage rings. An example
is the Munich compact light source (MuCLS)165. However, the photon energy is lower than at
a third generation synchrotron such as the ESRF and also the photon flux is 3 to 4 orders of
magnitude smaller. But this may change in the future.
Another approach is the carbon nanotube field emission x-ray technology. Schreiber and
Chang 166 performed a Monte Carlo study for MRT and came to the conclusion that a maximum
dose rate of 700 Gy/min would be reachable in the centre of a 3 cm diameter target and suggest
the use for small animal MRT experiments. However, the maximal acceleration voltage of the
tube is 160 kV, leading to a mean photon energy of 40 to 50 keV. Therefore both, dose rate and
photon energy are lower than desirable for MRT.
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Appendix A
Supplementary material to chapter 2
Geometrical of beams at the edge of the MSC
At the edge of the MSC the incidence of the primary synchrotron beam is inclined by a small
angle φ. Consequently some of the photons will hit the walls and therefore not contribute to the
microbeam. Some of them might be absorbed or reflected by total external reflection (see chapter
2.4). If one assumes a 100% absorbing material, the change in the photon flow in the microbeams
resulting from the inclined incidence can be determined from the following geometry:
ab
φ
φ
d
w
s
The number of photons in the case of normal incidence (φ = 0) in the microbeam in a certain
time interval is
N0 = Φws, (A.1)
where Φ is the fluence in front of the MSC. From the drawing we read
a = w cosφ (A.2)
b = d sinφ (A.3)
The effective aperture area in the beams eye view can therefore be calculated
A = (w cosφ− d sinφ)s ≈ (w − φd)s. (A.4)
The latter approximation is valid for small incidence angles, which is reasonable with regard to
the small beam divergence. The angle φ can furthermore be calculated as the ratio between the
distance of the slit from the central beam |x| and the distance of the collimator from the wiggler
h,
φ =
|x|
h
. (A.5)
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Thus the effective aperture area is
A = (w − |x|d
h
)s (A.6)
From that the number of photons that pass the collimator aperture in a certain time can be
obtained in
N
N0
=
ΦA
Φws
= 1− d
hw
|x|. (A.7)
This yields a factor of β = 0.041 cm−1 in equation 2.28 in section 2.3.3 for the geometry at the
ESRF. However, the absorption of the collimator material is not 100%. Therefore the effective
coefficient was determined as β = 0.030 cm−1
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Calibration of the CT-device
Position [mm]
Po
si
tio
n 
[m
m
]
100 200 300 400
50
100
150
200
250
300
350
−1000
−500
0
500
1000
HU
A
H
G
F
E
D
C
B
I
E
D
C
B
A
H
G F
A - dense bone
B - adipose
C - lung (exhale)
D - liver
E - trabecular bone
F - breast
G - lung (exhale)
H - muscle
I - water
Figure B.1 – The figure shows on the left a CT image of the CIRS electron density reference phantom, model
62. It was acquired at the AOI in Hünenburg (Switzerland). The right figure is a schematic view of the phantom
(adopted from CIRS Tissue Simulation & Phantom Technology 81). The letters in the cylindrical inlets denote
the imitated materials.
The calibration of the CT conversion is performed by assigning Hounsfield units (HU) to
the base materials, cortical bone, red/yellow marrow, adipose tissue, adrenal gland, small intes-
tine, connective tissue and air. We calibrated the CT with the CIRS electron density reference
phantom, model 62 (figure B.1) and determined the HU such that mass density and RED of the
converted HU match those stated by the manufacturer closest. The result is presented in the two
graphs of figure B.2 for mass density on the left and RED on the right. The blue curve shows
the calibration presented in Schneider et al. 45 . This comparison is made to demonstrate that
calibration is absolutely essential for any dose calculation. Especially for materials with higher
HU the two calibration curves differ substantially.
The differences between the HU in the CT image and the calibration curve values are smaller
than 18 HU with an average of 8.8 HU. For the materials of the electron density reference
phantom the following table compares the measured HU (Exp.), the HU that would be expected
from the calibration (Calibr.) and the difference |DHU|:
Tissue Exp. Calibr. |DHU| Tissue Exp. Calibr. |DHU|
Dense bone 1044 1029 15 Breast -33.2 -25 8.2
Adipose -69.2 -59 10.2 Lung (inhale) -792.5 -791 1.5
Lung (exhale) -489.5 -504 14.5 Muscle 48.2 48 0.2
Liver 56.2 55 1.2 Water -5.0 -13 8
Trabecular bone 286 298 12 Air -998.5 -981 17.5
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Figure B.2 – Density and RED calibration curves are shown. The “+” illustrate data points obtained with the
CIRS electron density reference phantom. The resulting calibration is shown as red lines and compared with the
calibration in Schneider et al. 45
Schneider et al. 45 analysed a more comprehensive set of materials. Table B.1 on the next
page shows the deviations from their calibration curve. Although the calibration is different in
our case, the table gives a good impression on the error for various materials. It also highlights,
that certain materials, such as connective tissue differ vastly from the CT-calibration and others
less. The reason is that the conversion is based on interpolation between base materials. For
some tissues with a very different composition this can be a poor approach. The HU standard
deviation for all the listed materials is 17 HU.
Taking into account the uncertainties from the calibration and the scattering of materials an
uncertainty of 20 HU seems to be a reasonable value. Figure B.3 illustrates the consequences for
the absorption coefficients.
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Figure B.3 – The figure shows the uncertainty for the absorption coefficient of photoelectric absorption and
Compton scattering if an average HU uncertainty of 20 HU is assumed.
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Tissue HU DHU Tissue HU DHU
Lung -750 40 Liver 2 53 -5
Lung, blood-filled -741 -8 Trachea 54 -6
Fat -108 0 Spleen 54 -6
Adipose tissue -98 0 Heart, blood filled 56 -8
Adipose tissue -77 1 Blood, whole 56 -8
Adipose tissue -55 1 Liver 3 63 -6
Yellow marrow -49 7 Skin 1 72 32
Mammary gland -37 6 Skin 2 74 30
Yellow/red marrow (1:1) -22 2 Skin 3 77 27
Mammary gland -1 3 Connective tissue 100 79
Red marrow 11 2 Cartilage 102 27
Brain, cerospinal fluid 13 -22 Spongiosa 262 -49
Adrenal gland 14 -1 Sternum 385 13
Small intestine (wall) 23 -10 Sacrum 454 11
Urine 26 -24 D6, L3 incl. Cartilage (male) 466 16
Gallbladder bile 27 -14 Whole vertebral column (male) 514 18
Lymph 29 -16 D6, L3 excl. Cartilage (male) 526 6
Pancreas 32 -1 Humerus, spherical head 538 -6
Prostate 34 -3 Femur, spherical head 538 -6
Brain, white matter 34 -3 Femur, conical trochanter 586 -4
Testis 36 -5 C4 incl. Cartilage (male) 599 17
Brain, grey matter 40 -9 Sacrum (female) 621 12
Muscle, skeletal 1 40 0 Humerus, whole specimen 636 -3
Stomach 41 -1 Ribs 2nd, 6th (male) 657 9
Heart 1 41 -1 Innominate (male) 658 8
Kidney 1 41 -1 C4 excl. Cartilage (male) 672 11
Muscle 41 -1 Femur total bone) 688 -5
Thyroid 42 -2 Femur (whole specimen) 702 -2
Aorta 43 -3 Innominate (female) 742 8
Heart 3 43 -3 Clavicle, scapula 756 -6
Kidney 2 43 -3 Humerus (total bone) 756 -6
Liver 1 43 -3 Humerus, cylindrical shaft 805 -4
Muscle, skeletal 2 43 -3 Ribs 10th (male) 843 8
Muscle, skeletal 3 44 -4 Cranium 999 4
Heart 3 45 -5 Mandible 1113 7
Mammary gland 3 45 3 Femur, cylindrical shaft 1239 -1
Kidney 3 46 -6 Compact bone 1454 -65
Ovary 46 -6 Cortical bone 1524 -24
Eye, lens 49 8
Table B.1 – This table was taken from the data in Schneider et al. 45 . It states the measured HU and the
differences to the calibration therein.
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A treatment planning example for Betty
The following image B.4 is a screen shot from the therapy planning system virtuos. It shows
CT slices from the first veterinarian patient, cat “Betty”, which suffered from a carcinoma at its
nose. The target volume is at the tip of the nose. The field size is adjusted to 26×30 mm2 in the
collimator window on the right. It is visualised as a yellow square in the top left, sagittal view.
At the bottom left the gantry, couch and collimator angle can be adjusted for the exposure. In
this treatment plan no contouring of target organs or organs at risk was carried out.
Figure B.4 – Screenshot of the TPS VIRTUOS.
The result of the Monte Carlo dose calculation is presented in figure B.5 as peak dose (left)
and valley dose (right) and in figure B.6 as PVDR. In all figures the contours of the CT image
are overlaid (black iso-HU curves). The water bolus is clearly visible which was placed around
the nose in order to protect the tissue from too high peak entrance doses.
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Figure B.5 – Peak dose (left) and valley dose (right) in the MRT treatment plan for the first “patient”, cat Betty.
The voxel size is approximately 0.2×0.2×1.25 mm. Hence there are some voxels in the field
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without microbeam. Furthermore the small voxel size leads to relatively high noise level in the
Monte Carlo simulations. Therefore the data was smoothed with a flattening filter. Nevertheless
the peak dose (right image) shows still some regions with a lower value, which is an artefact
from the small voxel size. Very high dose levels are reached in the bone in both, peak and
valley regions. These levels could potentially be hazardous. A shift to slightly higher photon
energies could significantly reduce the dose level (see chapter 3.6). The PVDR is computed in
the following image.
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Figure B.6 – PVDR in the MRT-treatment plan for Betty
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X-ray tube spectra simulated in Geant4
In order to determine the spectral sensitivity of radiochromic films we irradiated films with an
x-ray tube operated at 100, 150, 200 and 250 keV acceleration voltage. The anode material was
tungsten.
The tube spectrum was simulated in Monte Carlo calculations in Geant4 (version 9.3.p02)
with the PENELOPE physics libraries. The energy cut-off was set at 1.7 keV. A monoenergetic,
electron pencil beam was simulated to impinge onto the centre of a tungsten block under an
angle of 45◦.
A hollow cylinder (inner radius 2 mm, outer radius 10 mm) was defined around the electron
incidence on the tungsten surface and was placed on the block surface. The following figure
shows a sketch of the detector and scoring symmetry.
electron sourcetungsten block
2 mm
45°
γ
scoring volume
All photon energies of photons that crossed the boundaries of the hollow cylinder were scored.
Due to the heel effect the photon energies slightly depend on the emission angle. We did not
take account of this effect. The filtering of the raw tube spectrum Sraw(E) with the build-in 0.1
mm copper plate was computed with the aid of the photon absorption coefficients from Berger
et al. 64 . The final spectrum follows from
S(E) = e−µ0.5mm,Al(E)·0.1mmSraw(E), (C.1)
and is presented for the tube voltages 100, 150, 200 and 250 kV in the following graph:
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Figure C.1 – X-ray tube spectra are shown for 100, 150, 200 and 250 kV acceleration voltage, a tungsten
anode and 0.1 mm aluminium filtering. Apart from the continuous bremsstrahlung spectrum the K lines of the
characteristic spectrum are visible and at the very low energy end of the spectrum the L lines can be seen.
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Cell cycle distribution of cells irradiated with an MRT field
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Figure D.1 – Histograms of cells over their DNA content 1 hour (left) and 6 hours (right) after microbeam
exposure.
The graphs (figure D.1) show histograms of the fluorescence intensity of Hoechst 33342 in the
Dapi channel 1 hour after radiation on the left and 6 hours after radiation on the right for the cell
culture flasks irradiated with an MRT field (experiment 5). The cell phases are clearly distinct
from each other and can be easily assigned (see left figure). Nevertheless there are fluctuations
in the signal intensity. Therefore the delineation of cell phases has to be made manually for each
histogram. Quantitative comparisons between different experiments are therefore difficult.
Determination of foci sizes with autocorrelation
Foci sizes were determined from the fluorescence images in the green channel (GFP-channel).
The foci size was not determined individually for each focus but an average value was attributed
to each cell with autocorrelation. After segmentation of the nuclei the GFP-channel image of
the cell was taken for analysis. First the background was determined by convolution with a
Gauss filter of 10 pixel width. The background was subtracted from the image. From the
background subtracted image of the cell I(x, y) the autocorrelation IAC(x, y) was computed
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using the equation
IAC(x, y) =
∫
x
∫
y
I(x′, y′) · I(x− x′, y − y′) dy′ dx′. (D.1)
The autocorrelation has an unavoidable background level. We define a threshold value as one
half of the maximum autocorrelation intensity above the background level. The background level
was determined as the average < IAC > over x and y. The area of the foci is than the number
of pixels that have an intensity above the threshold intensity in the autocorrelation image.
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Figure D.2 – Steps for the determination of the foci size: A: GFP-channel image of the cell, B: Background
signal, C: Background subtracted image, D: Autocorrelation of the background subtracted image, E: Profile,
threshold value and mean of the autocorrelation.
Distribution of H2AX phosphorylation differences between closest
neighbours ∆ni,j and arbitrarily selected cells ∆i,j at the same dose
In order to assess whether closely neighbouring cells influence each other in the phosphorylation
of the histone H2AX the distribution of gH2AX fluorescence intensity differences ∆i,j = |Ii− Ij |
between 2 cells i, j was analysed at a fixed dose. The two graphs in figure D.3 show for 1 hour
(left) and 6 hours (right) after exposure with an MRT field of 100 Gy peak entrance dose these
histograms. The red graph is the distribution ∆i,j for arbitrarily chosen cells in a dose range
from 1.5 to 1.6 Gy. The blue curve shows this distribution ∆ni,j for close neighbour cell-pairs i, j
at a dose between 1.3 and 1.8 Gy. The second range of doses was taken a bit larger, to increase
the number of pairs in the statistics. The disadvantage is that the distribution may be made a
bit wider. Nonetheless the distribution of neighbour cell pairs is in both cases more concentrated
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Figure D.3 – The two figures show histograms of cell pairs over their gH2AX fluorescence signal difference.
at low intensity differences. This means that cells in close neighbourhood tend to react alike in
terms of H2AX phosphorylation. The effect is more pronounced 6 hours after exposure. From
the ∆i,j distributions it is possible to estimate the fraction of gH2AX bystander cells. This is
illustrated in the right figure. The grey fraction moves from ∆i,j to ∆ni,j towards low intensity
differences. This fraction is 9.2% 1 hour post-exposure and 42.7% 6 hours post-exposure.
Histograms over gH2AX fluorescence intensity and position
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These figures show gH2AX signal intensity histograms, normalised to the maximum in depen-
dence on the position across the microbeam. They were created by averaging over all microbeams
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in the field. The colour code shows red for a high and blue for a low frequency. The top row
shows the cells 1 hour after exposure and the bottom row 6 hours after exposure. The peak
entrance doses of 50, 100 and 250 Gy are shown in the first, second and third column.
Appendix E
List of abbreviations
ATM ataxia-telangectasia mutated
ATR ATM and Rad3-related
BER base excision repair
53BP-1 tumour suppressor p53-binding protein 1
BRCA1, 2 breast cancer 1, 2 (tumour suppressor protein)
BSA bovine serum albuminum
ctc centre to centre distance
CPKA convolution based point kernel algorithm
DMEM eagle’s minimal essential medium
DMSO dimethyl sulfoxide
DNA-PKcs DNA protein kinase catalytic subunit
DSB double strand break
ESRF European Synchrotron Radiation Facility
FWHM full width at half maximum
GFP green fluorescent protein
GPx glutathione peroxidase
GSH glutathione
HPLC high-performance liquid chromatography
HRR homologous recombination repair
HU Hounsfield units
KU-protein protein that binds DNA DSB ends, required in NHEJ
LED Light emitting diode
LET linear energy transfer
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LQM linear quadratic model
MMR mismatch repair
MRT Microbeam Radiation Therapy
MSC multi slit collimator
NADPH nicotinamide adenine dinucleotide phosphate
NER nucleotide excision repair
NHEJ nonhomologous end joining
NSLS National Synchrotron Light Source (in Brookhaven, USA)
OAR organs at risk
OF output factor
PBS phosphate buffered saline
PET positron emission tomography
PFGE pulse-field gel electrophoresis
PVDR peak to valley dose ratio
Rad50,51,54 DNA repair protein 50, 51, 54
RED relative electron density to water
ROS reactive oxygen species
RPA replication protein A
SOD superoxide dismutase
SPKA superposition point kernel algorithm in curved space
SSB single strand break
TGF tumour growth factor
TNF-a tumour necrosis factor-a
TPS Therapy planning system
XRCC1 X-ray repair cross-complementing protein 1
Index
gH2AX, 87, 89–91, 94–96, 100–103, 114–117
abscopal effects, 89
Animal Oncology and Imaging centre (AOI),
59, 141
apoptosis, 87, 115
autocorrelation, 99, 112, 116, 149
autophagy, 87
base material, 59, 141
beam reference frame, 18, 43, 45, 46
Bethe’s equation, 52
blood vessels, 11
Boltzmann transport equation, 47
bremsstrahlung, 22, 40, 43, 53
bystander effects, 89, 92, 93, 106, 113, 119
calculation time, 42, 46, 55, 63
calibration curve
CT conversion, 59, 141
film dosimetry, 69, 71, 72, 73, 76, 81
cell cycle, 15, 86, 88, 89, 93, 94, 96, 103, 105,
112, 117, 119, 149
cell death, 7, 87–88, 89
cell membrane, 87, 91–93, 95
Cell Profiler, 100, 113
cell survival curves, 87–88
centre to centre distance (ctc), 9, 13, 31, 35, 43,
46, 55, 75, 97
cerebral oedema, 11
chromosome aberrations, 87, 88, 90, 105
clastogenic factors, 91, 93
clonogenic assay, 88, 90, 94
cohort effects, 89
collimator scattering, 17, 29, 31
comet assay, 89, 114
Compton scattering, 21–22, 25, 52, 56, 37–56
coordinate transformation, 45
Coulomb scattering, 40
CSDA range, 24, 41
CT, computed tomography, 13, 39, 45, 54, 58,
60, 70, 82, 141
calibration, 142
cut-off ranges, 42, 81
dark image, 68
depth of field, 68, 100
diffraction, 35
dimethyl sulfoxide (DMSO), 93
divergence (beam), 17, 23, 29, 35, 75, 139
geometrical, 29
intrinsic, 31
DNA repair, 86–87, 89, 90, 104, 114–116
dose rate, 8, 9, 13, 14, 24, 28, 65, 70, 71, 81, 97
dose rate effect, 90
ionisation chambers, 67
dose volume effect, 90
double strand break (DSB), 85, 86, 89–91, 104,
114
electron density reference phantom, 59, 141
energy dependence, 40, 73, 81
European Synchrotron Radiation Facility (ESRF),
8–9, 11, 96, 97, 109
Fenton reactions, 92
field of view, 66, 68
fixation (cells), 95, 96, 103–106, 109, 115
foci detection, 94, 100–103
free radical, 85
Gafchromic® films, see radiochromic films
gap junctions, 93, 113, 118
Geant4, 17, 18, 42
grain size, 80–81, 122
grid therapy, 8
Hoechst staining, 94, 95, 105
Hounsfield unit (HU), 14, 39, 43, 54, 55
Conversion, 58–60
human head, anthropomorphic phantom, 60,
61, 70, 75, 80, 82
hydroxyl radical, 85, 92, 93
image processing, 66, 98
immunofluorescent staining, 89, 95, 106
inhomogeneities
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film, 66, 71
material, 57, 64
radiation fields, 106, 113
intensity modulated radiation therapy (MRT),
8
interface, material, 55, 63
inverse-transform method, 44
ionisation chamber, 9, 24, 67, 69, 71, 73, 81, 97
ionisation energy, 52
ischemia, 12
isocentre, 43, 70, 75
Köhler, Alban, 8
Kapur method, 100
Klein-Nishina formula, 21
Kramers-Kronig relation, 35
laboratory frame, 18, 43, 45
leakage (detector), 29, 34, 44, 55, 98
LED light source, 68
Livermore libraries, 22, 42, 72
maturation, 12
mean free path, 11, 40
microbeam radiation therapy (MRT), 8, 9–13
microdensitometer, 66, 67, 75
micronuclei, 90, 94
microscope
film readout, 66, 67–69, 78
microvasculature, 11
mitotic cell death, 87, 88
Monte Carlo simulations, 14, 17, 22, 41–52, 55,
60, 63, 71, 78, 81, 97, 109
semi-adjoint, 33, 46–52
morphology of gH2AX staining, 103
MOSFET flash memory detectors, 65
multislit collimator (MSC), 9, 23, 29, 32, 34–37,
70, 75, 97, 139
O’Connors theorem, 52
output factors, 14, 36, 47, 51, 71–72, 78, 83,
123
oxidative stress, 88, 92–93
Panc 1, human pancreatic carcinoma cells, 95,
106, 109, 117
particle frame, see beam reference frame
PAtient Safety System (PASS), 9
pay-off function, 47
peak to valley dose ratio (PVDR), 10, 29, 34,
36, 42, 73, 98, 109
pencilbeam irradiation, 50
PENELOPE, 17, 18, 23
libraries in Geant4, 81
pericytes, 12
phase difference, 19
phase space, 17, 23, 29, 37, 47, 51
photoelectric absorption, 21, 22, 39, 43, 52, 60
Poincaré sphere, 19
point kernel, 52
algorithm, 52–58, 63
convolution point kernel algorithm (CPKA),
52–55, 56, 60, 61
superposition point kernel algorithm (SPKA),
56, 56–58, 60, 61
polarisation (beam), 14, 18–22, 24–29, 52
influence on output factors, 83
polarisation ellipse, 19
pulse-field gel electrophoresis (PFGE), 88, 115
radiochromic films, 15, 61, 65, 68, 70, 73, 81,
82
radiological distance, 55, 57, 58, 64
rational fit, 69
Rayleigh scattering, 22, 40, 43
recombination
calibration, 24
effect, 67
refractive index, 35
relative electron density (RED), 59, 141
ROS, see oxidative stress
saturation
gH2AX foci, 104, 107, 109, 114
dose rate, 67
secondary electrons, 11, 40, 52
segmentation of cell nuclei, 100, 113
shading correction, 68, 99, 101
silicon strip detectors, 65
stereotactic radiation therapy (SRT/SBRT), 8
Stokes vector, 18–20
stopping power, 52
superoxide dismutase (SOD), 92
systemic response, 89, 94
TERMA, 14, 53
therapy planning system (TPS), 15, 39, 70
total external reflection, 35, 78, 139
vascular endothelial growth factor (VEGF), 11
VIRTUOS, 13, 45, 55, 60, 63, 70, 82
wavelet transformation, 100–103
white image, see shading correction
